Diagnosis and effects of cobalt deficiency in the pregnant ewe by Fisher, George Edward John
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
DIAGNOSIS AND EFFECTS OF COBALT DEFICIENCY 
IN THE PREGNANT EWE.
A thesis submitted for the Degree of Doctor of Philosophy 
in the Faculty of Science of the University of Glasgow.
By
GEORGE EDWARD JOHN FISHER. G.I.Biol. Hons.
Division of Animal and Food Sciences,
Department of Nutrition and Microbiology,
The West of Scotland College (for Agricultural, 
Horticultural and Food Studies),
Auchincruive, Ayr.
September 1988.
" ©  G.E.J, Fisher, 1988."
ProQuest Number: 10647944
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10647944
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
u 7 6 7 9
I Iajij io
SoSZ
I n
GLASGOW 
UNIVERSITY 
LIBRARY
"... in the morning, going down the lane, she heard the 
ewe call and the lambs came running, shaking and 
twinkling with new born bliss. And she saw them, 
stooping, nuzzling, groping to the udder, to find the 
teats, whilst the mother turned her head gravely and 
sniffed her own. And they were sucking, vibrating with 
bliss on their little, long legs, their throats stretched 
up, their new bodies quivering to the stream of blood-
f
warm, loving milk.
D.H. LAWRENCE,
From The Rainbow.
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SUMMARY.
The literature relating to the diagnosis and effects of 
cobalt (Co) deficiency, particularly in the pregnant ewe, 
was reviewed.
Two housed experiments, both with 60 hill ewes, were 
undertaken with the aim of characterising the effects of 
Co deficiency on reproductive performance. The diagnosis 
of sub-clinical Co deficiency was also studied. Three 
treatment groups of 20 ewes each were established in both 
experiments. The NS (non-supplemented) groups of both 
experiments were maintained on a Co-deficient intake for 
the whole of pregnancy. Sheep in the HS (half­
supplemented) group of Experiment 1 received a Co­
sufficient intake until mid-pregnancy after which they 
were maintained on a Co-deficient diet. The HS group of 
Experiment 2 received a Co-deficient intake until mid­
pregnancy, after which it was replenished with Co. The PS 
(fully-supplemented) group of both experiments received a 
Co-sufficient intake for the whole of pregnancy.
Co status of the ewes was monitored by fortnightly 
sampling and analysis for serum vitamin B12 and 
methylmalonic acid (MMA) concentrations. Serum B12 was 
determined by either microbiological assay or radio- 
immuno assay (RIA).
In Experiment 1 the NS and HS ewes were sub-clinically 
Co-deficient before lambing. In Experiment 2 the NS and 
HS sheep were sub-clinically Co-deficient at the start 
of tupping and the clinical disease was detected in the
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NS ewes at the start of lambing. After Co repletion from 
mid-pregnancy, serum B12 and MMA concentrations in the HS 
sheep returned to normal levels and they were Co­
sufficient before lambing. The FS ewes of both 
experiments were Co-sufficient throughout the 
investigations. In Experiment 1 and 2 the differences 
amongst treatments for serum B12 and MMA concentrations 
were significant (P<0.001).
Concentrations of MMA in serum were a more accurate and 
precise marker of sub-clinical and clinical Co 
deficiency, than serum B12 levels. Within treatments, 
serum B12 concentrations were more variable than serum 
MMA levels and could imply false positive diagnoses. In 
contrast, there were no problems from diagnosing false 
negatives with serum MMA concentrations. However, there 
was evidence to suggest that liver damage could lead to 
incidences of very high levels of MMA in serum. 
Concentrations of B12 in serum provided an effective 
indication of Co intake and responded to declining Co 
status before serum MMA levels. Thus, the joint analysis 
of serum B12 and MMA concentrations was necessary for the 
prognostic, as well diagnostic, detection of Co 
deficiency.
The microbiological assay and RIA of serum B12 both 
provided effective diagnostic data. However, for ewes fed 
a diet high in concentrates, mean serum B12 
concentrations determined by the RIA were 20 per cent
XV
lower than those measured by the microbiological assay (r 
= 0.97, P<0.001). The diagnostic criteria applied to RIA 
data therefore required alteration in this situation. For 
the microbiological assay, values between 200 and 400 
ng/1 were regarded as indicative of sub-clinical disease. 
If ewes were fed a high concentrate ration, the range 160 
to 340 ng/1 applied to data from the RIA provided the 
same diagnostic inference.
A small housed experiment with wethers was undertaken 
to determine the presence of diurnal fluctuations in 
serum B12 and MMA concentrations. Endogenously stimulated 
fluctuations, of either marker, were not detected. 
However, serum levels of both B12 and MMA in Co-deficient 
and sufficient sheep showed inconsistent but marked rises 
in response to the exogenous stimulation of twice daily 
feeding. Serum MMA levels also fell just before feed 
intake. The effect on serum B12 could be enhanced by 
delaying feeding for 2 hours. These fluctuations could 
render serum B12 and MMA data useless in the diagnosis of 
Co deficiency. Therefore, it was recommended that blood 
sampling for diagnostic purposes should be undertaken 
outwith the time period of 1 hour before and 2 hours 
after the provision of supplementary feed to sheep.
The sub-clinical Co deficiency imposed on the NS and HS 
ewes at tupping in Experiment 2, did not adversely affect 
mating performance. Neither was there any evidence of an 
effect, in either experiment, on conception rate, the 
number of barren ewes, the number of lambs born or lamb
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birthweights. However, in Experiment 2 there were 
significanlty more stillbirths in the NS group, compared 
to the HS and FS treatments (4 vs 1 vs 0, respectively, 
P<0.05). In both experiments, there was a tendency for 
the NS ewes to have lower lambing rates to 4 weeks post 
partum, relative to the FS controls, and in Experiment 1 
this effect was significant (P<0.05).
In Experiments 1 and 2, a study was made of the effect 
of Co deficiency on immune cell function in the sheep and 
the transfer of passive immunity from ewe to lamb. Sub- 
clinical Co deficiency in the HS and NS ewes resulted in 
a 50 per cent reduction in the killing activity of 
isolated neutrophils, against phagocytosed Candida 
albicans yeast cells, compared to FS controls (P<0.001). 
Co repletion of the HS ewes from mid-term in Experiment 2 
resulted in a rapid return of neutrophil function to 
normal levels.
Lambs from sub-clinically Co-deficient ewes were less 
vigorous and acquired lower levels of passive immunity 
than those from Co-sufficient dams. In Experiment 2 lambs 
from the NS and HS ewes took at least twice as long to 
commence suckling post partum, compared to those from FS 
dams (P<0.001). In both experiments the NS and HS group 
lambs also tended to have lower concentrations of 
immunoglobulin G (P<0.001), B12 (P<0.001) and ZST values 
(P<0.05) in serum, at 2 and 4 weeks post partum, relative 
to FS group controls. Normal concentrations of vitamin
X V I 1
B12 in the serum of pre-weaned lambs appeared to be in 
the range 200 to 400 ng/1.
These observations were related to decreased post-natal 
viability in lambs from NS and HS ewes, compared to those 
from FS dams. In Experiment 1 there were significantly 
more neonatal mortalities in NS group lambs, relative to 
the HS and FS groups (9 vs 1 vs 1, respectively, P<0.05) 
and more lambs in the HS group required treatment for 
ill-health, compared to NS and FS group controls 
(P<0.05). These incidences were associated with low serum 
immunoglobulin G concentrations and ZST values in lambs 
with depressed viability.
The consequences of the results for the diagnosis and 
effects of Co deficiency in pregnant ewes in the field 
situation were discussed. A survey of Co status in 
pregnant sheep on 15 farms in Scotland with a history of 
Co deficiency, was also undertaken. However, the use of 
one sampling during pregnancy was not adequate to 
indicate the Co status of flocks during tupping, 
pregnancy and lactation.
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CHAPTER 1.
LITERATURE REVIEW,
1.1 INTRODUCTION.
The literature relating to the diagnosis and effects of 
cobalt (Co) deficiency in the pregnant ewe will be 
reviewed. To gain a full understanding of the results to 
be presented, particularly those concerned with the 
effects of Co deficiency on immune status, a wider area 
of work will be discussed. This may not relate directly 
to Co deficiency, but is relevant to the original work of 
this project.
The condition in ruminants, especially sheep, which 
arises as a result of a dietary deficiency of the trace 
element Co, must have been recognised as a disease in 
ancient times. An early reference to the occurrence of Co 
deficiency in south west Scotland was made by Hogg (1831) 
in his report on common diseases in sheep. Although the 
'Ettrick Shepherd' had no knowledge of the causative 
agent, he did state that the problem was not contagious, 
but was related to diet.
Hogg (1831) also noted grazing and land types on which 
the disease most frequently occurred. He reported that 
the severity of this 'pining' varied from a marked 
wasting disease, to a mild ill-thrift and that the best 
curative measure was the periodical shifting of sheep to 
different pastures.
Reports of the same or similar conditions appeared over 
the years from many parts of the World. The names applied 
to the syndrome were wide and varied, for example, moor 
sickness, Moiroa dopiness, Morton Mains disease, bush
sickness, Denmark wasting disease, coast disease and 
coastiness. Other names derived from the clinical 
symptoms of the deficiency, such as pine, vinquish, 
daising, enzootic marasmus and neck ail.
A century after Hogg made his observations, Australian 
workers pioneered the investigation of the cause of the 
disease. Initial experiments led to the speculation that 
the problem was a deficiency of iron in the diet (Aston, 
1932). It was found that doses of limonite, a naturally 
occurring hydrated oxide of lime (Fe2 0 3 ), could cure the 
weight loss and anaemia associated with the clinical 
syndrome in sheep. Such treatment was widely used. 
However, that iron was the curative agent was challenged 
by Filmer (1933), who stated that the "...disease is due 
to some mineral which is present in the iron compounds 
found to be successful in prophylaxis and treatment."
The search for this mineral continued apace and 
fractionation studies on limonite (Underwood and Filmer, 
1935) and the dosing of diseased penned sheep with Co 
salts (Lines, 1935 and Marston, 1935), finally
ascertained that the disease was due to a dearth of Co in 
the diet. In field situations, the syndrome was often 
associated with a complicating copper deficiency, but 
Askew (1939) and McDonald (1942) reported cases of 
unequivocal Co deficiency in southern Australia.
In Scotland, early work on defining Co deficiency was 
undertaken by McGowan and Smith (1922); Corner (1939) in
Berwickshire, Roxburghshire and Selkirkshire; Stewart, 
Mitchell and Stewart (1941 and 1942 ) in Ro s s-s hire, 
Inverness-shire and Sutherlandshire; Stewart, Mitchell, 
Stewart and Young (1946) in Kirkcudbrightshire; Dunlop 
(1946a) in Dumfries and Galloway and Ayrshire and by 
Boddie (1947) in the Hebrides. These workers recognised 
the syndrome in both clinical and sub-clinical forms.
1.2 THE DISCOVERY OF VITAMIN B12.
The biological form of Co in animal tissues was not 
apparent until Smith (1948a), simultaneously with workers 
in North America, isolated an anti-pernicious anaemia 
factor from liver. Four tons of material yielded one gram 
of a red substance, which contained two red pigments. The 
compound was named vitamin B12 and the presence of Co in 
its molecular structure was quickly recognised (Smith, 
1948b).
When sufficient supplies of this newly discovered 
vitamin became available, Anderson and Andrews (1952) 
were able to show that injection of small amounts of B12 
were fully effective against Co deficiency disease in 
sheep. However, relatively large amounts were needed to 
show any effect if the vitamin was given orally (Andrews 
and Anderson, 1954 and Kercher and Smith, 1955). It was 
then a short step to postulate and determine that Co was 
active in preventing deficiency, because it was 
incorporated into B12 between ingestion and absorption 
into circulation (Phil1ips on and Mitchell, 1952 and
Kercher and Smith, 1956).
A further link in this story was made when notice was 
taken of the earlier studies of Tosic and Mitchell 
(1948). These workers reported that rumen microorganisms 
in sheep could concentrate Co. Thus, it became clear that 
dietary Co was incorporated into vitamin B12 by the rumen 
microbes (Smith and Loosli, 1957). These organisms 
synthesise B12 which is stored in the liver of the host 
animal (Andrews, Hart and Stephenson, 1958). Ford and 
Hutner (1955) reported that B12 was essential for rumen 
microbial metabolic processes, while Dryden, Hartman, 
Bryant, Robinson and Moore (1962) found that these 
microbes produced different forms of the vitamin, some of 
which were physiologically active and some inactive in 
the host animal.
The processes and inter-relations of the rumen 
microorganisms that produce vitamin B12 are little known, 
but that both cillâtes and bacteria perform this d^ novo 
synthesis, has been established (Bonhomme, Durand, 
Quintana and Halpern, 1982 and Jétera, Clivera and Roth, 
1984). Further, the absorption and transport mechanisms 
for vitamin B12 have also been researched and documented, 
particularly in humans (Smith, 1965 and Ellenbogen, 
1979 ) .
1.3 THE METABOLIC ROLE OF COBALT.
To the limit of present knowledge, Co has no 
physiological role in higher animals, except via 
incorporation into vitamin B12. Different forms of this 
vitamin, the 'cobalamins,' exist (Dryden et ad, 1962 ),
but only two are physiologically active in mammalian 
tissues (Millar and Penrose, 1980). These are 
adenosyIcobalamin and methyIcobalamin. The molecular 
structure of the former is shown in Figure 1. The 
'corrin' ring of this molecule, with four positions A, B, 
C, and D, has a Co atom as its centre. This is the case 
for all the cobalamins (Castle, 1975).
1.3.1 Vitamin B12 and Methylmalonyl CoA Mutase .
The function of adenosylcobalamin in mammalian tissues 
is as a co-factor in the reversible conversion of
methylmalonyl CoA to succinyl CoA. This conversion takes 
place on the pathway of degradation of propionyl CoA, as
shown in Figure 2. In this sequence, propionyl CoA is
carboxylated to D-methylmalonyl CoA in a biotin dependent 
reaction. D-methylmalonyl CoA then undergoes an enzyme 
catalysed racemization; a step which is necessary because 
the B 12 dependent mutas e is specific for the L-
enantiomer. L-methyImalony1 CoA is then converted to 
succinyl CoA by the B12 dependent enzyme methylmalonyl 
CoA mutase, EC 5.4.99.2 (Babior, 1975).
This reaction is of vital importance to the ruminant. 
The volatile fatty acid propionate is produced by the
OH OH
5 CH Adenine
H
^  \ /
H 3 C"
,.-CH3 (R)
H CH.(5)
^ CH3 CH3
C H - O - P
CHjOH
Figure 1. The molecular structure of adenosylcobalamin (vitamin 
B12), showing the A, B, C and D positions of the corrin ring. 
(After Schneider and Stroinski, 1987).
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rumen microbes and is a major energy source to the host 
animal (McDonald, Edwards and Greenhalgh, 1981), which is 
catabolised within the liver cells. Succinyl CoA thus 
produced is an intermediate of the Kreb's tricarboxylic 
acid cycle. Propionate can be used via this pathway 
(linked with the electron transport chain) as a substrate 
for the production of energy. Excess can also be employed 
in the production of glucose, when necessary.
The impairment of propionate catabolism is the primary 
metabolic defect, supervening Co/vitamin B12 deficiency 
in sheep. This was established by Marston, Allen and 
Smith (1961) and was also reported to occur in the rat 
by Smith and Monty (1959). More detailed work at the 
liver cell level, investigating the role of B12 as a co­
factor for this enzyme, was reported in monogastrics by 
Cardinale, Dreyfus, Auld and Abeles (19 69) and in the 
ovine by Peters and Elliot (1984).
1.3.2 Vitamin B12 and Methionine Synthetase.
The function of raethylcobalamin in mammalian tissues is 
as a co-factor to the enzyme homocysteine: N -
methy1tetrahydrofolate methyltransferase, EC 2.1.1.13 
(Schneider and Stroinski, 1987). The reactions in which 
this enzyme system is involved are shown in Figure 3. The 
end point of the pathway is the production of the amino 
acid methionine.
The importance of this reaction to ruminants is not 
entirely clear. The sequence was first studied in sheep
Histidine
histidase
Y NH-
U r o c a n i c  a c i d
u r o c a n a s e
V
4 - I m i d a z o l o n e - 5 - p r o p i o n i c  a c i d
Homocysteine
Methionine
4-I-5P hydrolase
Tetrahydrofolic 
acid
COOH
H— C— NH— CH=NH 
I
ÇH2
CHj— COOH
Formimino-L-glutamic acid
Vitamin B12 
dependent enzyme 
(EC 2.1.1.13)
5-Methyl 
tetrahydrofolate
5-Formimino 
tetrahydrofolate L-Glutamic acid
Figure 3* The role of Vitamin B12 in the homocysteine: N^-
methyltetrahydrofolate methyltransferase (EC 2.1.1.13) reaction, 
in the 'methionine synthetase' pathway. (Adapted from Givens, 
1978). 10
by Gawthorne ( 1968) and has been investigated in more 
detail since (Smith, Osborne-White and Gawthorne, 1974).
1.4 NUTRITIONAL ASPECTS.
Much work has been published regarding the 
physiologically active and inactive forms of vitamin B12, 
synthesised by the rumen microorganisms. The effects of 
Co intake and dietary composition on this production and 
subsequent absorption in the host amimal, have also been 
widely studied. This section will review the literature 
pertaining to these influences.
1.4.1 Synthesis of Vitamin B12 in the Rumen.
In terms of 'true' vitamin B12 supply to an animal, 
the relative proportions and rates of production by rumen 
microbes of the true forms and inactive analogues, are 
important factors. Bigger, Elliot and Rickard (1976) 
stated that the proportionate production of B12 forms in 
sheep was influenced by the dietary characteristics of Co 
content and roughage : concentrate ratio. Further, these 
workers proposed that the levels and proportions 
synthesised influence the absorption of true B12 by the
host animal and hence affect B12 status.
Smith and Marston (1970) reported that the efficiency 
of Co incorporation into B12 was higher when Co was
depleted in the rumen than when it was present in excess.
These workers also stated that the efficiency of Co 
incorporation by rumen microbes was greater when Co
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originated from the diet, than when Co was provided via 
an oral drench.
More specifically, Bigger et (1976) investigated the 
ruminai production rates of three inactive analogues of 
B12 in sheep, in relation to the synthesis of true 
vitamin. These data are shown in Table 1.
Table 1. Rumen microbial production of true vitamin B12
and three inactive analogues,
FORM OF B12 ug/day + S.D. ug/g DDMI + S.D.
Pseudovit. B12 324 ± 63 0.52 ± 0.10
Factor A 1309 ± 112 2.15 ± 0.19
Factor B 757 ± 86 1.24 ± 0.14
True vit. B12 1725 + 101 2.84 ± 0.17
DDMI = Digestible dry matter intake. 
[Adapted from Bigger ^  al. ( 1976)]
In comparison with this, Smith and Marston (1970) 
presented ranges of ruminai production rates from >400 
ug/d in Co sufficient sheep to <100 ug/d in deficient 
animals. Hedrich, Elliot and Lowe (1973) reported total 
B12 production levels in sheep given 0.047 (Co­
deficient), 0.41 and 0.83 mg Co/d in the diet, of 37, 
1006 and 1553 ug/d, respectively.
Sutton and Elliot (1972) also studied various 
nutritional aspects using duodenal and ileal re-entrant 
canulated sheep. These workers concluded that increasing
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the amount of concentrate feed given, relative to 
roughage, from zero to 60 per cent ground corn: 40 per 
cent ground hay, reduced the rate of microbial total B12 
production from 1.6 to 0.9 ug/g DDMI and also decreased 
the amount of true vitamin as a proportion of the total 
synthesised.
In dairy cattle. Walker and Elliot (1972) also reported 
that increasing the concentrate:roughage ratio in the 
diet resulted in a higher proportion of inactive 
B12 analogues being produced by the rumen microflora.
Gawthorne (1970a) studied the influence of Co intake on 
microbial B12 synthesis. His investigations showed that 
true vitamin as a proportion of the whole produced, 
increased from 35 to 65 per cent, as Co in the diet was 
reduced from 0.34 to 0.04 p.p.m. More recently, McDonald 
and Suttle (1986) reported that Co intake per se, as well 
as dietary form, could affect the type of rumen 
fermentation present. In studies with model in. vitro 
rumens, these workers concluded that decreasing Co intake 
lead to reduced growth of acetate producing 
microorganisms and increased growth of propionate 
producing microbes. The overall effect of declining Co 
intake was therefore to depress acetate : propionate ratio 
in rumen fluid, with a consequent propionate type 
fermentation.
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1.4.2 Absorption of Vitamin B12.
Smith and Marston (1970) and Hedrich et ^  (1973) both 
stated that the site of absorption is the small 
intestine. The former showed that over 90 per cent of B12 
was associated with the fibrous phase of rumen digesta, 
due to adherence of vitamin containing bacteria to solid 
material. These microbial cells are lysed in the acid 
conditions of the abomasum, releasing the B12, which is 
largely unharmed as it passes to the lower tract.
The efficiency of absorption is low, with the majority 
of the vitamin lost in the faeces. Efficiency values for 
the absorption of total B12 are quoted at circa 5 per 
cent (Smith and Marston, 1970 ) and circa 3 per cent 
(Gawthorne, 1970a).
By tracing the destination of ^^Co labelled B12 
analogues, Rickard and Elliot (1978) reported that the 
efficiency of absorption of cyanocobalamin and factor B 
in sheep was 8 to 38 per cent and 7 to 22 per cent 
respectively. These authors also noted that these 
efficiencies were "...higher with a diet which would 
result in predicted synthesis of B12 of 113 ug daily, 
than with those with predicted synthesis of over 1000 ug 
daily."
Once absorbed. Smith and Marston (1970) attempted to 
show the fate of B12, by tracing an injection of 30.4 ug 
of [^^Co] cobalamin. They recovered 5.7 per cent from 
faeces, 2.6 from urine and 25.6 in the liver. Of the 
vitamin deposited in the liver, 52 per cent was
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associated with mitochondria. The remainder of the 
vitamin was- distributed throughout the body organs and 
interstitiura.
Whether or not there is preferential absorption of true 
vitamin B12 over inactive analogues, is not entirely 
clear. Sutton and Elliot (1972) reported significant 
levels of inactive analogue forms as part of the total 
vitamin determined in sheep serum. On the contrary, 
Gawthorne (1970a), Marston (1970) and Halpin, Harris, 
Caple and Patterson (1984) found no or negligible amounts 
of inactive analogues in sheep serum, suggesting that 
true B12 is preferentially absorbed in the ovine.
1.5 THE COBALT REQUIREMENTS OF SHEEP.
Many reports in the literature have attempted to define 
the Co requirements of sheep. Such experiments have 
usually taken the form of 'dose/response' trials. Table 
2 reviews some of this data. From this table and the 
assertions of Andrews (1970a), young rapidly growing 
sheep have the greatest requirement for Co, followed by 
lactating ewes and finally mature ovines.
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Table 2, The requirement of sheep for cobalt
ANIMAL REQUIREMENT OBSERVATIONS
Young
lamb
0.20 mg Co/d^ Optimum liveweight performance, 
maintained blood haemoglobin.
Mature
ewe
0.08 rag Co/d^ Optimum liveweight and 
maintained blood haemoblobin.
Mature
ovine
0.07 - 0.08^
mg Co/kg DM
Normal clinical condition; 
serum B12 marginal.
Mature
ovine
0.10 rag Co/d^ Optimum liveweight and 
serum B12.
Mature
Ovine
0.11 - 0.13^ 
mg Co/Kg DM
Normal liveweight gain, serum 
and liver B12.
Ovine 0 .11® 
mg Co/Kg DM
Optimum liveweight gain and 
serum B12.
Lactating 0.15^ 
ewe mg Co/d
Normal milk yield and neonatal 
lamb growth rate.
REFERENCES:
a - Lee and Marston (1969) 
b - Somers and Gawthorne (19 69) 
c - Gawthorne (1970) 
d - Marston (1970) 
e - MacPherson (1982) 
f - Quirk and Norton (1987)
1.6 MANIFESTATIONS OF COBALT DEFICIENCY.
The effects of Co deficiency in ruminant livestock can 
be split into two broad areas, namely clinical and sub- 
clinical. The consequences of clinical Co deficiency are 
produced by prolonged periods of severe Co deprivation 
and are manifested by animal ill-health. Sub-clinical Co 
deficiency can occur during a development into clinical 
disease, before animal health is affected, or as a result
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of prolonged periods on a marginal Co intake (Latteur, 
1962).
The greatest loss, in terms of animal production, 
occurs through the sub-clinical syndrome (Andrews, 1965). 
Farmers may not realise that a sub-clinical Co deficiency 
problem exists, but livestock fail to attain maximal 
productive performance. With clinical deficiency, acute 
animal suffering is evident and investigation of its 
cause usually leads to its diagnosis.
It is important to note however, that these two degrees 
of Co deficiency are not static forms. In a Co-deficient 
area the situation is usually in a state of flux, with 
animals experiencing sub-clinical developing to clinical 
disease; or recovering from clinical symptoms to sub- 
clinical deficiency, or further to a sufficient state.
These changing circumstances will be affected by soil 
and herbage factors, along with climatic and seasonal 
influences. For example, it has long been established 
that severe Co deficiency is most prevalent in the grass 
growing season (Hogg, 1831) and some remission is 
afforded in the autumn and winter, when sward length is 
low and increased soil ingestion provides an improvement 
in Co status (MacPherson, 1982). Further, clinical 
deficiency can be more apparent in the field situation, 
where poor nutrition, inclement weather and parasitic 
attack may contribute as additional stressors. In such 
circumstances, a clinical deficiency may be precipitated 
more rapidly and with greater effect on animal health,
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than if the syndrome develops in a controlled housed 
situation (MacPherson, 1981).
1.6.1 Clinical Cobalt Deficiency.
The detrimental effects of Co deficiency arise from a 
dearth of Co/vitamin B12 for metabolic functions. As 
such, the development and existence of clinical disease 
is not only characterised by outward symptoms, but also 
by changes in the concentrations of metabolites in 
tissues. Thus, as the primary role of Co/B12 is in the 
catabolism of a major ruminant energy source, propionate, 
deficiency results in a lack of energy supply to the 
animal. This was shown by Marston, Allen and Smith 
(1972), who demonstrated a clear inability of Co­
deficient sheep to remove propionate from circulation. 
The liver catabolism and gain of energy from this 
volatile fatty acid, is therefore reduced. These 
observations were confirmed more recently by Peters, 
Bergman and Elliot (1983a and 1983b).
Prolonged high levels of propionate in blood lead to a 
reduction in voluntary feed intake, mediated by the 
nervous mechanisms which contol appetite and respond to 
concentrations of metabolites in circulation (McDonald, 
Edwards and Greenhalgh, 1981). Therefore, the main 
symptoms of clinical Co deficiency arise from a dearth in 
energy supply and inappetence and are mainly 
indistinguishable from those of starvation. Thus, animals
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appear lethargic and emaciated, with the musculature 
wasted (marasmus). The mucous membranes and skin are pale 
and fragile, from a progressive normochromic, normocytic 
anaemia (Smith and Loosli, 1957), with depressed packed 
cell volume (PCV) and red cell counts (Gawthorne, Somers 
and Woodliff, 1966). In addition, animals may be 
photosensitive, with profuse lacrymation.
These visual symptoms are accompanied by internal 
tissue and metabolite changes. The time taken to develop 
clinical disease will depend on Co history, individual 
animal variation and the degree of deficiency in the 
diet. However, MacPherson, Moon and Voss (197 6) reported 
a loss of appetite in housed sheep after 11 weeks of Co 
deficient intake. Plasma glucose levels fell after 34 
weeks implying an impaired propionate metabolism, with a 
fall in whole blood haemoglobin concentrations due to 
progressive anaemia, after 44 weeks. In serum, ascorbic 
acid levels were depressed and glutamic-oxalacetic 
transaminase (GOT) concentrations elevated, indicating 
liver damage (MacPherson and Moon, 1974). Low serum 
pyruvate kinase and blood pyruvate levels were also 
evident, implying an induced thiamine deficiency.
These studies demonstrate that clinical Co/B12 
deficiency leads to a series of complex biochemical 
changes, where primary and secondary causes and effects 
are difficult to characterise. For example, that 
cerebrocortical necrosis (CCN) is a consequence of 
thiamine deficiency is well documented (Edwin and Lewis,
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1971). However, Hartley, Kater and Andrews (1962), 
MacPherson et ad ( 197 6) and MacPherson, Moon and Voss. 
(1977) described the occurrence of CCN in severely Co 
deficient sheep. Although the numbers found suffering 
were not large, it was positively demonstrated that Co 
supplementation prevented the appearance of CCN in 
situations where prolonged and severe disease existed. 
Such findings have been refuted (Edwin, 1977), but the 
complex aetiology of clinical symptoms is thus 
demonstrated.
Further effects of clinical Co deficiency on the 
central nervous system (CNS) have been documented. 
Carton, Duncan and Fell (1981) reported atrophy and 
degeneration of neurones in the cerebral cortex and brain 
stem of clinically Co-deficient ewes. Lambs from these 
sheep showed reduced numbers and broadening of the 
cerebral gyri. These workers have also reported the 
occurrence of astrocytosis in the brain and spinal cord, 
with severe status spongiosus along the junction of the 
grey and white matters in clinically Co-deficient animals 
(Fell, Hesketh, Lough, Duncan and Mackie, 1985). Both of 
these papers concluded that such CNS changes were 
probably secondary to the clinical effects of Co 
deficiency on the liver and could, therefore, be 
described as resulting from hepatocerebral disease.
It may be surmised from these discussions that the 
symptoms of clinical Co deficiency occur mainly as a
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result of liver dysfunction. This observation is further 
enhanced by reports of white liver disease (WLD) in 
ovines suffering from the clinical condition. At post 
mortem the liver may appear pale, swollen and fatty. This 
may be a consequence of propionate and methylmalonyl CoA 
being used as precursors for the synthesis of 
triglycerides. Duncan, Morrison and Carton (1981) 
reported elevated levels of odd numbered and branched 
chain fatty acids in the livers of Co-deficient lambs. 
The former indicate the employment of propionate as a 
precursor for fatty acid anabolism; the latter implies 
that excess methylmalonic acid (MMA) replaces malonate as 
a chain extension unit during fatty acid production in 
the liver. These observations may be linked with the 
occurrence of ovine WLD, reported in New Zealand (Clark, 
Cornforth, Jones, McKnight and Oliver, 1978 and 
Sutherland, Cordes and Carthew, 1979), Northern Ireland 
(McLoughlin, Rice and Taylor, 1984) and Norway (Ulvund 
and Overas, 1980) .
Other symptoms of clinical Co deficiency in the ovine, 
such as hyperplasia of the bone marrow (Ibbotson, Shirley 
and Gurney, 1970) have not received much attention in the 
literature. However, the seriousness of the condition is 
well illustrated by the evidence which has been presented 
above.
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1.6.2 Sub-Clinical Cobalt Deficiency.
As no outward symptoms are evident in marginal, or sub- 
clinical Co defciency, this form of the disease is harder 
to characterise than the clinical syndrome. However, 
dose/response trials have demonstrated that ruminants of 
marginal Co/B12 status, show sub-optimal production. 
This was recognised by Dunlop (1946b), who reported that 
non-supplemented sheep in "...sub-minimal Co-deficient 
areas" had depressed fertility and reduced lamb 
liveweight gain, compared to Co-supplemented controls.
Many other such reports can be cited. For example, a 
detailed investigation by Andrews (1965) on the thrift of 
young sheep on marginally Co-deficient pasture at 
Wallaceville, Wellington, New Zealand, demonstrated the 
fluctuating state of deficient animals. In some years no 
response by growing lambs to Co supplementation could be 
reported and sufficiency was presumed. However, in other 
seasons, Co dosed animals showed lower death rates from 
parasitic infection and greater (though not statistically 
significantly different) liveweight gains, than undosed 
controls.
1.7 THE EFFECTS OF COBALT DEFICIENCY ON PREGNANCY AND
LACTATION.
1.7.1 Present Knowledge.
The possibility that Co deficiency might have a 
detrimental effect on ewe and lamb performance, received 
early recognition by Dunlop (1946b). Working throughout
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Scotland, he reported that on one farm, the 
administration of 100 mg Co /head per o s on three 
occassions (before tupping, before lambing and at the 
summer dipping) resulted in a reduction in the number of 
barren ewes and an increase in lambing percentage, 
compared to untreated controls (Table 3).
Table 3. The effect of 100 mg/head oral doses of Co 
before tupping, before lambing and at summer dipping on 
ewe mean reproductive performance, over four years on a 
Scottish hill grazing.
TREATMENT % BARREN EWES % EWES WITH LAMBS AT
(± SED) 8 WEEKS (± SED)
-Co 7.1 ± 1.5 76.3 ± 2.6
+Co 4 . 3 + 0 . 5  89.4 ± 2.4
(Adapted from Dunlop, 1946b).
In another experiment the administration of 100 mg 
Co/head per os 14 days before tupping, had a similar 
effect of improving reproductive performance. An 
additional observation in this trial was that treated 
ewes lambed earlier than untreated controls.
This pioneering work provided circumstantial evidence 
for an effect of Co deficiency on the presence of 
oestrus, blastocyst implantation and foetal development. 
The appearance of late lambs from ewes not dosed with Co, 
could be explained by deficiency affecting the timing of 
the first fertile seasonal oestrus. A delay in this first
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oestrus in Co-deficient sheep would result in the 
observed late lambing. The increase in the number of 
barren ewes in deficient compared to Co dosed sheep could 
be explained by anoestrus behaviour, or by failure of 
blastocyst implantation, with subsequent in. utero 
reabsorption. Further, the reduced lambing percentage 
might provide circumstantial evidence for decreased 
ovulation rates, increased numbers of abortions or 
depressed neonatal lamb viability in deficient ewes, 
compared to sufficient controls.
There is a lack of evidence in the literature which 
would explain Dunlop's findings in detail and whether or 
not these effects might be widespread in practice. 
However, some work can be cited which might provide clues 
to the explanations required.
For example, Mgongo, Gombe and Ogaa (1985) found that 
goats in the early stages of clinical Co deficiency, 
showed irregular oestrus (22.6 + 0.8 vs. 18.0+ 0 . 3  days 
between cycles) and lower cyclic progesterone and 
luetinising hormone concentrations in blood, than Co­
sufficient controls. In a later experiment, these same 
workers found evidence of a greater number of anovulatory 
cycles in Co-deficient compared to sufficient East 
African short-horned goats (Mgongo, Ogaa and Gombe, 
1986). They concluded that the site of action in this 
disruption of hormonally contolled oestrus, was the 
hypothalamus-pituitary axis.
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The Aberdeen w o r k e r s  D u n c a n  et a d  ( 1 9 8 1 ) ,  attempted to 
characterise the effect o f  Co d e f i c i e n c y  on e w e  
reproduction and lamb viability and relate observations 
to serum concentrations of vitamin B12 and urinary MMA 
levels. In a housed trial, a Co-deficient ration was fed 
to two groups of Scottish Blackface sheep. Group A, 
comprising 9 animals, were introduced to the deficient 
diet at tupping and two ewes received a Co supplement in 
the drinking water. The 8 sheep of group B fed on the Co­
deficient ration from 16  w e e k s  before mating and three of 
these animals were provided with the Co supplement.
Due to the small numbers of sheep used, differences 
between Co treated and control ewes were not 
statistically significant. However, these workers 
reported increased numbers of perinatal mortalities and 
stillbirths in lambs from deficient dams, compared to 
sufficient controls. These findings could be related to 
serum B12 and urinary MMA status, which indicated varying 
degrees of Co deficiency from mid-pregnancy to 
parturition. Three of the group B ewes and one from group 
A were clinically deficient by lambing time, as judged by 
serum B12 concentrations, although urinary MMA levels 
were more varied and difficult to relate to reproductive 
performance.
In a similar experiment, Garton et ^  (1981) reported 
comparable results and concluded that "...perinatal 
mortality and morbidity can be high amongst lambs born to 
Co-deficient ewes when they have received an inadequate
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intake of Co for some time before, and during pregnancy. 
It may be more than coincidental that enhanced production 
of MMA.., is apparently associated with failure of the 
ewes to produce viable lambs."
The Australian investigators Quirk and Norton (1987), 
reported that clinically Co-deficient ewes produced fewer 
lambs, with depressed birthweights and post natal 
liveweight gains, compared to sufficient controls. 
Clinically deficient ewes also yielded less milk than 
sufficient counterparts. This work was published after 
the completion of the studies to be reported in this 
project. Therefore, the results of Quirk and Norton 
(1987) will be discussed later in Chapter 5.
The detrimental effects of Co deficiency on milk yields 
and milk B12 content, have been studied by other 
investigators. Peters and Elliot (1983) could not find 
evidence of an influence of Co deficiency on milk yield. 
However, in a trial where ewes were rendered clinically 
Co-defclient, voluntary feed intake, liveweight change 
and daily milk protein production were lower in a group 
of deficient dams than in sufficient controls. In 
addition, O'Halloran and Skerman (1961) also reported a 
depression in colostrum and milk protein content in Co­
deficient ewes, as well as low lipid levels.
O'Halloran and Skerman (1961) also reported evidence of 
decreased B12 concentrations in milk from Co-deficient 
ewes, while lambs from these animals had low liver B12
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levels, compared to sufficient controls. Further, lambs 
born to deficient sheep were lighter at birth and had 
slower initial liveweight gains, than those from 
sufficient dams, although these effects were not 
statistically significant.
While studying the use of intra-ruminal cobalt oxide 
pellets as a cure for Co deficiency. Hart and Andrews 
(1959) found that providing ewes on marginally Co­
deficient pasture with this form of supplementation, 
raised their milk B12 levels at 3 months post partum 
above those in non-supplemented controls (10.3 vs. 2.5 ug 
B12/1 milk, respectively). Although these workers did not 
relate their results to lamb liveweight gain, this 
evidence suggests that a response to Co supplementation 
in terms of milk B12 content, can be achieved in a sub- 
clinical as well as in a clinical disease situation.
1.7.2 Future Research.
Mills (1981) identified the area of Co deficiency and 
reproductive performance as one which warranted further 
and close investigation. The study of Quirk and Norton 
(1987) contributed greatly to this requirement, but 
questions still remain. For example, the exact mechanisms 
of cause and effect between Co/B12 deficiency and reduced 
ewe fertility and lamb viability, are still largely 
unknown.
The influence of sub-clinical disease is unclear. Most 
of the evidence in the literature is
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derived from experiments where animals were rendered 
clinically Co-deficient. However, Dunlop (1946b) 
recognised that ewe fertility was depressed by the sub- 
clinical, as well as the clinical syndrome. Thus, the 
influences of s ub - cl in ic al  Co d e f i c i e n c y  on ewe 
reproductive performance await clarification.
In the clinical situation, it is difficult to 
differentiate between the direct effects of B12 
deficiency and those mediated indirectly, via an induced 
reduction in energy supply to the reproducing ewe. In 
marginal deficiency cases, energy supply to the ewe and 
lamb can be presumed to be normal, as voluntary feed 
intake is unaffected and clinical symptoms do not exist. 
Under these circumstances, direct effects of Co/B12 
deficiency may be assumed and at present, such influences 
need investigation and explanation.
1.8 IMMUNOLOGICAL ASPECTS OF COBALT DEFICIENCY IN
RUMINANTS.
In reviewing the literature concerned with Co 
deficiency in ruminant livestock, Andrews {1970b) stated 
that, "...we know little of what effects deficient states 
may have on immunity to common pathogens." Eighteen years 
on, characterisation of the effects of Co or vitamin B12 
deficiency on immune response and the resistance to 
pathogenic attack is not much further forward. This not 
only applies to the ruminant species, but to all other 
domesticated animals and man.
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This section will review evidence in the literature 
which does indicate a role for Co in host animal immune 
response to infection. Three areas will be discussed: a) 
The interaction of Co deficiency and immune status with 
respect to gastrointestinal parasitic worm infection, b) 
The effect of Co deficiency on immunocompetent cell 
function and c) The possible influence of Co deficiency 
on the transfer of passively acquired immunity from the 
ewe to the neonate lamb.
1.8.1 Immunity to Parasitic Worm Infestation.
That Co or vitamin B12 might be essential factors in 
the efficient immune response to pathogenic attack, was 
first implied by observations on interactions between the 
deficient state and gastrointestinal parasitic worm 
burdens. Investigative trials have taken the form of 
employing animals either sufficient or deficient in the 
trace element and free from worm burdens or given a 
m e a s u r e d  p a r a si ti c infestation. The influ en ce  of 
anthelmintics on top of a combination of these 
treatments, has also been studied.
A degree of confusion has arisen, where the evidence 
from some trials has suggested that supplementation of 
deficient animals with Co enhances worm infestation, 
compared to unsupplemented controls {Threlkeld, Price and 
Linkous, 1956, Downey, 1965, Nicol, Smith, Dimmock, 
Green, Murphy and Barry, 1983). Other experiments have
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concluded the opposite and indicate that Co-deficient 
ruminants are more susceptible to parasitism, compared to 
sufficient counterparts (Downey, 1966, Andrews, Hogan, 
Stephenson, White and Elliot, 1970 and MacPherson, Gray, 
Mitchell and Taylor, 1987).
The results of these conflicting reports, suggest that 
the worms themselves may require Co or vitamin B12 to be 
maximally infective. The number of worm eggs from 
established adults appearing in the host faeces and the 
number of adult worms present in the gut at post mortem 
examination are generally used as indicators of the 
degree of parasitic infestation and the level of immune 
resistance in the host animal.
In reviewing the literature which supports the 
contention that dosing deficient animals with Co actually 
enhances the establishment of parasitic worms, it is 
important to note the degree of deficiency imposed and 
the size of the worm burden given. Threlkeld et ad (1956) 
took lambs weaned at one week of age and fed a Co­
deficient ration, which eventually produced clinical 
symptoms. A large worm burden of 70,000 infective larvae, 
being a mixture of thg three abomasal parasites 
Haemonchus contortus, Ostertaaia circumcincta and 
Trichostrongylus axei, was administered in a single oral 
dose. Although at necropsy all treatments showed similar 
numbers of established worms in the abomasal mucosa, 
lambs recieving Co supplementation and given a worm 
infestation showed higher rates of mortality due to
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helminthosis than those clinically deficient in Co and 
also infected. Dosing with Co had a significant positive 
effect on liveweight gain compared to deficient controls, 
but seemed to encourage a more vigorous establishment.
In contrast, Andrews ejb ad ( 1970 ) investigated the 
effects of Co and anthelmintic (thiabendazole) therapy, 
on parasitic worm burdens in marginally Co-deficient 
grazing sheep. In animals where no anthelmintic was 
given, Co supplementation significantly reduced faecal 
worm egg counts compared to deficient controls (Table 5).
Table 5. Mean faecal worm egg counts (No:/g) in Co
deficient and sufficient sheep.
September December
-Co 290 1230
4-CO 70 100
Sign. P<0.05 P<0.01
(After Andrews et al, 1970)
The work of Downey (1966) supports these results. This 
investigator studied lambs given a mild to moderate 
infestation of Oj^  circumcincta, on top of a long standing 
T . axei burden. The lambs were maintained in a sub- 
clinically Co-deficient state and were infected with 
15,000 larvae, followed by 17,000 more 24 hours later. 
After 69 days, a further 32,000 Ou_ circumcincta larvae 
were administered to these animals.
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For infested lambs, those dosed with Co had lower mean 
faecal circumcincta worm egg counts (4920 vs. 9400); 
lower mean worm numbers recovered from the abomasum at 
necropsy (3906 vs. 6150) and higher mean whole blood 
haemoglobin levels 56 days post-infection (8.6 vs. 7.2 
g/lOOml), compared to controls left in the deficient 
state. Although none of these results were statistically 
significant due to the small numbers of animals used, an 
enhancement in immune response against the parasite was 
inferred.
Similar evidence was reported by Ferguson, Mitchell and 
MacPherson (1988) with lambs. From 6 weeks of age, housed 
animals were given 2,000 infective Lg larvae of 0. 
circumcincta per week, split into 3 doses. This was 
repeated for 16 weeks. Co-deficient lambs showed higher 
mean worm egg counts and greater plasma pepsinogen levels 
(1500 to 2000 u units/1 at 37 °C), compared to 
sufficient controls (1000 u units/1 at 37 °C).
Pepsinogen leaks into plasma as a result of structural 
damage to the cells of the abomasal mucosa, caused by the 
parasites and is thus a measure of worm establishment. In 
this trial the mortality rate in the infected and Co­
deficient group was much higher than in the Co 
supplemented and infected treatment, and significantly 
more worms were recovered at necropsy in the former 
animals.
In order to provide an explanation for these 
discrepancies in the literature, it must be presumed that
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Co and/or vitamin B12 are essential to the developing 
parasites in the abomasum, as well as to the host. 
Threlkeld et a_l (1956) concluded that "...the ability of 
Hjl contortus larvae to establish themselves within the 
host animal appears to be dependent upon the presence of 
Co in the diet of the host animal." Further, Richard 
Schumard, Pope, Phillips, Herrick and Bohstedt (1954), 
speculated that abomasal worms require Co for the 
efficient production of eggs.
Assuming that worms do use rumen microbially produced 
vitamin B12, Downey (1966) postulated that in situations 
where Co intake is very low and liable to precipitate a 
clinical deficiency in the host, along with the 
imposition of a large helminth burden, the parasites do 
not receive their Co/B12 requirement and perform a sub- 
optimal parasitic function. Thus, in trials where such a 
situation exists, dosing the host with Co effectively 
treats the worms for a Co deficiency and they are able to 
be normally infective. Hence, in such cases Co therapy 
seems to result in a more highly infective parasitic 
attack. This could account for the high mortality rates 
in Co treated and infected lambs, for.example in the 
studies of Downey (1965).
In contrast to this situation, where host Co intake is 
marginal and the deficiency sub-clinical and the imposed 
worm burden is mild to moderate, then the Co / B 12 
requirement of the parasites is met. Dosing with Co to
33
the host does not therefore enhance worm establishment. 
In this situation, the detrimental effect of Co 
deficiency on immune response to the parasite is evident 
and Co supplementation appears to offer some protection 
against an overtly vigorous establishment.
If this is indeed the case, it could be presumed that 
wherever a Co deficiency existed, immune dysfunction 
against the parasite would occur. Whether or not Co 
supplementation resulted in a more effective 
establishment in the host would then depend on the size 
of the worm burden imposed and the level of Co deficiency 
evident. Downey (1966) further pointed out that different 
worm species could have varying Co/Bl2 requirements and 
this would add to the complexity of the situation.
1.8.2 Immunocompetent Cell Function.
The immune system in higher animals is immensely 
complex and involves the independent and interdependent 
functions of mucosal barriers, cellular and humoral 
factors. The specific effects of Co deficiency on immune 
function could be in any or all of these areas. The 
delineation of cause and effect thus delves into the 
fields of immunology and cellular biology, not just that 
of trace element nutrition. However, there is some 
evidence in the literature which suggests possible 
mechanisms for a detrimental effect of Co and other trace 
element deficiencies on immunocompetent cell function.
Neutrophils are roaming polymorphonuclear (PMN) immune
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cells, which phagocytose and destroy foreign cells and 
particles. Phagocytosis is dependent on cell receptor 
recognition of a pathogen (antigen) and this can be 
mediated and enhanced by humoral factors such as 
antibodies (immunoglobulins - Ig) and complement, via the 
processes of opsonisation and agglutination. The 
'killing' or cellular digestion of engulfed cells and 
particles is dependent on many enzymic mechanisms within 
the neutrophil, which collectively serve as powerful 
intracellular reducing agents for antigen lysis and 
destruction.
Boyne and Arthur (1979) demonstrated that selenium (Se) 
deficiency in Friesian steers did not affect the ability 
of isolated neutrophils to phagocytose Candida albicans, 
but the ability of the cells to kill the yeast was 
significantly reduced in Se-deficient animals, compared 
to sufficient controls (P<0.001). These workers also 
found impaired nitroblue tétrazolium (NBT) reduction, 
depressed peroxidase activity and no glutathione 
peroxidase (GSH+Px) in neutrophils from deficient steers. 
Peroxidase is involved with hydrogen peroxide production 
in the cell. Hydrogen peroxide can act through 
myeloperoxidases to help destroy ingested particles in 
the neutrophil. Hence, the decrease in neutrophil 
peroxidase activity would contribute to the fall in 
candidacidal activity.
F u r t h e r ,  t h e  a n t i o x i d a n t  G S H + P x  i s  i m p o r t a n t  i n
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protecting the enzymes of the hexose monophosphate shunt 
(HMPS) pathway in neutrophils. This pathway produces 
nicotinamide adenosine dinucleotide phosphate (NADPH),. 
which is used in the production of the reducing and 
killing agent, superoxide (Og"). Thus, a lack of GSH+Px 
in neutrophils from Se-deficient steers would result in a 
depressed superoxide output, accounting for the impaired 
ability to reduce NBT and impaired microbicidal activity.
Similar effects on neutrophil and leucocyte activity 
have been reported for deficiencies of copper(Cu). Boyne 
and Arthur (1981) demonstrated that neutrophils isolated 
from Cu-deficient steers showed only a 10 per cent kill 
of Ç_î_ albicans after 28 weeks on a low Cu diet, compared 
to 40 per cent for Cu-sufficient controls. Jones and 
Suttle (1981) reported that while Cu deficiencies in 
ewes, lambs and cattle did not impair blood leucocyte 
viability or phagocytic activity against albicans, a 
depression in killing capacity was evident. In ewes, 
there was a direct relationship (r = 0.75, P<0.001)
between plasma Cu levels over the range 1 to 17 umol/1 
and per cent kill of yeast cells over the range 7 to 21 
per cent.
The effects of Co deficiency on immunocompetent cell 
function are less clear. In humans, there is much 
evidence that vitamin B12 is essential for nucleic acid 
synthesis. Deficiency (pernicious anaemia) can result in 
reduced dividing of cells which normally show great 
mitotic or meiotic activity. An example is in the
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haematopoietic tissue of the bone marrow, where 
immunocompetent lymphocytes and leucocytes are produced 
(Stinnett, 1983), Such changes due to vitamin B12 
deficiency have been shown to affect cell mediated and 
humoral immunity adversely in rats and mice (Gershwin, 
Beach and Hurley, 1985). However, Stinnett (1983) stated 
that in humans, these changes only produce moderate and 
probably insignificant effects on the immune system.
Kaplan and Bas ford ( 1976 ) found that leucocytes 
isolated from pernicious anaemic patients had a reduced 
killing capacity for engulphed Staphylococcus aureus 
cells, compared to those from healthy humans. However, 
Stinnett (1983) speculated that due to the 'overkill' of 
PMN activity, only a depression in per cent kill of more 
than one-half the log of normal levels would lead to a 
drop in actual resistance to usual pathogenic attack.
The differences between treated and control groups in 
the study of Kaplan and Basford (1976) were certainly not 
of this magnitude. It is interesting to note however, 
that the reduced per cent kill of leucocytes from these 
pernicious anaemic patients was associated with a reduced 
ability to initiate the HMPS pathway in these cells. 
Activated leucocytes from B12 deficient patients had a 
mean HMPS turnover that was 36 per cent of that evident 
in cells isolated from normal humans (P<0.005). This 
pathway produces NADPH, which is oxidised by a 
flavoprotein oxidase to produce the killing agents
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superoxide (O2 ") and hydrogen peroxide (H2 O2 ).
Returning to ruminants, Ibbotson et ad (1970) reported 
hypoplasia of haematopoietic bone marrow tissue of Co­
deficient ewes, with resultant reductions in white cell 
counts. These findings would appear to be similar to 
those already discussed in pernicious anaemic humans 
(Stinnett, 1983). However, this evidence came from a 
group of only three low Co intake sheep and only occurred 
in severe clinical deficiency.
The Russian worker Nuriev (1986) reported improvements 
in circulating levels of immunoglobulins M and G, 
leucocytes, properdin and lysozymes, by supplementing 
sheep with Cu, Se and Co. Fellow Russians Koval and 
Medvetskii (1986) reported shown increased white cell 
bacteriacidal activity, lysozyme levels and non-specific 
immune reactivity in calves dosed with Co, Cu, iodine 
and vitamins A and E. However, these latter two workers 
did not address the question of which combination of 
supplements resulted in such apparently beneficial 
effects.
In Scotland MacPherson et, aj^  ( 1987 ), working with 
cattle, reported a depression in neutrophil function due 
solely to a deficiency in Co. Per cent kill of C . 
albicans by neutrophils isolated from deficient steers 
was half that of cells from sufficient animals (P<0.001). 
These results were repeated in similar animals by 
Paterson and MacPherson (1987), where Co repletion 
rapidly restored neutrophil candidacidal activity to
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normal levels. However, these two investigations made no 
suggestions as to the mechanisms of such an effect.
1.8.3 The Transfer of Passively Acquired Immunity.
The transfer of immunity from ewe to lamb in the first 
day of life is of great importance to the survival of the 
neonate. Ungulates do not secrete immunoglobulin (Ig) 
across the placenta and are born agammaglobulinaemic. 
During the first 12 to 24 hr. post partum, the neonate 
lamb is able to non-selectively absorb a variety of 
macromolecules from ingested colostrum (Halliday, 1965), 
including beta lactobulin and all the Ig's (antibodies).
The Ig's absorbed in this way are specific for 
pathogens encountered by the dam in the enviroment in 
which gestation took place. Therefore, the lamb obtains 
passive immune resistance to the infective agents it is 
most likely to encounter in the early stages of life. 
This is designed to give the lamb protection until its 
own immune system develops sufficient iramunocompetence at 
approximately 4 to 6 weeks of age onward.
Absorption of Ig's across the intestinal mucosa and 
into circulation in the newborn ovine, is by pinocytosis 
and intracellular transport of the proteins by 
pinocytotic vesicles to large supranuclear vacuoles. The 
contents of these vacuoles are discharged into the 
extracellular fluid at the basolateral membranes of gut 
epithelial cells (Mayrhofer, 1984). This is the 'leaky
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gut" syndrome.
Campbell (1974) reported that 80 per cent of lambs 
given colostrum and an infection of Escherichera coli in 
a housed situation, survived the first week of life. Of 
those given no colostrum, only 50 per cent survived and 
in a group given no colostrum and a pathogenic challenge 
of Ej,, coli. 80 per cent died within a week of birth.
A measure of Ig levels in lamb serum can be obtained by 
using the zinc sulphate turbidity test (ZST). It is 
generally considered that an adequate level for serum ZST 
in lambs is >14 units. Marker (1974) reported that in an 
on-farm trial in lowland Scotland, the mean ZST value in 
lambs that died before two weeks of age was 5.7 ± 1.9 
(arbitrary units). For those that survived, the 
corresponding value was 43.4 ± 4.6.
The importance of passively absorbed Ig's to the immune 
status of neonate ruminants has also been demonstrated in 
cattle. Nocek, Braund and Warner (1984) showed that 
calves deprived of colostrum had lower liveweight gains 
(P<0.05), more incidence of scouring (P<0.01) and higher 
mortality rates than those fed colostrum. Further, calves 
given high levels of Ig's in colostrum gained weight 
faster (P<0.05), scoured less frequently (P<0.01) and had 
scours of shorter duration (P<0.05) than those fed 
colostrum but with a low Ig content.
Returning to lambs, Shubber, Doxey, Black and 
Fitzsimons (1979b) concluded that the "amount of Ig
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available to the lamb decreases much in the first 24 hr. 
and lambs which fail to feed in this time will have 
difficulty in getting enough Ig." These neonates would be 
more susceptible to infection and consequent morbidity 
and mortality. Indeed, Halliday (1974) observed that in a 
housed trial with lambs, neonatal mortalities showed 
lower serum IgG concentrations at 48 hr. post partum, 
than survivors, although no statistical significance was 
given.
This crucial absorption of maternal Ig's from colostrum 
may be influenced by many factors, including colostrum Ig 
concentrations, absorptive function and ewe/lamb 
behavioural interactions. Normal concentrations of Ig in 
pre-suckled colostrum vary between breeds (Halliday, 
1965). Typical values for total IgG are 8000 mg/100 ml 
for Border Leicester X Merino ewes (Dawe, Husband and 
Langford, 1982), 9000 to 9600 rag/100 ml in the Scottish
Blackface (Halliday, 1978a) and 11,500 mg/100 ml in the 
Columbia breed (Hunter, Reneau and Williams, 1977). IgG 
is the major maternal Ig in the colostrum of all ruminant 
species, and further varies in concentrations according 
to age of the dam and the number of previous lactations 
(Devery-Pocius and Larson, 1983).
Although Ig levels can easily be determined, many 
variables combine so that no correlation between ewe 
colostrum IgG concentrations and amounts of this Ig in 
lamb serum have been found (Hunter et. al , 1977 and
Halliday, 1978b). Further, Shubber et ^  (1979a) found no
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correlation between lamb total serum Ig and the amount of 
colostrum consumed for Greyfaced ewes and their lambs. 
One factor may be that colostral Ig concentrations are 
meaningless unless whey proportion is taken into account 
(Shubber et. al., 1979b). Taking an over-view of the 
literature in general, within breed variation in the 
proportion of whey in colostrum and the amount of Ig's 
contained in that whey, are large. Taking into account 
the possibility of variation in absorptive function 
between lambs (Halliday, 1978b), the absence of simple 
correlations between ewe and lamb serum concentrations is 
not surprising.
Large inter-breed differences in the degree of non- 
selective absorption of immunological proteins also gives 
rise to great variation in the normal concentrations of 
lamb serum Ig's between breeds. Further, while some 
investigations have shown significant differences in 
serum Ig levels between lambs of the same breed due to 
litter size and sex of twins (Halliday, 1974 and Shubber 
et al, 1979a), other trials have shown no such influences 
(Hunter et al, 1977 and Halliday 1971a). In addition, ewe 
and lamb weight seems to have no effect on lamb serum Ig 
concentrations at 48 hr. post partum (Halliday, 1974), 
but more vigorous lambs show increased suckling frequency 
and thus greater levels of Ig in circulation (Shubber ^  
al, 1979a).
With these influences noted, typical values for lamb
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serum Ig concentrations quoted in the literature are 
shown in Table 6.
Table 6. Typical serum immunoglobulin levels in lambs.
BREED ig TIME post 
partum (hr.)
CONCENTRATION 
(mg/100 ml)
REFERENCE
Finnish 
Landrace 
X Dorset 
Horn
Total 48 2950 Halliday
1971a
Scottish
Blackface
Total 18-21 2500
1960
±
+
190 S 
150 T
Halliday
1971b
Columbia G 0
8
24
7
2534
3556
+
±
+
0
270
327
Hunter 
et al 
1977
Scottish
Blackface
Total 168 1560 + 119 Halliday
1978a
Greyface 
X Suffolk
Total 54 3140
2770
+ 100 S 
99 T
Shubber 
et al 
1979a
(Border G1 24 900 + 75 Dawe
Leicester G2 24 35 ± 8 et al
X Merino) M 24 135 ± 30 1982
X Dorset A 24 115 40
S = Singles 
T = Twins
When the many factors influencing the transfer of 
passive immunity are considered, the possible mechanisms 
of a direct or indirect effect of Co deficiency on this 
process may be varied and complex. To add to the picture, 
Newby (1984) stated that neutrophils and macrophages as 
well as Ig's are present in colostrum. Thus in terms of
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the gut lumen only and pathogenic attack on the lamb in 
this area, opsonisation of bacteria and polymorphonuclear 
phagocytosis within the intestine by colostral Ig's and 
cells may be a viable protective mechanism. The 
detrimental effect of Co deficiency on neutrophil 
microbicidal activity has already been reviewed. The 
possibility that this area of the passive transfer system 
could be affected by Co deficiency and thus render the 
neonatal lamb more susceptible to intestinal infection, 
particularly leading to scouring, can not be ruled out. 
However, no investigations pertaining to this theory can 
be found in the literature.
The work of this project includes investigation of the 
possibility that Co deficiency in the ewe, has a 
detrimental influence on the transfer of passive immunity 
to the new born lamb. The only evidence of a possible 
effect to date of trace element deficiency on the 
transfer of passive immunity, comes from Nuriev (1986), 
working in the Kazan region of the Soviet Union. Lambs 
from ewes dosed with Co, Cu and Se during gestation 
showed higher gamma and beta globulins in serum and 
higher total blood protein levels, than controls from 
undosed ewes. However, statistical significance was not 
given.
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1.9 THE DIAGNOSIS OF COBALT DEFICIENCY IN SHEEP.
Work concerned with the metabolic changes which occur 
as a result of Co deficiency and investigations designed 
to ascertain the ruminant requirement for Co and vitamin 
B12, have provided basic data and potential methods for 
use in diagnosis of the disease. Other work has sought to 
predict when ruminant livestock might suffer production 
loss due to Co deficiency, as well as to establish the 
degree or severity of a suspected problem. Thus, while 
the aim of earlier experiments was to define techniques 
and criteria for diagnosis of the clinical syndrome, 
later investigations have concentrated more on employing 
new and existing methods for the prognosis of Co 
deficiency. This has attempted to define the sub-clinical 
form of the disease, where the greatest loss in 
production is incurred (Latteur, 1962).
Techniques used in the prognosis and diagnosis of Co 
deficiency, ranging from soil/herbage analysis to 
sophisticated determination of blood parameters, will be 
discussed. The literature concerned with the problems of 
different approaches will be critically reviewed, with 
special reference to the diagnosis of the sub-clinical 
condition.
1.9.1 A Regime for Diagnostic Techniques.
No diagnostic technique for any disease of veterinary 
importance is useful unless it can be practically and 
economically accommodated in the routine of a relevant
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laboratory.
-A proposed method should be accurate and precise in the 
diagnosis of acute (clinical) and chronic (sub-clinical) 
disease, to permit the dissemination of reliable advice 
on the basis of the data produced. Of increasing 
importance given reduced financial support for scientific 
work, especially in the field of agriculture, is the need 
for a method to have a quick turn-round time and to be 
cost effective. Finally, a more challenging criterion may 
be added. Great advantage in terms of time and financial 
saving on the farm would be gained if a technique could 
be used prognostically, as well as diagnostically.
1.9.2 Soil and Herbage Analysis.
An approach to diagnosis which focuses on the cause of 
deficiency, is the determination of Co levels in the soil 
and herbage on which livestock graze. Many techniques and 
modifications have been developed in an attempt to 
ascertain representative values of Co content. These most 
notably include colourimetric (Kidson and Askew, 1940), 
spectrophotometric (McNaught, 1948a) direct current arc 
spectrographic (Scott, Mitchell, Purves and Voss (1971) 
and atomic absorption (Gelman, 1972) methods.
The use of soil and herbage Co contents as diagnostic 
indicators of Co deficiency may, in theory, be 
appropiate. Particularly when consideration is given to 
the fact that pasture improvement on British upland and 
hill farms in recent times, especially the practice of
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liming, has reduced the amount of Co in such lands, or 
rendered it unavailable to the herbage. For example, 
Burridge, Reith and Berrow (1983) working in the north 
east of Scotland, reported that liming of soils, thereby 
changing the pH from 5.6 to 6.9, reduced the available 
levels of Co in ryegrass and clover from 0.07 to 0.06 and 
0.11 to 0,08 mg Co/Kg DM, respectively.
The level of Co in forage is not only dependent on soil 
type and pH, but also on the type of herbage present 
(Burridge et 1983). Clover (Trifolium spp.) usually
contains 0.15 mg Co/Kg DM and ryegrass {Lolium perenne) 
0.08 mg Co/Kg DM. Hence the use of nitrogen fertilizers 
to improve pastures may tend to reduce Co content by 
virtue of increasing the proportion of grass to clover, 
particularly where the soil Co level is intrinsically 
low. Further, the use of large quantities of sulphur and 
phosphates (superphosphates) to improve grazing land, may 
reduce the availability of herbage Co to ruminant species 
(Halpin, Caple, Shroder and McKenzie, 1981).
The interaction of factors affecting soil/herbage Co 
content and availability is complex. In addition, the 
techniques used to determine levels are too lengthy for 
them to be ideal for the diagnosis of animal Co 
deficiency. However, the continued characterisation of 
soils in respect of Co status should be encouraged, as 
such work has proved successful in identifying areas at 
highest risk from deficiency (Andrews, 1970a and Clark,
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Fraser, Mortleman, Bithell and Williamson, 1985).
Further, where Co deficiency disease is suspected a 
farmer may wish to sample and obtain values for pasture 
Co content, particularly if Co salt top-dressing of the 
land is envisaged as a curative treatment. In this 
respect MacPherson (1982) listed typical herbage Co 
contents, which might be found on Co-deficient and 
borderline soils. These are shown in Table 7. It is 
worthy of note that sward Co contents are also influenced 
by season, with levels tending to be lower in the summer 
than in the winter.
Table 7. Typical values for herbage Co content on
different soils and swards.
SWARD
TYPE
Co
(mg
CONTENT 
Co/Kg DM)
COMMENTS
Mixed <0.08 On Co-deficient soils.
Mixed <0.10 On soils of borderline Co 
content.
Grass <0.08 On freely drained soils of 
borderline Co content.
Clover >0.10 On soils of borderline Co 
content.
Clover <0 .10 On freely drained soils of 
borderline Co content, in the 
summer months.
(Adapted from MacPherson, 1982).
Interestingly, Jones and Anthony (1970) found a 
significant correlation between faecal vitamin B12
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concentration and dietary Co content. They devised the 
equation :
y = 0.0779X - 0.0757 
r^ = 0.73 n = 12 
where, y = Co intake (mg/Kg DM) and x = mg vitamin 
B12/g dry faeces. These workers recommended the use of 
this equation for surveying areas grazed by sheep, for 
potential Co deficiency problems.
In practice, many difficulties have arisen with 
employing soil and herbage Co contents in the diagnosis 
of ruminant Co deficiency. This is partly due to problems 
with methodology and also from confusion over the 
influence of various factors on availability, from soil 
to plant and from plant to animal. Early recognition of 
these disadvantages was provided by Dunlop (1946c), 
working in the south west of Scotland. This worker 
described the determination of adequate Co contents in 
soil and herbage, from areas where animals were suffering 
from pine.
Recently, in a survey of the north east Roramia 
territory of Brazil, Sousa and Darsie (1985) found 
herbage contents of 0.06 rag Co/Kg DM, but could provide 
no evidence of deficiency in free grazing ruminants, 
Further, McLaren, Lawson, Swift and Purves (1985) 
reported that current methods of determining soil and 
herbage Co content produced unreliable results on soils 
above pH 6.0, with no correlation between soil and
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pasture Co levels at any pH. Additionally, out of twelve 
sites where animals were suffering from Co deficiency, 
only five could be predicted by soil and herbage Co 
analyses.
1.9.3 Animal Parameters.
While it is useful to gain as broad a view as possible 
in a Co-deficient situation, it is perhaps more 
appropiate for routine analysis and diagnosis to 
concentrate directly on the animals concerned. This is 
particularly so when doubts exist as to the accuracy and 
precision of soil and herbage Co content data and the 
difficulty of their interpretation. To this end, many 
approaches to the prognosis and diagnosis of Co/vitamin 
B12 deficiency in ruminant animals have been 
investigated.
1.9.3.1 Animal response trials.
A definitive technique in diagnosis is to use animal 
response trials, such as those reported by Andrews (1970a 
and 1970b). In such experiments, the presence and 
severity of deficiency can be deduced by the degree of 
animal response, usually in liveweight gain, to Co 
supplementation.
The animal response trial approach is costly, time 
consuming and not practical for routine use. Although it 
provides an accurate and (if designed carefully) precise 
diagnosis, it is inherently not prognostic. However, such
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work must form the basis against which other techniques 
should be compared. Indeed, subsequent methods have been 
widely developed as diagnostic parameters in controlled 
dose/response trial type experiments,
1.9.3.2 Liver cobalt/vitamin B12 analysis.
The primary storage organ and site of metabolic action 
for vitamin B12 in ruminants is the liver. It is in the 
liver cells that the main function of B12, in the 
catabolic handling of propionate, takes place (Marston et 
al, 1961). It is therefore logical to measure liver Co 
content, or vitamin B12 concentration, as a diagnostic 
marker of deficiency.
Liver Co and vitamin B12 levels have been measured in 
many Co dose/response trials and related to animal 
performance to give diagnostic criteria. For example, 
Andrews, Grant and Stephenson (1964) attempted to define 
the relationship between liver/kidney B12 concentrations 
and wool growth/body weight, as response parameters to 
doses of Co. By such work, ranges of concentrations have 
been established for sheep of adequate, sub-clinical 
and clinical deficient Co status. Examples of these 
diagnostic ranges are shown in Table 8. For this data, 
measurement of Co was by accepted techniques of soil and 
herbage analysis. Determination of vitamin B12 was by 
microbiological, or radio-immunoassay.
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Table 8. Liver Co and vitamin B12 concentrations in the
diagnosis of Co deficiency in sheep.
TYPE LIVER B12
(ug/g wet wght.)
LIVER Co 
(mg/Kg DM)
STATUS REFERENCE
Lamb >0 . 08 A McNaught
<3 mnth • <0.04 D (1948b)
Lamb >0.10 A
>3 mnth • <0.06 D
Lamb >0.19 A Andrews,
0.11 - 0.19 M Hart and
0,07 - 0,11 D Stephenson
<0.07 Very D (I960)
Lamb >0.09 A Andrews
0.07 - 0.09 M (1965)
<0.07 D
Ewe >0.20 A Millar and
0.10 - 0.20 M Penrose
<0.10 D (1980)
Mature >0.19 >0.10 A MacPherson
sheep 0.11 - 0.19 0.06 - 0.10 M (1982)
<0.11 <0.06 D
KEY:
A = Adequate 
M = Marginal 
D = Deficient
There is general agreement on the range for liver B12, 
although opinions on the diagnostic values for liver Co 
are more varied. Andrews et aj^  ( 1960) stated that liver 
B12 concentrations were more closely related to the 
degree of deficiency and less variable in a group of 
sheep receiving the same Co intake, than liver Co 
contents. Whether this was due to differences in the 
sensitivity of analytical methods used for determining 
these two liver parameters, or is an inherent
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characteristic of liver levels in different deficient 
situations, is unclear. However, it is generally 
considered that liver B12 is a more accurate and reliable 
diagnostic marker of Co deficiency, in both clinical and 
sub-clinical forms, than liver Co.
The analysis of liver vitamin B12 concentration has 
been used routinely in diagnostic laboratories. For 
example, in New Zealand the measurement of total B12 in 
liver, as cyanocobalamin, was widely used in diagnosis 
until about 1980 (Millar and Penrose, 1980). A standard 
of <0.10 ug B12/g wet liver was employed as indicative of 
Co deficiency.
The sampling of liver in live animals by surgical 
biopsy is not practical in many on-farm situations and 
the sampling of liver post mortem is of no prognostic 
use. Therefore, much effort has been expended in finding 
other parameters, which are more amenable to routine use.
As the liver is the primary site of metabolic action of 
vitamin B12 in ruminants, the determination of B12 in 
this tissue may be considered the 'ideal' for diagnosis 
of Co deficiency and severity of disease. Thus, as liver 
B12 levels have been related to animal performance in 
dose/response trials, alternative diagnostic techniques 
should in turn be compared to liver B12 analysis, as well 
as animal response (Sutherland, 1980).
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1.9.3.3 Serum vitamin B12 analysis.
If the collection of liver samples by biopsy is 
impractical on farms, then obtaining blood samples and 
the determination of vitamin B12 in serum or plasma, is 
an alternative and more practical technique. Much work 
and argument has surrounded the use of serum vitamin B12 
as a diagnostic marker for Co deficiency in sheep. There 
is substantial evidence in the literature, both for and 
against its employment.
The problems involved with serum B12 are based on 
confusion over methodology and the measurement of 
physiologically inactive analogues of the vitamin, by 
different analytical techniques (McMurray, Rice, 
McLoughlin and Blanchflower, 1985). Further, it seems
debatable whether or not this parameter can be related to 
animal response and liver B12 concentrations, especially 
in the sub-clinical region of deficiency (Findlay, 1972). 
However, serum B12 has been positively developed and 
diagnostic criteria are given in Table 9.
The confusion which has arisen over different methods 
for the determination of vitamin B12 in serum and the 
possible presence of inactive analogues, still remains. 
The vitamin can be measured by microbiological assays, 
which depend on the turbidimetric estimation of microbial 
growth. Culture growth is allowed to occur in nutrient 
broths, where vitamin B12 is the only limiting factor and 
test and standard amounts of the vitamin have been 
added. Examples are the use of the bacterium
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Table 9. Serum vitamin B12 in the diagnosis of Co
deficiency in sheep.
TYPE SERUM VIT. B12 
(ng/1)
STATUS REFERENCE
Lamb # >450 N Andrews and
300 - 450 Indefinite D Stephenson
200 - 300 Probable D (1966)
<200 D
Mature @ 1000 - 3000 N Findlay
sheep >700 A (1972)
300 - 700 M
<300 D
Mature $ >1000 A Halpin
sheep 500 - 1000 M (1979)
<500 D
Ewe $ >300 A Millar and
200 - 300 M Penrose
<200 D (1980)
Mature * >400 A MacPherson
sheep 200 - 400 M (1982)
<200 D
KEY:
N = Normal 
A = Adequate 
M = Marginal 
D = Deficient
Microbiological assay with Lactobacillus leichmannii 
" " " Ochromonas malhalmensis.
" " " unknown microbe.
Radio-immuno assay.
Lactobacillus leichmannii in the methods of Thompson, 
Dietrich and Elvehjem (1950) and Skeggs, Nepple, 
Valentik, Huff and Wright (1950) the employment of the 
bacterium Ochromonas malhamensis by Ford (1953) and the 
utilisation of the protozoan Euolena by Hutner, Bach and 
Ross (1956). These techniques convert all B12 analogues
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into cyanocobalamin before measurement and thus detect 
'total B12'. However, the use of different microbes on 
the same samples, can produce markedly different results 
(Millar and Penrose, 1980).
An alternative technique is the radio-immuno assay 
(RIA), which is based on the principle of competitive 
protein binding. This method was developed for the 
diagnosis of pernicious anaemia (vitamin B12 deficiency) 
in humans by Lau, Gottrieb, Wasseman and Herbert (19 65), 
Green, Newmark, Musso and Mollin (1974) and Buchanan, 
McIntyre, Scheffel and Wagner (1977). A blocking agent 
can be employed, so that only 'true B12' and no inactive 
analogues are measured. According to Millar and Penrose
(1980) the RIA technique is cheaper, faster, more 
specific and suffers less from contamination than all of 
the microbiological methods.
Confusion over methodology still exists, because 
different techniques are employed (often with the same 
diagnostic criteria applied to them) and perhaps not 
surprisingly, contradictory results are evident in the 
literature. Further, it is clear from Table 9 that 
different techniques and situations result in dissimilar 
diagnostic ranges being set.
For example, it is generally accepted that the use of 
O . malhamensis in the microbiological assay of serum B12, 
is more specific to the true vitamin than methods 
employing L_i_ leichmannii. However, Carlos, Givens,
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Johnson, Slade and Telfer (1985) reported that in 
cattle, malhamensis yielded higher results for B12
than an assay employing leichmannii on the same sera. 
In addition, for some cases the RIA technique gave 
B12 values over 50 per cent less than the I^ leichmannii 
method. Such discrepancies cast doubt on the use of such 
data for diagnostic purposes, or at least point out that 
correct diagnosis depends on criteria being appropiate to 
the assay employed.
Superimposed on this picture is the presence in serum 
of inactive analogues of vitamin B12. While Gawthorne 
(1970a and 1970b), Marston ( 1970) and Halpin e_t ^  (1984) 
found that these were in negligible amounts in the blood 
of sheep, other workers have presented opposing evidence. 
For example, Sutton and Elliot (1972) reported 
significant levels of inactive forms (i.e. those other 
than hydroxycobalamin and methylcobalamin) in sheep 
serum.
From such work, it seems that the RIA technique 
provides more accurate and precise diagnostic data, as it 
can be employed to determine true, physiologically active 
forms of the vitamin only.
However, that this is the case has been disputed by 
Millar and Penrose (1980) and Wright, Taylor and Greer 
(1982), These workers reported inaccuracies in the RIA 
technique in measuring true B12, due to the phenomenon of 
residual protein binding in the method. Slater, Harkins, 
Suttle, Herbert and McDonald (1985) attempted to define
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exactly which forms of vitamin B12 the RIA method 
measured and how consistently they were detected. They 
compared RIA data with cobalamin determination using a 
specific and sensitive high performance liquid 
chromatography (HPLC) technique. The results obtained 
were confusing, with many inconsistencies. These workers 
concluded that in some cases the RIA determined forms of 
B12 other than the physiologically active ones, even 
though inactive analogues were apparently not present by 
HPLC analysis.
Assuming that serum vitamin B12 can be and is used as a 
diagnostic marker of Co deficiency in ruminants, the 
question of how it relates to animal response and storage 
B12 levels in the liver must be addressed (Mills, 198^). 
Initial work found a close correlation between serum B12 
concentrations and Co status in terms of sufficiency, 
sub-clinical and clinical deficiencies (Andrews and 
Stephenson, 1966). Marston (1970) reported a 
statistically significant regression between serum and 
liver levels of the vitamin in sheep. However, continued 
research has questioned these findings. For example, 
Millar and Albyt (1984) and Millar, Albyt and Bond (1984) 
found no relationship between B12 concentrations in serum 
and liver in the ovine. In growing cattle, Givens and 
Simpson (1983) and Judson, McFarlane, Riley, Milne and 
Horne (1981) could not relate serum B12 levels to the 
incidence or otherwise of Co deficiency and effects on
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performance.
Sutherland (1980) attempted to clear up this state of 
obvious confusion. He argued that for sheep, although 
most work in the literature reported cases where liver 
and serum B12 levels did not correlate, to conclude that 
serum B12 concentrations were therefore an unreliable 
index of Co status was simplistic. Serum vitamin levels 
do not always correspond to liver concentrations, because 
the biological function of B12 in these two tissues is 
different. He concluded that serum B12 is a useful 
diagnostic and prognostic indicator of Co deficiency, but 
only if the data are interpreted correctly.
The arguments that Sutherland (1980) put forward can be 
supported by evidence in the literature. It should be 
assumed that serum B12 is a sensitive indicator of Co 
intake (Somers and Gawthorne, 1969 and MacPherson ^  al, 
1976), while liver B12 is a marker of storage reserves 
and responds more slowly to changes in Co intake 
(Underwood, 1977). Thus, serum can be viewed as having a 
transport function for the vitamin, while liver has a 
utilisation and storage role. In this sense, serum should 
be used as a test of Co intake and not vitamin reserve, 
although animals with low liver B12 levels invariably 
also show low serum B12 concentrations. If this is the 
case, then the fact that serum and liver B12 data do not 
correlate statistically becomes irrelevant to the aim of 
diagnosis. To illustrate these points, Sutherland (1980) 
presented a model of Co deficiency and liver/serum B12
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status. This model is reproduced in Figure 4.
The four phases represented in this model, describe all 
aspects of the development of Co deficiency and repletion 
and the application of serum vitamin B12 to the diagnosis 
of Co status. In phase 1, Co sufficiency exists and 
marked diurnal fluctuations in serum B12, observed by 
Somers and Gawthorne (1969), make mathematical 
correlation between serum and liver vitamin 
concentrations impossible.
In phase 2, which describes the development of Co 
deficiency, B12 levels fall in serum, before liver 
concentrations decline. Thus, vitamin B12 in serum is 
utilised before stores in the liver. This is in agreement 
with the work of Frenkel and White (1973), who evolved a 
similar model for B12 depletion in the rat. During this 
phase, mathematical correlation between serum and liver 
B12 concentrations is still impossible. This period of 
ensuing deficiency would account for the confusing 
results of Millar and Penrose (1980) and Millar and Albyt 
(1984) .
In phase 3, the animals are in a state of functional Co 
deficiency and both liver and serum B12 levels remain 
consistently low. Such situations have been described by 
Andrews et ^  (1960), Marston (1970), MacPherson et ^
(1976) and Sutherland ^  ad (1979).
In phases 2 and 3, the variation in serum B12 
levels within and between animals declines, with no
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influence of diurnal fluctuations. Within the third 
phase, correlation between serum and liver B12 
concentrations is possible, as found by Marston (1970). 
However, the absence of diurnal fluctuations in levels is 
not a valid argument according to Millar and Albyt 
( 1984 ), who could find no evidence of such daily 
variations in sheep serum B12 concentrations.
In phase 4, serum B12 levels respond more rapidly 
to Co supplementation than liver concentrations. This 
sharp response in serum B12 has been reported by Tressol 
and Lamand (1979) and MacPherson (1987). Diurnal 
fluctuations in serum vitamin levels again become more 
apparent in this phase and no correlation between serum 
and liver B12 concentrations is possible. This model is 
further supported by the conclusions of Gardiner (1977), 
in his review of Co deficiency in ruminant nutrition.
However, Suttle (1986), while accepting the scientific 
basis of such arguments, proposed that dicussions for and 
against serum and liver B12 "...are irrelevant, unless
one or the other can be indicative of functional 
deficiency." He suggested that serum, as well as liver, 
has a storage role for vitamin B12. As such, both 
indicators show a classic pattern of decline in the 
development of deficiency, but serum stores are used 
before liver B12 so that concentrations of the vitamin in 
blood provide a prognostic, as well as diagnostic marker 
for Co deficiency in the liver.
On the basis of Suttle ( 1986 ) the only relevant
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question is, below which concentration of B12 in serum 
does functional deficiency occur? While this may depend 
on the definition of 'functional', Suttle (1986) proposed 
that the threshold between marginal and functional 
Co/vitamin B12 deficiency, occurs at a serum B12 level of 
approximately 190 ng/1.
In a final analysis, there is much evidence in the 
literature to suggest that serum B12 is an accurate and 
precise prognostic and diagnostic marker of clinical Co 
deficiency in sheep. This applies as long as data are 
interpreted properly and care is taken to note the 
analytical techniques employed. The ability of serum B12 
levels to indicate sub-clinical deficiency is more 
questionable. For example, although Sutherland (1980) 
stated that the approach is reliable in a marginally 
deficient situation, Millar and Penrose (1980) and 
Findlay (1972) suggested that in the sub-clinical area, 
great within- and between-animal variations mean that the 
determination of serum B12 is of little use in diagnosing 
the Co status of a flock of sheep.
Millar and Albyt (1984) asserted that serum B12 should 
not be used as an indicator of liver B12 concentrations 
in sheep, but it is reasonable to conclude from the 
literature that serum B12 is a useful indicator of Co 
intake (MacPherson ^  ad, 1976). It is also a prognostic 
marker of deficiency at the liver (Sutherland, 1980) and 
can be used as evidence of functional (clinical)
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deficiency, when concentrations are very low.
1.9.3.4 Urinary and serum Formiminoglutamic acid
analysis.
Due to the apparent confusion surrounding the use of 
serum vitamin B12 in the diagnosis of ruminant Co 
deficiency, some investigators have explored the 
possibility of employing other metabolic parameters as 
markers for the syndrome. Among these attempts is the 
determination of formiminoglutamic acid (FIGLU) in urine. 
This metabolite is excreted as a result of dysfunction in 
the B12 dependent methy1tetrahydrofolate-homocysteine 
transmethylase reaction, due to vitamin B12 and/or folic 
acid deficiency (Givens, 1978).
The use of urinary FiGLU as a diagnostic marker for 
vitamin B12 or folic acid deficiencies, was developed in 
humans. The analytical technique is an enzyme linked 
spectrophotometric method, devised for pernicious anaemic 
patients by Tabor and Wyngarden (1958).
Pioneering investigations into the use of urinary FIGLU 
in the diagnosis of Co deficiency in sheep, were carried 
out by Gawthorne (1968). The promising results of this 
work were reiterated by Russel, Whitelaw, Moberly and 
Fawcett (1975). These workers found that the detection of 
0.05 to 0.31 umol FIGLU/ml urine in Scottish Blackface 
lambs, facilitated the diagnosis of both clinical and 
sub-clinical Co deficiency. On repletion with oral doses 
of Co, levels of this metabolite in the urine of these
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lambs fell to virtually zero.
Contrary to these reports, Givens (19 78) and Givens, 
Cross, Shaw and Knight (1978) found that levels of FIGLU 
in the urine of lambs were too variable and appeared too 
late in the development of deficiency, to be of any 
practical prognostic or diagnostic use. Stebbings and 
Lewis (1983) supported these findings. These latter 
investigators provided evidence that FIGLU was only 
detectable in the urine of lambs when they were severely 
Co-deficient and some weeks after serum B12 
concentrations had fallen below 200 ng/1. Further, one 
Co-sufficient animal in this trial showed small amounts 
of the metabolite in urine, during a period of weight 
loss. They concluded that urinary FIGLU was of no 
diagnostic use for Co deficiency and only appeared to be 
excreted during periods of weight loss, whether this was 
induced by Co deficiency or not.
Urinary FIGLU estimations are not used routinely as a 
diagnostic marker for Co deficiency. Besides the problems 
of applicability, this may also be due to the fact that 
sampling urine in an on-farm situation is not as 
practical on a routine basis as blood sampling.
1.9.3.5 Urinary and serum methylmalonic acid analysis.
The initial investigations of Gawthorne (1968) into the 
appearance of FIGLU in the urine of Co deficient sheep, 
also included some original work on the excretion of 
methylmalonic acid (MMA) by the same animals. MMA rises
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in serum and urine due to dysfunction of the vitamin B12 
dependent enzyme methylmalonyl co-enzyme A mutase (EC 5.4 
99.2). Reduced activity of this enzyme, particularly in 
the liver, results in a large increase in the excretion 
of MMA.
The detection of this metabolite in urine was first 
proposed as a screening technique for the diagnosis of 
pernicious anaemia in humans (Barnes s, 1967 ). The
analytical methods employed were colourimetric (Giorgio 
and Plaut, 19 65) and by thin layer chromatography (TLC), 
(Bashir, Hinterberger and Jones 1966). However, Williams, 
Spray, Newman and O'Brien (19 69) demonstrated in rats 
that while these techniques were useful for screening 
surveys, they were not sensitive enough to be employed in 
detecting the extent of a B12 deficiency.
In ruminants, investigations proceeded using these 
techniques, mainly on the determination of MMA in the 
urine of sheep (Andrews et ajL, 1970; Hogan, Lorentz and 
Gibb, 1973 and Lough and Calder, 1976). Early experiments 
proved promising. Smith, Osborne-White and Russell (1969) 
demonstrated in pair-fed sheep, that MMA levels in the 
livers of clinically Bl2~deficient animals, determined 
at post mortem by isotope dilution analysis, were
over twice those shown by sufficient animals.
At this stage in the development of MMA determination 
as a diagnostic marker, the analytical methods used were 
not specific or sensitive enough to employ the technique
6 6
in the detection of sub-clinical deficiency. To overcome 
this problem, more sensitive packed column gas 
chromatographic anlysee were developed (Millar and 
Lorentz, 1974 and Elliot, Haluska, Peters and Barton, 
1979) .
Subsequent investigations proved more successful in the 
accurate diagnosis of deficiency. Millar and Lorentz 
(1979) suggested that the determination of >30 ug MMA/ml 
urine in grazing sheep was indicative of clinical Co 
deficiency. However, these workers did not recommend the 
employment of this approach in the diagnosis of sub- 
clinical disease. Judson, Hannam, Benson and Reuter
(1981), found that serum MMA was raised in grazing Co­
deficient sheep when serum B12 concentrations fell below 
300 ng/1. In addition, serum MMA levels were less
variable than urinary concentrations and these 
investigators concluded that MMA in serum was a more 
sensitive marker of Co deficiency than urinary MMA. 
Further, they postulated that serum MMA was probably 
preferable to serum vitamin B12 in the diagnosis of the 
sub-clinical form of the syndrome.
The application of MMA analysis to the detection of 
clinical Co deficiency was therefore established, but its 
use as a marker of sub-clinical disease was still 
questioned (Mills, 1981 and Elliot et. a%, 1979).
However, further development using a capillary gas 
chromatographic technique for the determination of MMA in 
plasma and urine by McMurray, Blanchflower, Rice and
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McLoughlin (1986) provided further scope for the 
employment of this metabolite as a prognostic, as well as 
diagnostic, marker (McMurray, Rice, Kennedy, Blanchflower 
and McLoughlin, 1985).
McMurray, Rice, McLoughlin and Blanchflower (1985) 
presented criteria for employing plasma MMA in 
conjunction with plasma B12, for prognostic and 
diagnostic usage. These ranges are shown in Table 10.
Table 10. Possible diagnostic criteria for plasma vitamin
B12 and MMA in sheep.
VIT. B12 
(pg/ml)
MMA
(umol/1)
COMMENT STATUS
>300 * <4.6 High B12/Normal MMA Normal
<300 <4.6 Low B12/Normal MMA Normal
<300 <15.0 Low B12/Moderate MMA Sub-Clinical
<300 >15.0 Low B12/High MMA Clinical
* Analysed by RIA, as 'true vitamin Bl2.' 
(After McMurray et aüL, 1985).
This Irish team also stated arguments in favour of the 
diagnostic employment of MMA in addition, or as an 
alternative to serum B12. They viewed serum B12 "... as a 
passive marker of Co status, because it has no direct 
functional role in serum, being bound to the 
transcobalamins." For MMA, this alternative approach was 
regarded as having "...the potential of being used as an 
active marker. A raised concentration in serum or urine
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is a direct reflection of abnormal metabolism, since it 
results from' degradation of accumulated levels of 
methylmalonyl CoA, a metabolic event directly associated 
with Co or vitamin B12 deficiency." (McMurray et. al, 
1985) .
These positive remarks are balanced by the caution of 
other investigators. Andrews and Hogan (1972), although 
working with a less sensitive technique, stated that 
"...there may be considerable limitation as to the 
precision with which serum B12 values can be used to 
predict the vitamin B12 status of grazing sheep and this 
could be of special significance when liver reserves are 
close to, or below, deficient levels." However, these 
authors went on to point out that, "Present results 
indicate that, in a non-Co-deficient flock, there will be 
a few individuals of apparent adequate vitamin B12 status 
that will excrete measurable amounts of MMA." Further 
caution is added to this possibility of MMA analysis 
producing false positives, when these workers suggested 
that, "...the amount of MMA found may depend upon the 
amount of feed consumed during the recent past and the 
time elapsed between ingestion and sampling. These points 
require investigation."
In addition to these more negative comments, Suttle 
(1986), while recognising that the use of serum MMA 
increases the precision of diagnosing Co deficiency 
compared with the employment of serum B12 alone, offered
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a note of warning. He proposed that high MMA levels only 
reflect a deficiency in adenosylcobalamin and will not 
show a deficiency of the other physiologically active 
form of vitamin B12, methylcobalamin. Thus, if situations 
exist where deficiency of the methylcobalamin form 
predominate, then analysis of MMA will not diagnose this.
Further to these points, there is also a possibility 
that a deficiency in selenium or vitamin E may affect MMA 
levels, as well as a deficiency in Co/vitamin B12. 
Working with rats, Pappu, Fatterpaker and Sreenivasan 
(1978) found increased concentrations of MMA in the urine 
of Vitamin E-deficient/vitamin B12-sufficient rodents. 
They postulated that vitamin E, as well as vitamin B12, 
may have an effect on the methylmalonyl CoA mutase 
enzyme. In vitamin E deficiency, adenosylcobalamin may 
not have its usual activity as a co-factor for this 
enzyme.
In contrast to these sceptical views. Rice, McLoughlin, 
Blanchflower, Goodall and McMurray (1987) reported that 
concentrations of MMA in the plasma and urine of sheep, 
were accurate indicators of Co status. These workers 
published their results after the completion of the 
studies to be reported in this project. Therefore, their 
findings which relate to the work of this project will be 
discussed later in Chapter 3.
More work is needed on factors affecting levels of MMA 
in blood and urine before this apparently accurate and 
precise prognostic and diagnostic technique can be
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advocated for use in sheep. Firstly, Rice et ^  ( 1987 ) 
stated that whereas urinary MMA "...represents the total 
MMA excreted from plasma over a period of hours," plasma 
MMA is a reflection of the liver's ability to convert 
propionate to succinate, over a shorter time period. 
Thus, study of the relative merits of both should 
continue. It may prove that blood MMA levels are a more 
accurate indicator of Co/B12 deficiency in the liver, as 
Judson et al (1981) postulated.
Secondly, Co-deficient inappetence may reduce the 
levels of MMA excreted in clinical disease (Rice ^  al, 
1987). In this situation, propionate load on the liver 
would be markedly reduced with a subsequent drop in the 
amount of excess methylmalonyl CoA present. Thus, it may 
be that in severe deficiency, the measurement of MMA in 
blood or urine is irrelevant to diagnosis. This point 
requires clarification.
Thirdly, Andrews and Hogan (1972) postulated that there 
might be an effect of feeding time and period from 
feeding to sampling on MMA concentrations. These 
investigators also raised the possibility of diurnal 
fluctuations in serum MMA levels. The influence of such 
factors on the use of MMA as a diagostic marker, also 
need investigation.
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1.9.4 Diagnostic Strategy.
From this review of the literature, it seems that the 
single most accurate, precise and reliable way of 
diagnosing Co/vitamin B12 deficiency in sheep, is by the 
measurement of the indirect marker, MMA (Suttle, 1986).
The use of soil and herbage analysis is inaccurate 
(McLaren et ad, 1985) and difficult to relate to animal
trace element status. Determination of liver B12 is 
perhaps the ideal strategy in terms of accurate 
diagnosis, but is not practical for routine employment. 
The measurement of serum B12 is a widely used approach, 
but suffers from problems of variability and data 
interpretation (Sutherland, 1980). The detection of FIGLU 
in urine, as a routine diagnostic marker, now seems to 
have been abandoned.
Much work is needed before the analysis of MMA alone 
can be used as a diagnostic approach with full 
confidence. Even if this is a possiblity for the future, 
perhaps the most accurate, precise, reliable and 
routinely applicable diagnostic strategy, which also 
meets the challenge of prognosis, is the joint use of 
serum B12 and MMA concentrations in a similar manner to 
that advocated by McMurray, et ad (1985).
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CHAPTER 2.
ANALYTICAL TECHNIQUES
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2.1 INTRODUCTION.
The analytical techniques used in this project will be 
described in the order in which they appear in the text. 
Methods which were integral to the work will be detailed 
in full. Techniques which yielded additional, but 
secondary information, will be given in outline only.
2.2 ANALYSIS OF COBALT CONTENT IN FEEDS AND LIVER SAMPLES. 
The Co contents of feeds and liver samples were
determined by a DC arc spectrochemical technique, using 
the method of Scott ^  al (1971).
2.3 BLOOD SAMPLING.
On all occassions blood samples were collected from 
sheep by jugular-venipuncture, employing 7 ml silicone 
coated and 10 ml lithium heparin containing re-evacuated 
sampling tubes ('Monoject,' Sherwood Medical, St.Louis,
Mo., USA). For the neutrophil function test (section 2.9) 
blood was collected in 10 ml re-evacuated silicone coated 
tubes, which contained 1 ml of EDTA/saline solution (pH 
6.8) .
2.3.1 Preparation of Sera.
Blood samples in 7 ml silicone coated sampling tubes 
were placed in a water bath at 30 °C and allowed to clot
for 1 hr. The clots were removed and the sera were
centrifuged at 1000 g for 20 min. The supernatant sera
were then pipetted off into plastic storage tubes and
74
stored at -20 °C.
2,3.2 Preparation of Plasma.
Blood samples in 10 ml lithium heparin containing 
sampling tubes were centrifuged at 1000 g for 20 mins. 
The supernatant plasma were pipetted off into plastic 
storage tubes and stored at -20
2.4 ANALYSIS OF SERA FOR VITAMIN B12.
Serum vitamin B12 concentrations were determined either 
by microbiological assay using Lactobacillus leichmannii 
as the test organism, or by radio-immuno assay (RIA). The 
microbiological assay and RIA were based on the work of 
Skeggs et al (1950) and Lau et al ( 1965), respectively. 
The RIA employed a commercial analytical kit, produced by 
Becton and Dickinson (Orangeburg, New York, USA).
2.4 J Microbiological Assay.
2.4.1.1 Summary.
Test sera were diluted 1 to 9 in an acetate buffer (pH 
4.85), containing 20 mg/1 potassium cyanide. After 
heating at 100 °C for 30 min., the serum proteins were 
precipitated and the vitamin B12 content converted to 
stable cyanocobalamin. 2 ml of the protein free 
supernatant were removed and added to 8 ml of an assay 
broth. The broths were sterilised and inoculated with a 
L. leichmannii suspension. After incubation for 18 to 24
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hr. at 40 growth levels in the assay tubes were
measured to determine spectrophotometric optical density 
and compared with standards of known vitamin B12 content. 
There was a direct relationship between vitamin B12 
concentration and growth of Lj. leichmannii. and hence 
optical density of an inoculated broth.
2.4.1.2 Preparation of sera.
Sera stored at -20 °C were allowed to thaw and mixed 
thoroughly. Acetate buffer was distributed in 4.5 ml 
aliquots into 100 x 16 mm conical bottomed polypropylene 
tubes. Test sera were added to each tube in 0.5 ml 
amounts. The tubes were capped and sterilised by heating 
at 100 in a covered boiling bath, or 108 in an 
autoclave, for 30 min. After cooling, the tubes were 
'ringed' to remove adherent protein deposits and 
centrifuged for 15 min. at 1000 g. The supernatant 
contained the vitamin B12 extract.
2.4.1.3 Preparation of assay broth.
A. A vitamin B12 free assay medium was prepared by 
reconstituting a powdered formula (Difco B12 assay medium 
USP, Difco Laboratories, Detroit, Michigan, USA) in 
deionised water, heating to 100 and simmering for 2 to 
3 min.
B. 2 ml of test sera vitamin B12 extract were added
to pyrex glass tubes, along with 8 ml of the medium. The
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tubes were stoppered and sterilised by autoclaving at 15 
pounds per square inch for 5 min. Longer heat exposure 
would result in destruction of media constituents and 
subsequent poor bacterial growth.
C. Once cool each tube was inoculated with a
standard drop (approximately 0.025 ml) of prepared 
culture suspension. The tubes were again stoppered and 
incubated in a water bath at 40 °C for 18 to 24 hr.
2.4.1.4 Preparation of inoculum.
A. leichmannii (ATCC 7 830) was grown in continuous
culture at 37 with daily subculturing using Difco B12
culture broth (Difco Labs.). The culture was shaken to 
resuspend the deposit, A sterile Pasteur pipette was used 
to transfer 2 ml to a sterile plastic universal bottle.
B. This aliquot was centrifuged at 1200 g for 15 min.
C. The supernatant was discarded and the deposit
resuspended in 10 ml of sterile Hank's balanced salt 
solution (BSS). The suspension was gently and thoroughly 
mixed, then recentrifuged as above. This procedure was 
repeated four times.
D. After the final wash, 0.2 ml of the suspension was
diluted in 20 ml of BSS. This dilution was used as the 
inoculum strength.
E. Vials of this final strength were stored for use 
in a 15 per cent glycerol/BSS (v/v) solution, and kept at 
-20 °C.
By this procedure a culture of pure, viable L_j
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leichmannii in a smooth phase, with no contaminants, 
could be maintained at a satisfactory concentration to 
achieve adequate growth levels within the set incubation 
time and temperature.
2 . 4 . 1 . 5  S t a n d a r d s .
Two sets of standards were employed. The first set was 
prepared with and incorporated into each run, using a 
sera of known vitamin B12 value (Wellcomtrol abnormal 
K3072) and calibrated against the IRBI reference serum 
(British standard secondary). The standard B12 
concentrations in these sera were 143, 285, 360, 567 and 
1,250 ng B12/1.
The second set of 'aqueous' standards were prepared 
separately and used on every third run as an overall 
check on the method. These were made up using a 
commercial formula of cyanocobalamin, as follows:
A. One 250 ug ampoule of vitamin B 12 standard
(Cytamen, Glaxo Group Research Ltd., Greenford, 
Middlesex) was made up to 250 ml in a volumetric flask 
with 30 per cent v/v ethanol. This 1 ug/1 vitamin B12 
solution was kept in a dark bottle at 4 *^ 0 for up to two 
weeks.
B. 1 ml of 1 ug/1 concentration was made up to 100
ml in a volumetric flask with deionised water, to give a 
10 ng/ml solution.
C. 1 ml of 10 ng/ml concentration was made up to 200
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ml in a volumetric flask with deionised water, to give a 
50 pg/ml solution.
The protocol, which was used to prepare two replicates 
of each aqueous standard, is shown in Table 1. When the 
aqueous standards were employed, they were inoculated and 
incubated at the same time as a test run.
Table 1. Protocol for preparing aqeous standards.
A(ml) B(ml) C(ml) STANDARD 
CONG, (ng/1)
0 5.00 5.00 Blank
0.25 4.75 5 . 00 63
0.50 4.50 5.00 125
0.75 4.25 5.00 188
1.00 4 . 00 5 .00 250
1.00 4.00 5.00 250
2.00 3.00 5.00 500
3.00 2.00 5 . 00 750
4.00 1.00 5.00 1000
5.00 0 5.00 1250
KEY:
A - Standard solution (50 pg/1)
B - Fresh deionised water 
C - Double strength vitamin B12 media
2.4.1.6 Calculation of results.
Using water as a blank at 540 nm, the top standard 
(1250 ng/1) recorded an optical density of 1.4 to 1.8
units on a Phi lips /Pye Unicam PU 8610 UV kinetics 
spectrophotometer, when satisfactory growth had been 
attained. A standard curve was obtained by plotting
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optical density (y axis) against known vitamin B12 (ng/1) 
content in prepared standards (x axis). Determination of 
vitamin B12 in test sera was by interpolation from this 
curve.
2.4.2 Radio-immuno Assay (RIA).
2.4.2.1 Summary.
The principle used in this assay was that of 
competitive protein binding (CPG), which is summarised 
below:
S* - B
+ B
S — —  S - B
Where 'S' is unlabelled vitamin B 12 , ' S * ' is
radioactively labelled vitamin B12 and 'B ' is a binder. 
The binder had equal affinity for prepared and test serum 
vitamin B12. Labelled (prepared) and unlabelled (test 
serum) vitamin B12 competed for a limited number of 
available specific binding sites, until an equilibrium 
was established. The level of radioactive bound vitamin 
B12 was therefore inversely related to the concentration 
of non-radioactive vitamin in test sera. After adequate 
incubation the bound and free fractions were separated 
using charcoal, and the amount of bound radioactivity 
quantitatively measured by gamma scintillation.
The commercial kit (Becton and Dickinson) was employed 
to measure only physiologically active ('true') vitamin
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B12. Inactive analogues were not included in the 
determination. This was achieved by altering the 
specificity of the binder used. The binder had sites for 
reception of true vitamin (intrinsic factor - IF) and
inactive B12 analogues (non-intrinsic factor - NIF). A
NIF blocking agent, derived from inactive analogues, was 
used to bind all NIF sites on the binder. Thus the 
binder, only having IF sites available which were 
specific for true B12, would react and bind with only
labelled and unlabelled true vitamin B12 in the assay
mixture.
2.4.2.2 Reagents.
A. Dithiothreitol solution: Dithiothreitol (5 per
cent) and stabiliser (2 ml/vial).
B. NIF blocking agent: Analogues derived from
vitamin B12 (10 ug/ml) in borate buffer with
preservatives (2.0 ml/vial).
C. Vitamin B12 tracer: Less than 1.5 uCu [^ "^ Coj true
vitamin B12 in borate buffer (pH 9.3) with human serum 
albumin, dextran, potassium cyanide, dye and preservative 
(100 ml/bottle).
D. Working tracer/buffer solution, with NIF blocking
agent: One vial NIF blocking agent and one vial
dithiothreitol were added to one bottle of vitamin B12 
tracer, to make up this working solution.
E. Vitamin B12 standards: Formulated in a synthetic
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matrix with sodium chloride and preservatives.
F. Vitamin B12 binder: A lyophilised preparation,
containing porcine intrinsic factor, human serum albumin, 
dextran and preservatives. The intrinsic factor was 
designed to have a trace binding (Bo) of 55 + 15 per 
cent. The binder contained R-protein, which when used 
with NIF blocking agent, contributed no vitamin B12 
binding activity.
G. Dextran - charcoal tablets: Contained charcoal
dextran and inert fillers.
2.4.2.3 Procedure.
A. Polypropylene tubes were numbered 1 to 16 for the
standards. Beginning at 17, two tubes for each test serum 
were used.
B. Standards and test sera were added as shown in
Table 2.
Table 2. Organisation of tubes, standards and test
samples.
TUBES STANDARD 
OR SAMPLE
VITAMIN B12 
CONG, (ng/1)
1,2 (Totals) 0
3,4 (Blank) 200 ul 0
5,6 (Bo) II 0
7,8 II 100
9,10 II 200
11,12 II 400
13,14 II 1000
15,16 II 2000
17,18 etc. " Test serum Unknown
82
c. 1 ml of working tracer/buffer solution with NIF
blocking agent was added to each tube. All were mixed 
gently and covered with aluminium foil.
D. All tubes (except 1 and 2) were heated in a water
bath at 100 +_ 2 °C for 15 min. The tubes were then
removed and cooled to between 20 and 25 °C in a running 
water bath.
E. The binder was then added in 0.1 ml amounts to 
tubes 5 to 16 and all test sera and mixed gently by hand. 
Tubes 3 to 16 and all sample sera were incubated at room 
temperature for 30 min. from the time of the last 
addition of the binder. The rack of tubes was covered 
throughout this period with aluminium foil to exclude 
light.
F. One charcoal tablet was added to each tube, except
tubes 1 and 2. The tubes were vortexed for 5 seconds each 
and kept at room temperature for 10 min., from the time 
of the last addition of charcoal. In order to pellet the 
charcoal, all tubes were then centrifuged at 1000 g for 
10 min.
G. The supernatant of each tube, which contained the
bound vitamin B12 fraction, was decanted into fresh 
polypropylene tubes. Maximum transfer was achieved by 
hitting the rims of the two tubes together, taking care 
not to include any of the charcoal in the supernatant 
transfered.
H. The radioactivity of the supernatants and tubes 1
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and 2 were counted in sequence for one minute each, using 
a scintillation (gamma) counter (LKG, Sweden).
2 . 4 . 2 . 4  C a l c u l a t i o n  o f  r e s u l t s .
A. The counts of the blank tubes 3 and 4 (no binder
added) were averaged. This blank value was subtracted 
from all other tube results to obtain 'corrected counts.' 
The corrected counts were used in the following 
calculations.
B. The corrected counts of tubes 1 and 2 were 
averaged to give a 'total count' for the assay.
C. The average of the corrected counts for tubes 5
and 6 (binder added, but no B12 present) was divided by 
the corrected total count to give the trace binding. Bo. 
This value was greater than 40 per cent.
Bo = Trace binding =
Average corrected counts, tubes 5 and 6
------------------------------------------------------------ X  100
Total Count
D. The corrected counts of each tube were divided by
the average corrected counts for tubes 5 and 6, to give 
the per cent of trace binding for each tube:
Per cent of Trace Binding =
Corrected count
  X 100
Average corrected counts tubes 5 and 6
E. A standard curve was plotted, using log graph
paper, of per cent trace binding in standards (y axis)
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against vitamin B12 (ng/1) of the standards (x axis). The 
concentration of vitamin B12 in test sera was determined 
by interpolation from this curve.
2.5 ANALYSIS OF SERA FOR METHYL MALONIC ACID.
2.5.1 Summary.
Methyl malonic acid (MMA) was extracted from serum by 
shaking with ethyl acetate under acidic conditions. The 
butyl ester was formed using butanol acetyl chloride and 
was dissolved in hexane. The butyl ester of MMA in hexane 
was quantified by capillary gas chromatography (GC) using 
a Hewlett Packard 439 GC. Ethyl malonic acid (EMA) was 
used as an internal standard (McMurray et. 1986).
2.5.2 Reagents.
All the solvents and reagents used were 'Analar' grade 
and obtained from BDH Ltd. (Poole, Dorset), unless 
otherwise stated.
A. MMA (Stock standard) 10 umol/ml. 1.18 mg/ml of MMA
(Sigma Chemicals Co., Poole, Dorset) were dissolved in
acetone, A working standard of 0.5 umol/1 was prepared by
diluting the stock standard 1 to/9 in acetone.
B. EMA (Stock standard) 10 umol/1. 1.32 mg/ml of EMA
(Aldrich Chem. Co., Gillingham, Dorset) were dissolved in 
acetone. A working standard of 1.0 umol/1 was prepared by
diluting the stock standard 1 to 9 in acetone.
C. Saturated sodium chloride solution. Approximately
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150 g of sodium chloride dissolved in 500 ml of distilled 
water.
D. 10 M sulphuric acid. 38 ml of concentrated
sulphuric acid were mixed with 200 ml of distilled water 
in a conical flask, with cooling. To avoid boiling, the 
acid was added to the water slowly and carefully while 
swirling the flask. This solution was then made up to 250 
ml with distilled water.
E. 0.5 M sulphuric acid/ saturated sodium chloride.
10 M sulphuric acid was diluted 1 to 9 with saturated 
sodium chloride solution,
F. Butanol/acetyl chloride reagent. 0.5 ml of acetyl 
chloride was added slowly and with swirling to 5.0 ml of 
butan-l-ol ('Aristar' grade) in a 30 ml glass vial. This 
reagent was freshly prepared before use.
2.5.3 Gas Chromatography Conditions.
The GC technique employed a flame ionisation detector, 
with a 25 m X 0.22 mm capillary column (Hewlett Packard 
CP-SIL 5B). Split injections were made onto the column, 
using a 2.5 ul injection capacity. The split ratio was 
10:1 (hexane : sample) using hydrogen as the carrier gas.
The injection port temperature was maintained at 200 °C, 
with the detector temperature held at 280 *^ C.
Oven temperature profile.
1. 120 ^C for 2 min.
2. Rise of 5 ^C/min. to 150 ^C.
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3. Rise of 40 °C/rain. to 230 °C.
4. 230 for 5 min. to flush the column.
2,5,4 EGGGSdWPe,
A. 500 ul aliquots of sera were placed in small
quickfit tubes. The samples were tested singly. Standards 
containing 100 ul of 0.5 umol/1 MMA were also set up. The' 
volume of these was made up to 500 ul with distilled 
water.
B. 100 ul of 0.1 umol/1 EMA were added to each tube
as the internal standard. 500 ul of acetone were then
added to each tube, while vortexing, followed by 2.0 ml 
of 0.5 M sulphuric acid/saturated sodium chloride 
solution.
C. 1.0 ml of ethyl acetate was added and each tube
was shaken vigorously for 20 seconds. The tubes were then 
centrifuged at 1000 g for 10 min. and the ethyl acetate 
layers transfered to 1 ml capacity microtubes. The ethyl 
acetate in each microtube was evaporated off in a dry 
block heater set at 60 °C, under a constant flow of 
oxygen free nitrogen.
D. A further 1.0 ml of ethyl acetate was added to
each tube and the extraction, centrifugation and 
evaporation stages were repeated, with the ethyl acetate 
layers again being transfered to the corresponding 
microtubes.
E. 100 ul of the butanol/acetate chloride reagent
were added to each microtube. These tubes were then
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stoppered and placed in a water bath at 7 0 . After 2
min. the microtubes were vortexed and returned to the 
water bath for a further 20 min.
F. After cooling, 300 ul of hexane and 600 ul of
distilled water were added to each microtube. These tubes 
were then shaken for 5 seconds and the layers allowed to 
separate. The upper layers were then transfered into GC 
autosampler vials for analysis.
2,5,5 Calculation of Results.
Examples of chromatograms of standard and test samples 
are shown in Figure 1. For each standard in a run, the 
ratio of MMA to EMA was calculated from the chromatograms 
as follows:
MMA peak area
Standard ratio = ---------------
EMA peak area
An average standard ratio for a run was then obtained. A 
test ratio for each sample was calculated in the same 
manner; by dividing the test MMA peak area by the 
internal standard EMA peak area. For each sample, the 
concentration of MMA in serum was then calculated as 
follows :
Serum MMA concentration =
Test ratio
-------------------------  X 100
Average standard ratio
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M M A
E M A
a)
M M A
E M A
b)
F i g u r e  1. T w o  c h r o m a t o g r a m s  s h o w i n g  t h e  b u t y l  e s t e r s  of M M A  a n d  
E M A  i n  a) a  s t a n d a r d  p r e p a r a t i o n  a n d  b) a t e s t  s e r u m  p r e p a r a t i o n .
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Serum MMA concentrations in the test sera were thus 
calculated in umol/1.
2.6 ANALYSIS OF WHOLE BLOOD FOR HAEMOGLOBIN.
Whole blood collected in the lithium heparin containing 
sampling tubes, was analysed for haemoglobin (Hb) 
content. The procedure used was that detailed by Sigma 
Chem. Co. (1980), employing a Philips/Pye Unicam SP8 - 
500 UV/VIS spectrophotometer.
2.7 ANALYSIS OF WHOLE BLOOD FOR GLUTATHIONE PEROXIDASE. 
W h o l e  b l o o d  c o l l e c t e d  i n  t h e  l i t h i u m  h e p a r i n  c o n t a i n i n g
sampling tubes, was analysed for glutathione peroxidase 
(GSHy/px) activity by the enzymic method of Paglia and 
Valentine (1967), as modified by Anderson, Berrett and 
Patterson (1978).
2.8 ANALYSIS OF PLASMA FOR COPPER, CALCIUM AND MAGNESIUM.
Plasma samples were analysed for copper (Cu), calcium 
(Ca) and magnesium (Mg) content by an atomic absorption 
technique.
2.9 THE NEUTROPHIL FUNCTION TEST.
2.9.1 Summary.
Neutrophils were isolated from blood and incubated with 
a suspension of Candida albicans. After staining for dead 
yeast cells, the phagocytic and killing activity of
neutrophils from sheep could be determined.
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2.9.2 Isolation of Neutrophils.
A. Within two hours of collection, blood samples were
centrifuged at 1000 g for 20 min. The plasma portion and 
uppermost part of the red cell column (mono-fraction) 
were then removed by aspiration. The remaining sample, 
which contained the neutrophils, was resuspended in 4ml 
of 0.8 per cent buffered saline.
B. This fraction was transfered to 50 ml conical
based tubes. To each sample 20 ml of distilled water were 
added with gentle mixing, to lyse the red blood cells. 
After 45 seconds, 10 ml of 2.7 per cent buffered saline 
were added to restore isotonicity.
C. Each tube was centrifuged at 500 g for 10 min.
and the supernatant carefully removed by aspiration. The
white cell buttons were resuspended in 25 ml of 0.8 per 
cent buffered saline to facilitate washing. The tubes 
were then recentrifuged for a further 10 min. at 500 g. 
This procedure was repeated for a further two washes.
Finally, The white cell buttons were resuspended in 1.0 
ml of Hank's balanced salt solution (BSS).
2.9.3 Assay of Candidacidal Activity.
A. Fresh ovine serum and the suspensions of
neutrophils were pre-warmed at 37 ^C. Neutrophils (1.0 X 
10^), albicans (2.0 X 10^) and Hank's BSS were added 
to plain siliconised vials to give a total volume of 0.6 
ml. To this was added 0.15 ml serum and the test was 
incubated in a pre-set oven for a total of 75 min. at 37
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°C, with mild agitation.
B. A control to candidacidal activity was prepared by 
adding all the normal constituents to a vial, except the 
neutrophils.
C. After 60 min. of the incubation period, dead C .
albicans cells were stained by adding 0.2 ml of 0.4 per 
cent methylene blue to each tube.
D. The relative concentrations of neutrophils and C .
albicans were determined by use of a Coulter counter 
('Model Ta 2'). In general, employing 10 ml of blood 
initially and a three day old culture of the yeast, 0.25 
ml of neutrophil suspension, 0.20 ml of C_^  albicans and 
0.15 ml of Hank's BSS were required. The yeast was grown 
continuously at 30 centrifuged and resuspended in 5ml
Hank's BSS, then diluted 1 in 4, again in Hank's BSS.
E. After full incubation the preparation was
examined using a Neubauer chamber under a light 
microscope at a magnification of X 550. One hundred 
isolated neutrophils were counted and the number 
containing killed (blue stained) Cj_ albicans recorded. 
Clumped neutrophils were not used in counting as this 
bunching made viewing of individual cells difficult and 
inaccurate. To avoid excessive clumping the vials were 
shaken vigorously before microscopic examination. Dead 
yeast cells took up the methylene blue stain and appeared 
blue on examination. Phagocytosed, but still viable 
Candida, were not stained and appeared translucent.
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F. Neutrophils containing no, or viable Candida,
were scored negative. Those containing at least one 
killed yeast cell were scored positive. Thus, a 
percentage kill for each sample was obtained. The control 
was considered satisfactory if it contained less than 1.0 
per cent dead C_i_ albicans. On no occassion while using 
this technique did the control show a non-viable cell 
population above this level.
G. That Co deficiency does not affect the ability of
neutrophils to phagocytose the yeast cells has already 
been established repeatedly at these laboratories 
(Taylor, pers. comm.). Consequently, a measure of 
phagocytic activity was not taken.
2.10 ANALYSIS OF SERUM AND COLOSTRUM FOR IMMUNOGLOBULIN G,
2.10.1 Summary.
The single radial immunodiffusion (SRID) technique used 
to determine IgG in colostrum whey and serum was that 
described by Mancini, Carbonara and Heremans (1965) and 
modified by Fahey and McKelvey (1965). IgG^ and IgG2 were 
measured together. All statements concerning IgG relate 
to these two immune proteins. In ovines, the IgG2 form is 
present in negligible amounts, relative to total IgG.
The method relied on the formation of a precipitate due 
to an antigen/antibody reaction. An unknown amount of 
protein antigen, in this case colostrum whey or blood 
serum, was allowed to diffuse radially from a point 
application, in a uniformly thin layer of antibody
93
(antiserum) containing agar, for a sufficient time to 
allow most of the antigen to combine. The 
antigen/antibody reaction took place in the agar and 
formed a precipitin ring. The area reached by the 
precipitate was directly proportional to the amount of 
antigen (Cag) employed and inversely proportional to the 
concentration of antibody.
A plot of ring diameter squared (d^) against known 
standard antigen concentration, produced a straight line 
after complete diffusion. This linear relationship was 
expressed by the equation:
d^ = K[Cag] + SO 
The intercept (SO) was a function of Cag and of the 
diameter of the well cut into the agar, in which the 
antigen was placed.
Mancini et al (1965) described Cag for equal volumes of 
test fluids and their corresponding precipitin ring 
diameters after complete diffusion. Fahey et al (1965) 
discovered that ring diameter could be measured well 
before the end point of diffusion. These latter workers 
also showed that the logarithm of Cag was proportional to 
precipitin ring diameter after just 18 hr. incubation. 
This relationship was linear when plotted on semi-log 
chart paper, and was time and temperature dependent.
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2.10.2 Reagents and Materials.
All chemicals were reagent grade and obtained from BDH 
Ltd., unless otherwise stated.
A. Agar Noble: Low ash agar for use in
electrophoretic and immunodiffusion techniques. (Difco 
Labs). 1.8 g of agar noble were dissolved in 150 ml of 
0.1 M barbitone acetate buffer, pH 8.6. The agar was 
allowed to cool in a water bath maintained at 56 °C. This 
yielded a 1.2 per cent agar solution.
B. Sodium acetate: ('Analar' grade).
C. Sodium barbitone:
D. 0.1 N Hydrochloric acid:
E. 0.1 M Barbitone acetate buffer, pH 8.6: 5.0 g
sodium barbitone and 3.25 g sodium acetate were dissolved 
in 32.2 ml of 0.1 N HCl. This mixture was diluted to 
500ml with distilled water.
F. Standard ovine IgG: A lyophilised, essentially
salt free preparation. No: 1-5131 (Sigma Chemicals Co.,
P.O. Box 14508, St. Louis, Mo., USA). 10 mg reconstituted 
in 0.25 ml distilled water gave a concentration of 4000 
mg/100 ml.
G. Antibody {Antiserum to ovine IgG): Anti-sheep
IgG, heavy and light chains. (ICN Immuno-biologicals, 
P.O. Box 1200, Lisle, Illinois, USA). Code 65-130. Lot 
No: R962. Control RIOO. Produced in a lyophilised form
and raised in rabbits. Titre was 2.9 mg antibody/1.0 ml, 
determined by quantitative precipitin analysis, using 
sheep serum in the test. Specific for ovine IgG only.
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Each vial was reconstituted with 2 ml distilled water.
H. Plastic calibrated plates and well cutter: Plates
(95mm X 46mm) and 2mm well cutter, with cutting template. 
(Miles Laboratories Ltd., Stoke Poges, Slough).
2.10.3 Preparation of Plates.
A. In a water bath maintained at 56 °C, the agar was
dispensed in 5.6 ml aliquots into pre-warmed glass bijou 
bottles, using a pre-warmed glass pipette. Each aliquot 
represented the amount of agar needed to fill one plate.
B. For each 5.6 ml of agar, 0.2 ml of antiserum was
added to 0.8 ml of sodium barbitone buffer, with gentle 
mixing. This 1.0 ml suspension was added to the agar 
immediately before plate pouring. The agar and antiserum 
contained in each bijou were mixed thoroughly and gently 
in the water bath.
C. The concentration of antiserum required was 
calculated from the following equation:
4 Vag Cag
T ^ h  (D^ - d%)
where P = antiserum concentration required (ul/ml gel); 
Vag = volume of antigen (ul); Cag = maximum concentration 
of antigen (g/1); T = antiserum titre; h = depth of gel; 
D = maximum precipitin ring diameter (mm) and d = well 
diameter (mm).
D. The agar was poured into plates (Figure 2)
directly from the bijou bottles. To ensure even agar
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thickness, this was carried out on a perfectly flat 
surface. Once the agar had set the plates were stored at 
4 °C before use.
E. Immediately before use seventeen 2 mm diameter, 5
ul capacity wells were cut from the agar of each plate, 
employing a template and 2 mm well cutter.
2.10.4 Preparation of Standards.
2.10.4.1 Experiment 1.
The standard suspension of ovine IgG was 3000 mg 
IgG/100 ml. This was diluted with normal saline to 
produce standards of 3000, 1500, 750, 375, 187.5 and
93.75 mg IgG/100 ml.
2.10.4.2 Experiment 2.
The standard suspension of ovine IgG was 4000 mg 
IgG/100 ml. This was diluted with normal saline to 
produce standards of 4000, 2000, 1000, 500, 250 and 125
mg IgG/100 ml.
In both experiments, standards were replicated in 
triplicate and distributed among several plates in a 
batch. This was in order not to give any bias to the 
standard results due to possible inacurracies in plate 
pouring. Standards were added to the wells in 4.0 ul 
amounts.
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2.10.5 Preparation of Whey.
Whey was extracted from colostrum samples by the method 
of Sharp (1965). 0.25 ml of rennet (BDH Ltd.) was added
to every 1 0  ml of colostrum in centrifugation tubes. 
After gentle mixing and leaving to stand at room 
temperature for 2 hr., the tubes were centrifuged at 1 0 0  
g for 10 min. The supernatant whey was pipetted off into 
2 ml sample storage tubes.
2.10.6 Procedure.
A. Samples of colostrum whey or serum were diluted to
half concentration by mixing 0 . 2  ml with 0 . 2  ml normal 
saline. In some cases, the colostrum whey samples were 
diluted further to a third of the initial concentration, 
to ensure that the resultant precipitin ring diameters 
were within the range of the standards.
B. The test solutions were added to the agar wells in
4 ul amounts. The water trough of each plate was filled 
to ensure that the agar did not dry out during 
incubation. Tests and standards were run together in the 
same batch, with 18 hr. incubation at room temperature.
C. After incubation, all precipitin ring diameters
were measured directly from the millimeter calibration 
marks on the plates.
2.10.7 Calculation of results.
A standard curve was obtained by plotting IgG 
concentration (mg/ 1 0 0  ml) on the logarithmic y axis of
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semi-logarithm chart paper, against ring diameter (mm) 
(x axis). The amount of IgG in test colostrum whey or 
serum was interpolated from this graph. The results were 
multiplied by 2 or 3, depending on initial dilution, to 
give concentrations in mg IgG/100 ml.
2.11 ANALYSIS OF SERUM BY THE ZINC SULPHATE TURBIDITY
TEST.
2.11.1 Summary.
A turbidimetric method for the detection and estimation 
of increases in blood gamma-globulin levels was first 
described for human serum. The technique measured the 
degree of turbidity developed when highly dilute salt 
solutions, such as copper or zinc sulphate, were allowed 
to react with serum. Relative turbidity in standards and 
test samples was determined spectrophotometrically. The 
immune globulins are similar in structure and reaction 
behaviour to gamma-globulins. It was therefore possible 
to apply the zinc sulphate turbidity (ZST) test as an 
indirect measure of lamb immune status, according to the 
method of McEwan, Fisher, Selman and Penhale (1970).
2.11.2 Procedure.
A. A stock solution of zinc sulphate (BDH Ltd.) was
prepared by dissolving 250 mg ZnSO^. 7 H2 O in 1 litre of 
distilled water. The distilled water was boiled for 15 
min. immediately before use, to remove dissolved carbon 
dioxide.
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B. This stock solution was diluted by adding one part 
distilled water to five parts stock. The pH of this 
solution was adjusted to pH 7.0. If such precautions were 
taken, it was unnecessary to buffer the system.
C. For each test serum, 6.0 ml of diluted zinc 
sulphate solution were dispensed into disposable plastic 
tubes. 0 . 1  ml of serum was added to each tube, making 
sure that all serum had been expelled from the pipette 
tip. Sera were tested singly.
D. The tubes were shaken vigorously, covered and 
allowed to stand for 1 hr. at room temperature. The 
mixture was again shaken vigorously before reading,
E. The degree of turbidity in each tube was 
determined spectrophotometrically by measurement of 
optical density (OD) at 620 nm, in a 1 cm plastic 
cuvette. Distilled water was used as a blank.
F. The spectrophotometer (MSE, Spectro-plus) was
calibrated with a solution of barium sulphate. To make 
this standard, a solution of 3 ml of barium chloride (BDH 
Ltd.), containing 1.15 g BaCl2 • 7 H2 O per 100 ml, was made 
up to 100 ml with 0.2 N sulphuric acid. When measured 
under the same conditions as the ZST test, this solution 
gave an OD of 0.60.
In accordance with the work of McEwan et ^  ( 19 70), 
this calibrating solution, giving an OD of 0.60, was 
assigned an arbitrary ZST value of 20 units. A direct 
linear relationship existed between OD and ZST value.
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Thus, any test serum OD could be given a value relative 
to the barium sulphate calibration standard. A straight 
line plot of OD against ZST value, passing through the 
origin and the coordinates 0.60 (OD) and 20 (ZST units), 
sufficed in obtaining ZST values from test OD results.
G. Red blood cells in haemolysed samples interfered
with the passage of light to the light sensitive detector 
of the spectrophotometer. This resulted in falsely high 
OD readings being obtained from haemolysed test sera, In 
these cases, 6 . 0  ml of boiled distilled water and 0 . 1  ml 
of serum were mixed and used as a blank. Twice the OD of 
the blank was subtracted from the test OD, to obtain an 
estimate of the true OD of the sample. This correcting 
procedure for haemolysed samples was that recommended by 
Fisher and Martinez (1975).
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CHAPTER 3
THE DIAGNOSIS OF COBALT DEFICIENCY IN THE PREGNANT EWE
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3.1 INTRODUCTION.
Much work, has been reported in the literature which 
relates to the diagnosis of ovine Co deficiency. However, 
surprisingly little has been directed specifically at 
pregnant sheep.
Sub-clinical Co deficiency has been shown to have 
detrimental effects on ewe fertility and neonatal lamb 
growth (Dunlop, 1946b). Clinical disease has also been 
reported to lead to an increase in the incidence of 
stillbirths and neonatal lamb mortalities (Duncan et a_l, 
1981). With this background, it would be pertinent to 
develop methods for the efficient diagnosis of Co 
deficiency in reproducing sheep (Mills, 1981), 
particularly for the sub-clinical syndrome. The Sub- 
clinical disease is more difficult to detect than the 
clinical form (Andrews, 1970b) and losses in production 
due to marginal deficiency may pass unnoticed by the 
farmer (Latteur, 1962). Thus, the ability to detect Co 
deficiency in pregnant ewes, both prognostically and 
diagnostically, would help to reduce animal production 
losses.
The role of serum vitamin B12 and MMA concentrations in 
the prognosis and diagnosis of Co deficiency in sheep, 
was discussed in the literature review. For the purpose 
of the work to be reported here, it is important to note 
that serum B 12 is an essential Co-factor in the 
methyImalonyl CoA mutase system in liver cells. Limiting 
concentrations of B12 in the liver due to Co deficiency
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lead to the appearance of elevated levels of MMA in blood 
(McMurray et 1985).
The chronology of developing deficiency is an important 
influence on the employment of these two diagnostic 
markers. As the appearance of MMA in blood is dependent 
on a limiting concentration of liver B12 in the Co­
deficient state, it may be expected that a fall in B12 
levels in serum will precede a rise in MMA concentrations 
(Mills, 1981).
This apparent advantage of serum B12 over MMA as a 
diagnostic marker may be balanced by other factors. 
McMurray et ^  (1985) regarded plasma Bl2 as a 'passive' 
marker of the condition and MMA as an 'active' marker. 
Serum MMA concentrations may also provide a more reliable 
indication of sub-clinical Co deficiency, than serum B12 
levels (Judson ^  ad, 1981 and Suttle, 1986 ). Further,
difficulties have been reported with the interpretation 
of serum B12 data (Millar and Penrose, 1980, Sutherland, 
1980 and Millar et al., 1984).
Another problem with the' use of serum B 12 
concentrations in the diagnosis of Co deficiency is the 
confusion which exists over the different analytical 
methods available (Slater et ad, 1985). A further 
complication is added by the possible presence of 
inactive analogues of the vitamin in sheep serum (Sutton 
and Elliot, 1972 and Halpin et ad/ 1984).
The objectives of this investigation were to assess the
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application of serum B12 and MMA concentration to the 
prognosis and diagnosis of Co deficiency in pregnant 
ewes. Particular reference was made to the detection of 
the sub-clinical form of the disease. A comparison of 
serum B12 analysis by microbiological and radio-immuno 
(RIA) assays was also undertaken, which aimed to clarify 
the employment of these two techniques for routine 
diagnostic work.
3.2 MATERIALS AND METHODS.
The data presented were obtained from two experiments 
undertaken at the Brickrow Farm Unit, The West of 
Scotland College, Auchincruive, Ayr, Scotland, in 1985/86 
(Experiment 1) and 1986/87 (Experiment 2). These 
investigated the effect of Co deficiency in pregnant hill 
ewes on reproductive performance and lamb viability. 
Results were derived from sheep of high and low Co status 
and from animals experiencing a progressive development 
into, as well as recovery from, the deficient state.
3.2.1 Animals and Treatments.
3.2.1.1 Experiment 1 (1985/86).
Sixty Co-sufficient Scottish Blackface X Swaledale ewes 
(Plate 1) were housed in four pens and bedded on sawdust 
(Plate 2). A Co-deficient ration (Table 1) was fed from 
30/9/85. This was 17 days before Suffolk rams were 
introduced to the sheep. All ewes were initially blood 
sampled on day zero (10/10/85) and for the last time on
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P l a t e  1. S c o t t i s h  B l a c k f a c e  X  S w a l e d a l e  e w e s  e m p l o y e d  i n
E x p e r i m e n t  1.
P l a t e  2. T h e  s h e d  a n d  p e n s  u s e d  i n  b o t h  E x p e r i m e n t  1 a n d
E x p e r i m e n t  2.
Table 1. Co-deficient diet fed to all ewes in Experiments
1 and 2.
FEED Co CONTENT 
(mg Co/Kg DM)
MAX. FRESH WEIGHT 
FED (Kg/head/day)
Timothy hay 0.06 ± 0 . 0 1 ad libitum
Micronised
maize 0.026 ± 0.005 0 . 64
Maize gluten 0.03 ±0.009 0.25
Skimmed milk 
powder 0.015 ± 0.007 0 . 1 0
Dicalcium
phosphate 0.03
Na Cl 0 . 005
Water — ad libitum
day 189. This period included 2 weeks pre-mating, mating, 
pregnancy and the first 4 weeks of lactation.
According to weight and condition score on 30/9/85, the 
sheep were randomly assigned to three treatment groups, 
of 2 0  animals each:
1. Non-supplemented
2. Half-supplemented
'NS' - Co-deficient intake 
throughout pregnancy.
'HS' - Co-sufficient intake for
the first half of pregnancy, 
but deficient from mid-term.
3. Fully- supplemented - 'FS' - Co-sufficient intake for
the whole of pregnancy.
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The NS ewes were maintained on the basal Co-deficient 
ration throughout the experiment. The HS group received a 
weekly Co supplement of 0.7 mg Co/head, given as an oral 
dose of cobalt sulphate (C0 2 SO4 . 7 H2 O), from 30/10/85
(day 20) until mid-pregnancy on 23/12/85 (Day 74), 
inclusively. These animals were then maintained on the 
basal diet for the remainder of the experiment. The FS 
sheep were given the weekly Co supplement from day 20, 
until the end of the investigation.
3.2.1.2 Experiment 2 (1986/87).
Thirty Scottish Blackface X Swaledale and thirty pure 
Scottish Blackface ewes, all Co-sufficient, were housed 
and bedded on sawdust, in the same four pens used in 
Experiment 1. A Co-deficient ration (Table 1) was 
introduced on 10/10/86. This was 57 days before Blue- 
Faced Leicester rams were introduced to the sheep. All 
ewes were blood sampled on day zero (10/9/86) and 
fortnightly thereafter, until day 260. This period 
included 8 weeks pre-mating, mating, gestation and the 
first 4 weeks of lactation.
According to weight and condition score on 2/9/86, the 
sheep were randomly allocated to three treatment groups, 
of 2 0  animals each:
1. Non-supplemented - 'NS' - Co-deficient intake
throughout pregnancy.
2. Half-supplemented - 'HS' - Co-deficient intake for the
first half of pregnancy, 
then Co-supplemented from 
mid-term.
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3. Fully-supplemented - 'FS' - Co sufficient intake for
the whole of pregnancy.
The ewes were maintained on the basal Co-deficient 
ration throughout the experiment. The HS group also 
received only this diet until mid-term (18/2/87 - day
161), when they were replenished with weekly oral doses 
of 0.7 mg Co/head as cobalt sulphate, until the end of 
the experiment. The FS sheep were given the weekly Co 
supplement from day 50, (37 days before the start of
tupping), until the end of the experiment.
3.2.2 Blood Sampling and Analysis.
All ewes were bled fortnightly by jugular-venipuncture. 
In both experiments, sera were analysed for vitamin B12 
content by the microbiological assay using Lactobacillus 
leichmannii as the test organism (Chapter 2, section 
2.4.1). In Experiment 2, B12 was also determined in sera 
by the RIA method (Chapter 2, section 2,4.2). MMA 
concentrations in the sera from both experiments were 
measured by a capillary gas chromatographic method 
(Chapter 2, section 2.5).
3.2.3 Statistical Analysis.
In both experiments, one way analysis of variance was 
used to test for significant difference between mean 
serum vitamin B12 or MMA concentrations among treatments 
at all the fortnightly samplings. Where an analysis of
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variance for a particular sampling was significant, the 
least significant difference test was used to determine 
significant differences between the means of individual 
treatments.
A regression analysis of treatment mean serum B12 
levels, determined by the microbiological assay in 
Experiment. 2, on RIA concentrations was performed. Thus, 
the mean serum B12 concentrations of each treatment at 
each sampling, analysed by the microbiological assay, 
were regressed on the corresponding results from the RIA 
technique.
3.3 RESULTS AND DESCRIPTION OF TRENDS IN THE DATA.
This section will present the serum B12 and MMA results 
of Experiments 1 and 2. A description of trends in the 
data will also be included. This will be derived directly 
from, and will contain no interpretation of, the results. 
For the purpose of data analysis and discussion, the 
following diagnostic criteria will be applied to the 
results:
Serum vitamin B12 >400 ng/1 - Co adequate status.
(Lower normal limit - LNL)
200 - 400 ng/1 - Marginal Co deficiency.
(Sub-clinical)
<200 ng/1 - Functional Co deficiency. 
(Clinical)
(After MacPherson, 1982).
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Serum MMA <5.0 uraol/1 - Co adequate status.
(Upper normal limit - UNL)
5.0 - 15.0 umol/1 - Marginal Co status.
(Sub-clinical)
>15.0 umol/1 - Functional Co deficiency.
(Clinical)
(After McMurray et al, 1985).
3.3.1 Serum Vitamin B12 by Microbiological Assay
- Experiment 1.
3.3.1.1 General trends.
Treatment mean serum B12 results are presented in 
Figure 1 and Appendix 1. Serum B12 concentrations in the 
NS ewes fell to be consistently below the LNL from day 55 
onward, which was 65 days after the introduction of the 
Co-deficient diet.
The serum . B12 status of the HS animals was high and 
above the LNL until mid-pregnancy, when these sheep were 
taken off the Co supplement (day 74). Serum B 12 
concentrations in this treatment then fell below the LNL 
on day 133 (59 days after the introduction of a Co­
deficient intake) and remained low for the rest of the 
experiment.
Serum B12 levels in the FS sheep remained above the 
LNL for the whole of the experiment.
3.3.1.2 Statistical evaluation.
There were no statistically significant differences in 
mean serum B12 concentrations among treatments until day
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Figure 1. Mean serum vitamin B12 concentrations, analysed 
by the microbiological assay, for the ewes in Experiment
1. (I------1 = Tupping period, f---- -f = Lambing period, j, =
Point at which the HS sheep were taken off the weekly Co 
supplement),
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41. At this time, the NS ewes had significantly lower 
serum B12 levels compared to the HS and FS sheep 
(P<0.001). Serum B12 concentrations in the NS animals 
then remained significantly below the FS controls for the 
remainder of the experiment (P<0.01 to P<0.001).
After removal of the Co supplement from the HS ewes on 
day 74, serum B 12 levels in this group became 
significantly lower than those in the FS sheep (P<0.001), 
but still higher than the NS treatment (P<0.01), on day 
90. Serum B12 concentrations in the HS animals were then 
significantly lower than the FS controls for the rest of 
the experiment (P<0.01 to P<0.001). No statistically 
significant differences were found for serum B12 levels 
between the HS and NS ewes on day 133, or for the 
remainder of the experiment.
3.3.2 Serum MMA - Experiment 1.
3.3.2.1 General trends.
Treatment mean serum MMA results are presented in 
Figure 2 and Appendix 2. Serum MMA concentrations in the 
NS ewes rose to be consistently above the UNL, from day 
133 onward. This was 143 days after the introduction of a 
Co-deficient intake.
Serum MMA concentrations in the HS animals rose above 
the UNL on day 161; 87 days after the introduction of a 
Co-deficient intake. However, MMA levels in this group 
fell below the UNL on day 189, after being above this 
threshold on day 175. This unexpected result may have
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F i g u r e  2 .  M ean  s e r u m  MMA c o n c e n t r a t i o n s  f o r  t h e  ewes i n
E x p e r i m e n t  1 .  ((-----------1 = T u p p i n g  p e r i o d , ! ---------- -| = L a m b i n g
p e r i o d ,  J, = P o i n t  a t  w h i c h  t h e  HS s h e e p  w e r e  t a k e n  o f f  
t h e  w e e k l y  o r a l  Co s u p p l e m e n t ) .
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been due to the small number of ewes available for 
bleeding at this last sampling date, producing an 
unrepresentative value.
Serum MMA Levels in the FS sheep remained below the UNL 
throughout the experiment.
3.3.2.2 Statistical evaluation.
There were no statistically significant differences in 
mean serum MMA concentrations among treatments until day 
104, when all groups differed from one another (P<0.05). 
A significant difference was again detected among all 
treatments on day 119 (P<0.01 to P<0.001). On days 133
and 146, mean serum MMA levels in HS and FS sheep were 
not significantly different, but were significantly lower 
than those in the NS animals (P<0.001).
After removal of the Co supplement from the HS sheep on 
day 74, serum MMA levels in this group became 
significantly higher than those in the FS treatment on 
day 161 (P<0.001) and remained so for the rest of the
experiment. From day 161 onward, serum MMA levels in the 
HS and NS ewes were not significantly different.
MMA concentrations in the serum of NS and FS ewes 
differed significantly from day 104, to the end of the 
experiment (P<0.05 to P(O.OOl).
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3.3.3 Comparison of Serum B12 and MMA Data
- Experiment 1.
Serum MMA concentrations in the NS ewes rose above the 
UNL 77 days after serum B12 levels in the same animals 
had fallen below the LNL. Similarly, MMA concentrations 
in the serum of the HS group rose above the UNL 28 days 
after serum B12 levels in the same sheep had fallen below 
the LNL.
A plot of treatment mean serum B 12 concentrations, 
determined by the microbiological assay, against 
treatment mean serum MMA levels for Experiment 1, is 
presented in Figure 3. The points enclosed within the box 
in this figure represent occasions where the mean serum 
B12 concentration in a treatment, at a particular 
sampling, was <400 ng/1, with a corresponding mean serum 
MMA level <5.0 umol/1.
3.3.4 Serum Vitamin B12 by Microbiological Assay and
RIA - Experiment 2.
3.3.4.1 General trends.
Treatment mean data for the microbiological and RIA 
determination of serum B12 in Experiment 2, are presented 
in Figures 4 and 5 and Appendices 3 and 4, respectively. 
In the section below, details of the RIA results are 
given in brackets, following those for the 
microbiological assay.
Serum B12 concentrations in the NS and HS ewes fell to 
be consistently below the LNL from day 84 (42 ) onward.
This was 54 (12) days after these sheep were placed on a
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F i g u r e  3 .  S c a t t e r  d i a g r a m  s h o w i n g  t h e  r e l a t i o n s h i p  
b e t w e e n  t r e a t m e n t  mean s e r u m  MMA a n d  s e r u m  v i t a m i n  B12  
c o n c e n t r a t i o n s ,  a t  e a c h  s a m p l i n g ,  f o r  t h e  e w e s  i n  
E x p e r i m e n t  1 .  ( S e r u m  B 1 2  a n a l y s i s  b y  m i c r o b i o l o g i c a l  
assay).
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F i g u r e  4 .  Mean s e r u m  v i t a m i n  B12 c o n c e n t r a t i o n s ^  a n a l y s e d  
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S t a r t  o f  w e e k l y  o r a l  Co s u p p l e m e n t a t i o n  o f  t h e  HS s h e e p ) .
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F i g u r e  5 .  M ea n  s e r u m  v i t a m i n  B12 c o n c e n t r a t i o n s ,  a n a l y s e d
b y  t h e  R I A ,  f o r  t h e  ewes i n  E x p e r i m e n t  2 .  (I 1 = T u p p i n g
p e r i o d , ! -----------1= L a m b i n g  p e r i o d ,  = S t a r t  o f  w e e k l y  o r a l
Co s u p p l e m e n t a t i o n  o f  t h e  HS s h e e p ) .
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Co-deficient intake. The serum B12 status of the NS group 
fell further, with mean values consistently below 200 
ng/1 from day 133 (98).
Serum B12 concentrations in the HS treatment fell until 
the introduction of the weekly oral supplement on day 
161. Levels in these animals then increased and rose 
above the LNL, 43 (43 ) days after the start of Co
repletion.
Serum B12 levels in the FS animals remained generally 
above the LNL throughout the experiment.
3,3,4.2 Statistical evaluation.
There were no statistically significant differences in 
mean serum B12 concentrations among treatments, until 
after the introduction of Co supplementation to the FS 
ewes on day 50. On day 56 (70), serum B12 levels in the
FS sheep were significantly above those in the NS and HS 
animals (P<0.01). Serum B12 concentrations in the FS and 
NS animals then remained significantly different for the 
rest of the experiment (P<0.001).
Serum B12 concentrations in the HS ewes were 
significantly below those in the FS sheep, from day 56 
(70) to 189 (218) inclusive (P<0.01 to P<0.001). On day
204 (232), 43 (71) days after the start of Co repletion, 
levels in HS animals were not significantly different 
from the FS treatment and remained so for the rest of the 
experiment. Serum B12 levels in the HS group rose to be 
significantly above those in the NS ewes on day 175 (175)
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(P<0.001). This was 14 (14) days after the start of Co
repletion and this difference between the HS and NS 
groups was maintained for the remainder of the 
experiment.
3.3,5 Serum MMA - Experiment 2.
3.3.5.1 General trends.
Treatment mean serum MMA data are presented in Figure 6 
and Appendix 5. Serum MMA concentrations in the NS ewes 
rose to be consistently above the UNL from day 119 
onward. This was 149 days after the introduction of the 
Co-deficient ration. MMA levels in the NS sheep continued 
to rise and were consistently above a mean of 15 umol/1 
from day 232 to the end of the experiment.
Mean serum MMA levels in the HS ewes rose above the UNL 
on day 133 (163 days after the introduction of the Co­
deficient diet) and remained above this threshold until 
after the initiation of Co repletion on day 161. Levels 
in this treatment then fell below the UNL on day 189, 28 
days after the start of Co supplementation.
Serum MMA levels in the FS animals remained below the 
UNL throughout the experiment.
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122
Table la. Serum MMA and Vitamin B12 concentrations in
ewes 3, 4 (HS) and 24 
in
(NS) compared 
Experiment 2.
with treatment means
DAY OF EWE SERUM TREATMENT SERUM TREATMENT
EXP, No: MMA MEAN VIT. B12 MEAN
0 3 ND 1.3umol/l 865ng/l 2383
4 ND 1.3 985 2383
24 B.Oumol/l 1.3 630 2152
14 3 20.5 1.5 840 1559
4 56.8 1.5 510 1559
24 7.2 1.8 625 1545
26 3 62.4 1.4 668 1449
4 ND 1.4 940 1449
24 6.0 1.8 560 1398
42 3 39 .5 1.5 ND 444
4 25.8 1.5 ND 444
24 8.3 1.3 455 406
5 6 3 97.4 1.4 290 436
4 31.0 1.4 280 436
24 9.8 1.9 390 509
70 3 78.4 1.9 165 425
4 65.0 1.9 150 425
24 14.9 2,4 170 401
84 3 180.5 3.4 110 235
4 223.2 3.4 130 235
24 33.4 3.3 165 228
89 3 165.9 3.9 80 231
4 180.1 3.9 140 231
24 85.0 4.2 120 234
119 3 446.2 4.8 75 199
4 325.9 4.8 140 199
24 163,4 6.3 110 210
133 3 464,4 5.0 90 220
4 ND 5.0 180 220
24 145.8 5.4 80 152
147 3 384.0 6.4 ND 206
4 496.4 6.4 ND 206
24 271.8 8.0 ND 187
161 3 610.9 6.2 180 165
4 506.2 6.2 190 165
24 280.8 6.6 ND 161
3.3.5.2 Statistical evaluation.
Serum MMA concentrations in ewes 3, 4 (HS) and 24 (NS) 
were much higher than the mean levels for the respective 
treatments (Table la). Elevated serum MMA concentrations 
(>15 umol/1) were evident in these sheep when 
corresponding serum B12 levels were in the sufficient 
region (>400 ng/1). For these reasons, the data from 
these three ewes was not included in the statistical 
analysis of serum MMA concentrations. This anomaly will 
be discussed later in section 3.4.2.4.
There were no statistically significant differences in 
mean serum MMA concentrations among treatments until day 
98, when levels in the NS and HS groups rose to be 
significantly above those in the FS animals (P<0.01). A 
statistically significant difference in serum MMA levels 
between the NS and FS groups was then maintained for the 
rest of the experiment (P<0.01 to P<0.001).
Serum MMA concentrations in the HS sheep were 
significantly above those in the FS treatment from days 
98 to 161, inclusively (P<0.01 to P< 0.001 ) . On day 175 
(14 days after the start of Co repletion), MMA levels in 
the HS ewes were not significantly different from those 
in the FS group and remained so for the remainder of the 
experiment. Also on day 175, serum MMA concentrations in 
the HS ewes fell to be significantly below those in the 
NS treatment (P<0.001). This difference was maintained 
for the rest of the experiment.
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3.3.6 Comparison of Serum B12 and MMA Data
“ Experiment 2 .
Mean serum MMA concentrations in the NS and HS ewes 
rose above the UNL 35 (77) and 49 (91) days respectively, 
after serum B12 levels in the same sheep had fallen below 
the LNL.
From the start of Co repletion of the HS treatment, 
mean serum B12 concentration took 15 (15) days longer to 
return to a normal value than serum MMA levels.
A plot of treatment mean serum B 12 concentrations, 
determined by the microbiological assay, against 
treatment mean serum MMA levels for Experiment 2 is 
presented in Figure 7. The points enclosed within the box 
in this figure represent occasions where the mean serum 
B12 concentration in a treatment, at a particular 
sampling, was <400 ng/1, with a corresponding mean serum 
MMA level <5.0 umol/1.
3.3.7 Comparison of Serum B12 Data as Determined by
Microbiological Assay and RIA - Experiment 2.
A statistically significant regression was found 
between B.12 concentrations analysed by the 
microbiological and RIA techniques, in the sera of ewes 
from Experiment 2 (Figure 8). On average, the mean 
results for each treatment at each sampling differed 
between the two methods by 20 per cent, when this 
difference was expressed as a percentage of the 
microbiological assay data. Thus, the microbiological 
technique gave serum B 12 concentrations 20 per cent
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Figure 7. Scatter diagram showing the relationship 
between treatment mean serum MMA and serum vitamin B12 
concentrations, at each sampling, for the ewes in 
Experiment 2. (Serum B12 analysis by microbiological 
assay).
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Figure 8. Scatter diagram showing the relationship 
between serum- vitamin B12 concentrations analysed by the 
microbiological assay or the RIA, at each sampling, for 
the ewes in Experiment 2.
y = 0.71X + 57.11 (P<0.001, RSD = 77.7, n = 54, r = 0.97)
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higher than the RIA method, on the same sera. The
regression equation is shown below:
y = 0.71X + 57.11 
RSD for variation about y = 77.71
r = 0.97 n = 54 (P<0.001)
Where, y = serum B12 concentration by RIA and x = serum 
B12 by microbiological assay,
3.4 DISCUSSION.
3.4.1 Levels of Cobalt Deficiency in Ewes - Experiments
1. and 2.
3.4.1.1 Experiment 1.
Using the diagnostic criteria stated at the beginning 
of the results section, both the NS and HS ewes of 
Experiment 1 were sub-clinically Co-deficient before the 
start of lambing. As deficiency progressed, mean serum 
B12 concentrations in these treatments fell to between 
200 and 400 ng/1 (Figure 1) and mean serum MMA levels 
increased to within the 5.0 to 15.0 umol/1 range (Figure 
2). Mean serum B 12 and MMA levels in the FS ewes 
indicated Co sufficiency throughout the experiment.
Mean serum B12 concentrations in the NS group did fall 
to 150 ng/1 on days 133 and 189. However, the appearance 
of such values in the clinical range were not consistent 
and serum MMA levels did not indicate clinical Co 
deficiency at these samplings. Between days 133 and 189, 
there was a peri-parturient rise in serum B 12
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concentrations in all treatments.
These conclusions were supported by observations of 
animal health. All animals were clinically normal 
throughout the experiment, with no symptoms of clinical 
Co deficiency disease evident.
3.4.1.2 Experiment 2.
Both the serum B12 and MMA data from this experiment 
indicated that Co deficiency had progressed in the NS 
ewes during pregnancy and that by the end of the 
investigation these sheep had experienced sub-clinical, 
developing to clinical, disease. However, the clinical 
deficiency evident from the start of lambing was not 
severe. Mean serum B12 concentrations in the NS animals 
(Figure 4) were within the sub-clinical range from 
approximately day 70 to day 133, and in the clinical 
region thereafter. Mean serum MMA levels for this 
treatment (Figure 6) were in the sub-clinical range from 
day 119 until day 232, after which they were consistently 
in the clinical region. Mean serum B12 and MMA 
concentrations in the HS ewes indicated sub-clinical Co 
deficiency from tupping until mid-pregnancy, when these 
sheep were supplemented with Co. Mean levels of B12 and 
MMA in the serum of the FS group implied Co sufficiency 
throughout the investigation.
As in Experiment 1, these conclusions were supported by 
observations of animal health. Ewes in the HS and FS 
treatments were clinically normal throughout Experiment
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2. The NS sheep appeared to suffer from clinical Co 
deficiency at the start of lambing, although the symptoms 
were not clear. These ewes were lethargic at lambing 
time and this continued until the end of the experiment. 
However, no other symptoms such as pale and sensitive 
skin and mucous membranes, lacrymation, photosensitivity, 
loss of appetite or emaciation were evident.
3.4.2 Comparison of Serum B12 and MMA as Diagnostic
Markers.
3.4.2.1 Variability in serum B12 and MMA data.
In both experiments, mean serum B12 concentrations in 
pregnant ewes were more variable than serum MMA levels 
(Figures 1, 2, 4 and 6). For example, in Experiment 2 the 
mean serum B12 concentrations in the FS sheep fell 
briefly below the LNL on days 70 and 119 (Figure 4). This 
would supposedly indicate sub-clinical Co deficiency in 
these Co supplemented animals. However, serum MMA levels 
in these same ewes did not rise above the UNL at any 
time.
Another example occurred in Experiment 2 where mean 
serum B12 concentrations in the NS sheep were variable 
around the LNL between days 14 and 90 (Figure 1). This 
made it difficult to decide whether or not these animals 
were sub-clinically Co-deficient at this time. In 
contrast, mean serum MMA levels in the same ewes were 
less varied between samplings and when concentrations 
rose above the UNL on day 133, thus inferring sub-
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clinical disease, this was decisive with concentrations 
remaining above this threshold thereafter.
3.4.2.2 Serum B12 and MMA in the diagnosis of cobalt
deficiency in pregnant ewes.
Serum B12 concentrations indicated Co deficiency in 
pregnant ewes before the same conclusions could be drawn 
from the serum MMA data. This was evident in Experiment 
1, where mean serum B12 levels in the NS and HS ewes 
indicated sub-clinical disease, 77 and 28 days 
respectively, before mean serum MMA concentrations in the 
same sheep implied this degree of deficiency. The same 
conclusion could also be derived from the NS and HS 
treatment data of Experiment 2. Further, mean serum B12 
levels in the the NS sheep consistently indicated 
clinical Co deficiency from day 133, while serum MMA 
concentrations did not consistently imply this degree of 
disease until 99 days later, on day 232.
These results suggest that serum B12 levels reflected a 
fall in Co status in pregnant ewes some weeks before the
same diagnostic inference could be drawn from the serum
MMA data. This finding is in agreement with the
theoretical discussions concerning the biochemistry of Co 
deficiency in section 3.1.1. The appearance of MMA in 
blood is dependent on a limiting concentration of B12 in 
the liver (McMurray et. a%, 1985 ). Thus, it is not
surprising that serum B12 levels fall before a rise in 
serum MMA concentration is detected.
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3.4.2.3 Implications for the diagnosis of cobalt
deficiency in pregnant ewes.
These observations on the variability and chronological 
characteristics of serum B12 and MMA concentrations, in 
relation to Co deficiency, may have implications for the 
use of these two markers in the diagnosis of the disease 
in pregnant ewes. These effects will be discussed in this 
section.
That serum B12 concentrations declined before serum MMA 
levels increased means that there were inevitably a 
proportion of cases where the use of these two markers 
did not coincide in terms of diagnosis. These instances 
of disagreement occurred at serum B12 concentrations of 
between 200 and 400 ng/1, in the sub-clinical range.
In the field situation, the chronological 
characteristics of these two markers in a developing Co 
deficiency may not be important, as a diagnosis would be 
made on samples taken on only one or two occasions. 
However, it is possible to envisage a proportion of cases 
where these differences in the diagnostic interpretation 
of serum B12 and MMA concentrations could affect the 
advice given to farmers. For instance, where a sub- 
clinical deficiency problem on a farm might be diagnosed 
by analysis of serum vitamin B12, measurement of serum 
MMA on the same samples may not lead to the same 
conclusion. If the diagnostic criteria employed in these 
experiments are applied, then a number of such situations 
will arise.
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This point is well illustrated by the scatter plots of 
Figures 3 and 7. These represent mean serum vitamin B12 
(microbiological assay) and MMA data from both 
experiments. Without exception, for all samplings where 
mean serum B12 concentrations for a treatment were above 
the LNL (i.e. Co-sufficient), the corresponding MMA 
levels were in the sufficient range below the UNL. 
However, in Experiment 1 on 15 occasions where mean serum 
B12 levels for a treatment were in the deficient range 
below 400 ng/1, 8 (53 per cent) also showed
concentrations of MMA in the sufficient region. 
Similarly, in Experiment 2, on 26 occasions where levels 
of the vitamin were below the LNL, 11 (42 per cent) had
corresponding serum MMA concentrations below 5 umol/1. 
The anomalous values are enclosed in the boxes in Figures 
3 and 7. Similar results to these were reported by Rice 
et al, (1987). Thus, a deficient serum vitamin B12
concentration may not be reflected by a serum MMA level 
which would yield the same diagnostic conclusion. There 
are three possible reasons for this anomaly.
Firstly, the ranges set as diagnostic criteria for 
either marker may be wrong, at least in the context of 
pregnant ewes. Those employed for the microbiological 
determination of serum B12 using L_i_ leichmannii, have 
been tested and found to be useful in many animal 
response experiments, both in tightly controlled housed 
experiments (MacPherson ^  197 6) and in the field
(MacPherson, 1982). The ranges set for the employment of
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serum MMA in the diagnosis of ovine Co deficiency, were 
studied by McMurray et aJ, (1985) and Rice et a%, (1987)
and were found to correspond to animal response in terms 
of C0 /BI2 status.
Assuming that the two markers did broadly reflect 
response of the sheep to Co status, a second explanation 
for the anomaly might be inconsistency in analysis. It 
has long been postulated that spurious low values ('false 
positives') can occur in serum B12 analysis (Findlay, 
1972 and Mills, 1981). This possibility of false values 
and the problems associated with great variability of 
serum B12 data in the diagnosis of Co deficiency, has led 
some workers (Findlay, 1972, Millar and Penrose, 1980 and 
Judson et ad, 1981) to conclude that this parameter is of 
little use as an indicator of sub-clinical Co deficiency 
in sheep. Variability in mean serum B12 concentrations 
between samplings for the same treatments, was certainly 
evident in the two experiments reported here.
The charges of inconsistency and variability can not be 
levelled at the serum MMA data of Experiments 1 and 2. 
Indeed, levels of MMA in serum were less variable than 
concentrations of B12. Further, Rice et, aA ( 1987 ) 
concluded that there were no problems from the diagnosis 
of false positives or negatives with the analysis of MMA 
in the blood of grazing sheep.
The third possible explanation is that as the imposed 
deficiency developed, voluntary feed intake was reduced.
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or the deficient animals stopped feeding completely. This 
would have the effect of lowering the propionate load on 
the liver. The production of MMA would subsequently 
decline leaving little in serum, while serum B12 remained 
low. This possibility was highlighted by Andrews and 
Hogan (1972) and Rice ^  al. ( 1987 ). However, the ewes in 
these experiments were housed and under close 
supervision, and inappetence due to Co deficiency did not 
occur.
The correct interpretation of the anomaly perhaps lies 
with the second explanation and with the consideration 
that serum B12 is a passive marker of Co deficiency, 
while serum MMA is an active indicator. For these 
reasons, a decline in serum B12 concentration is not 
necessarily an accurate indication of functional vitamin 
levels and stores in the liver. At some point during B12 
depletion the amount of vitamin in the liver becomes 
limiting to the methyImalonyl CoA mutase enzyme. The 
difficulty in relation to diagnosis is to determine the 
B 12 concentration in serum which reflects such a 
situation in the liver.
Comparison of the results from these two experiments 
with evidence in the literature suggests that it may be 
impossible to define a concentration of B12 in serum, 
which would accurately and precisely make such a 
prediction. Vitamin B12 has no functional role in serum 
and blood may simply act as a transport mechanism 
(McMurray et aj., 1985) and store (Suttle, 1986) for B12.
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This store, if such it be, has to be used before there is 
any possibility of deficiency at the liver level.
If this is the case, low concentrations of B12 in serum 
would not be caused by a dearth of functional vitamin 
levels and stores in the liver. Rather, a serum B12 
decline would precede a deficiency in the liver. When 
serum stores are utilised and concentrations fall, then 
at some point, a deficiency in the liver would ensue. A 
direct cause and effect relationship between serum and 
liver B12 levels can not then be inferred and serum 
concentrations would have a purely passive role in the 
diagnosis of Co defciency.
With this scenario, a low level of vitamin B12 in serum 
would not necessarily indicate metabolic deficiency in 
the liver. In comparison, it is postulated that MMA does 
not rise in serum until B12 actually becomes limiting to 
the methlmalonyl CoA enzyme in liver cells. Therefore, 
MMA is a more positive and active marker of Co deficiency 
than serum B12, especially in the grey area of sub- 
clinical disease (McMurray et aj.', 1985 and Rice et al/
1987). Further, there should be no possibility of 
diagnosing false negatives with serum MMA analysis (Rice 
et al, 1987). That is, when serum MMA concentrations are
below the UNL, B12 is not deficient in the liver. When 
serum MMA levels are high, functional concentrations of 
the vitamin in liver must be limiting.
Rice ^  (1987) compared the use of plasma B12 and
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MMA concentrations for the diagnosis of Co deficiency in 
grazing sheep. They concluded that it "...should be 
possible to make a positive diagnosis of Co deficiency on 
the basis of a high plasma MMA result from one animal." 
However, to avert any possibility of false negatives, 
"...it would be best to assess the status of a flock 
using a small group of animals."
The results from these Experiments 1 and 2 were 
consistent with these arguments. That Co deficiency was 
indicated in the pregnant ewes by increased MMA 
concentrations in serum weeks after serum B12 levels had 
fallen below the LNL, is therefore not relevant to 
accurate diagnosis (Suttle, 1986). It is postulated here 
that such 'early' low concentrations of vitamin in serum, 
during the development of disease, are false in terms of 
indicating a sub-clinical B12 deficiency in the liver.
It may therefore be argued that the diagnostic ranges 
applied to the serum B12 data should be changed, in order 
to increase their accuracy and precision in diagnosing 
ovine Co deficiency. If this was undertaken, the problem 
of variability in the serum B12 results would not be 
overcome, but the data would be more applicable to the 
positive identification of Co deficiency disease in the 
liver.
However, it should be remembered that in the pregnant 
ewes of both experiments the fall in serum B 12 
concentrations before the observed rise in serum MMA 
levels, was a consistent phenomenon. Further, serum B12
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concentrations are reported to be a reliable indication 
of Co intake (MacPherson et e^, 1976 and Sutherland,
1980). For these reasons, serum B12 concentrations may 
provide an acceptable indication of ensuing deficiency 
(Sutherland, 1980) and the diagnostic ranges applied to 
serum B12 data should therefore not be changed. Thus, 
while serum MMA levels may be a more accurate and precise 
diagnostic marker of Co deficiency at the liver in 
reproducing sheep, concentrations of B12 in serum may be 
used in the prognosis of the condition. The results 
reported here suggested that only serum B12, and not 
serum MMA, could be used as a prognostic marker of sub- 
clinical and clinical Co deficiency.
The most accurate and precise means of detecting Co 
deficiency in pregnant ewes, both prognostically and 
diagnostically, may thus be to determine the 
concentrations of both of these markers in serum and use 
them as joint indicators of disease. Such an approach was 
described by McMurray et ^  (1985). For this purpose,
proposed criteria for the joint use of serum B12 and MMA 
concentrations in the diagnosis of Co deficiency in 
pregnant ewes, are presented in Table 2.
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Table 2. Proposed diagnostic criteria for serum B12 and
MMA in pregnant ewes.
VIT. B12* 
(ng/1)
MMA
(umol/1)
COMMENT STATUS
>400 <5.0 High B12:Normal MMA Co-sufficient.
200 - 400 <5.0 Moderate B12:Normal MMA Co-sufficient, 
but deficient 
intake.
200 - 400 5.0 - 
15.0
Moderate B12 and MMA Sub-clinical 
Co deficiency.
<200 >15.0 Low B12:High MMA Clinical 
Co deficiency.
* Serum B12 determination by microbiological assay, using 
L . leichmannii as the test organism.
3.4.2.4 A possible problem with serum MMA.
In Experiment 2, three ewes showed consistently high 
concentrations of MMA in serum throughout the experiment. 
Recorded levels in these animals reached as high as 600 
umol/1. Concentrations were generally around 15.0 umol/1 
when corresponding mean levels in their counterparts were 
in the Co-sufficient range, below'5.0 umol/1.
Two of these sheep (No:3 - HS and No:24 - NS) were 
found to be barren at scanning. The other (No:4 - HS) 
gave birth to a small lamb weighing only 2.4 Kg (the mean 
birthweight of the lambs in the HS treatment was 4.8 Kg). 
Ewes 3 and 24 were culled and the Co content of their 
livers analysed. Deficient liver Co values of 0.02 mg/Kg 
fresh weight were evident in both these animals. Their
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livers also appeared fatty on gross inspection and No : 3 
was diagnosed as suffering from white liver disease.
These observations provide a note of caution in 
relation to the use of serum MMA in the diagnosis of 
ovine Co deficiency. Where liver damage is present, this 
metabolite may 'leak out' into circulation in much higher 
concentrations than normal. This could produce situations 
where the analysis of serum for MMA would yield a false 
positive diagnosis of Co deficiency in individual 
animals.
In these cases, the liver damage was probably caused by 
the Co deficiency. In other circumstances, liver damage 
may result from different causes, but where Co status is 
adequate. Further work is needed to establish whether or 
not leakage of MMA from the liver would occur in such 
situations, resulting in abnormally high serum MMA 
concentrations in Co-sufficient animals.
3.4.2.5 The diagnosis of cobalt deficiency in flocks.
The results presented suggested that serum vitamin B12 
concentrations were variable and somewhat inconsistent 
over time, compared to serum MMA levels. Thus, the 
diagnosis of Co deficiency in a whole flock of 
reproductive ewes, can not be based on the B12 analysis 
of serum samples from just one or two sheep. 
Determination of the more accurate and precise marker, 
serum MMA, may render such a diagnosis possible on the 
basis of a few samples. However, the possibility of
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obtaining false positives due to liver damage and the 
general lack of background research, lead to the 
conclusion that such confidence can not yet be placed in 
the diagnostic efficiency of serum MMA.
The best possible approach to take in the prognosis and 
diagnosis of Co deficiency in a flock of reproducing 
ewes, would be to sample a larger proportion of the 
animals. This is particularly the case when it is 
necessary to detect the sub-clinical disease. A guideline 
proportion to sample, to enable an accurate diagnosis to 
be made, might be 10 per cent of a flock.
3.4.2.6 Cobalt repletion of the HS ewes in Experiment 2.
There is no evidence in the literature of any 
investigations which studied the effect of Co repletion 
on high serum MMA concentrations in Co-deficient ewes. In 
Experiment 2, the HS sheep were rendered sub-clinically 
Co-deficient and were then replenished from day 161.
In terms of mean serum concentrations, both B12 and MMA 
took several weeks to return to normal levels, after the 
start of Co supplementation (Figure 4 and 6). The 
fortnightly samplings were too infrequent to determine 
exactly when serum B12 and MMA levels indicated Co 
sufficiency in the HS sheep, but mean serum MMA 
concentrations seemed to fall below the UNL approximately 
2 weeks before serum B12 levels rose above the LNL. These 
results suggested that both serum B12 and MMA
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concentrations were sensitive indicators of Co intake in 
deficient ewes.
The fact that the two markers responded decisively to 
Co supplementation of the HS sheep, increases confidence 
in their use as diagnostic indicators of Co deficiency in 
pregnant ewes. Further, there were no marked fluctuations 
or variations in the response of either serum B12 or MMA 
concentrations. Both markers did take weeks, and not 
days, to return to normal levels, but the level of Co 
repletion provided was not great.
That serum MMA levels returned to the normal range in 
advance of serum B12 suggested that functional 
concentrations of the vitamin in liver were restored to 
adequate levels before this was reflected by B12 levels 
in circulation. This is in disagreement with the 
assertions of Sutherland (1980). The model for ovine Co 
depletion and repletion presented by this worker (Chapter 
1, Figure 4), implied that in response to Co 
supplementation, serum B12 concentrations should rise 
before liver B12 levels. The results of Experiment 2 
indicated that liver B12 status increased (leading to a 
decline in serum MMA concentrations) before serum B12 
levels.
It should be noted, however, that comparison between 
the model of Sutherland (1980) and the results from 
Experiment 2, is difficult. If the HS sheep had been 
sampled more frequently, then serum B12 concentrations 
may have been shown to rise before serum MMA levels fell.
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This would fit Sutherland's model. The results that were 
obtained suggested that increased rumen microbial 
production of B12 after repletion was not reflected by- 
rapid rises in serum B12 concentrations from fortnightly 
samplings.
Weekly oral dosing of the deficient HS ewes with Co, 
may have led to transient increases in serum B12 
concentrations. This extra vitamin would have been used 
or stored in the liver. Such an effect would tend to 
increase B12 levels in the liver, with a consequential 
fall in serum MMA concentrations, while serum B12 status 
fluctuated according to time of sampling in relation to 
the last weekly Co supplement. The increase in B12 status 
of the liver was therefore not reflected in serum B12 
concentrations from fortnightly samplings. The exact 
sequence of events could only have been determined by 
collecting blood more frequently from the HS ewes during 
the period of Co repletion.
These arguments imply that the model of Sutherland 
(1980) for Co repletion, is simplistic. The smooth, 
graded fashion in which this model envisaged the réponse 
of serum B12 to Co repletion, was not reflected in this 
investigation. Rather, weekly Co supplementation probably 
led to a more staggered response, which was not reflected 
by the sampling regime until several weeks after the 
start of Co repletion. Such a pattern is supported by the 
work of MacPherson (1987).
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3.4.3 Comparison of the Microbiological Assay and RIA 
Techniques for the Determination of Serum Vitamin B12.
Due to the confusion which exists in the literature 
over the methodology of determining serum vitamin B12 
(Millar and Penrose, 1980 and Slater et 1980),
provision was made in Experiment 2 to study two 
analytical techniques. Serum vitamin B12 data measured by 
the microbiological assay method were compared with those 
determined by the RIA technique. Both methods provided 
serum B12 results which revealed the same trends in ewe 
vitamin status, in the three treatments of Experiment 2. 
However, the mean serum B12 concentrations for each group 
at each sampling differed between the two techniques by 
(on average) 20 per cent. In this way the microbiological 
assay consistently yielded mean serum B12 levels which 
were higher than those evident from the RIA. This was 
shown by the regression analysis performed on the two 
techniques, presented in Figure 8.
This phenomenon meant that confusion could arise in 
interpreting the results from these two methods. If the 
diagnostic criteria applied to the microbiological assay 
results were imposed on the serum B12 data from both 
techniques, they suggested different timings in the 
chronology of developing Co deficiency. Unfortunately, 
in advisory work, the same diagnostic ranges are applied 
to both techniques, but the RIA B12 data implied the 
presence of progressive Co deficiency in NS and HS ewes 
some days before the microbiological assay results.
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The reasons for this discrepancy arise from the 
analytical methods employed. In sample preparation for- 
the microbiological assay, all analogues of B12 were 
converted to cyanocobalamin. This form of the vitamin was 
then measured indirectly by the growth of the test 
bacterium, 1 eichmanni i . Thus, this technique
determined 'total' B12 in serum, which included both 
physiologically active and inactive forms of the vitamin.
The RIA employed a blocking agent to inactive B12 
analogues, hindering their ability to bind to the added 
binder. These analogues were therefore not measured by 
this technique. Hence, the RIA determined only 'true' B12 
and yielded lower values for serum concentrations, than 
the microbiological assay measurement of 'total' B12.
The relationship between the data produced by these two 
analytical techniques was linear, as presented in Figure 
8. The regression analysis was calculated and the graph 
was drawn from the means of over 1000 sera samples. The 
regression also had a high 'r ' value of 0.97, which gives 
a high degree of confidence in the derived equation.
3.4.4 Implications for the diagnosis of cobalt
deficiency in pregnant ewes.
The data presented here suggested that a change in the 
diagnostic criteria applied to the RIA (Becton and 
Dickinson) technique, may be appropiate. This might be 
achieved by simply reducing the ranges applied to the RIA 
method, which were established for use with the
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microbiological assay, by 20 per cent. Thus, when this 
RIA method is used in the diagnosis of Co deficiency in 
pregnant ewes, serum B12 concentrations between 160 and 
340 ng/1 should be considered as indicative of sub- 
clinical (marginal) deficiency. Values less than 160 
ng/1, would indicate clinical disease.
Before these new criteria can be employed, two factors 
must be clarified. Firstly, the diagnostic ranges 
superimposed on the data from either method, should 
enable accurate diagnosis. Taking the limitations of 
serum B12 concentrations in the diagnosis of Co 
deficiency into account, the two methods used did 
indicate the occurrence of the disease in the pregnant 
ewes of Experiments 1 and 2. Thus, in terms of diagnosis, 
the new criteria applied to the RIA technique would be 
effective.
The second factor to be noted is that these results 
were obtained from sheep fed a high concentrate type 
ration. There is evidence in the literature to suggest 
that high concentrate intakes reduce the amount of rumen 
microbially produced true vitamin B12, as a proportion of 
the whole, compared to high roughage intakes (Sutton and 
Elliot, 1972 and Walker and Elliot, 1972 ), This 
phenomenon may result in an increased proportion of 
inactive analogues being present in serum. Thus, for this 
data, the microbiological assay gave higher values for 
serum B12, because it measured all forms of the vitamin. 
On the contrary, the RIA technique did not determine such
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increased levels of inactive analogues and in consequence 
produced lower serum B12 values than the microbiological 
assay.
An opposing situation to this might occur at pasture, 
where rations are high in roughage. In such cases it may 
be expected that the proportion of true B12 in serum will 
be more and that of inactive analogues less than that 
present in this experiment. In this situation, the 
difference between the two methods in serum B12 analysis 
would not be as great.
Work carried out at the Veterinary Investigation
Centre, Auchincruive, supports this argument (Taylor and 
Greer, 1982). When analysing sera from 29 sheep at grass 
for serum B12 content, using exactly the same two
techniques employed in Experiment 2, the following
regression equation was obtained:
y = 0.91x + 47.7 
r = 0.97 n = 29
Where. ' y ' = serum B12 by RIA and ' x ' = serum B12 by
microbiological assay. This equation implies only a 
negligible difference in serum B12 concentrations between 
the two methods. This is in strong disagreement with the 
consistent 20 per cent discrepancy found in the
Experiment 2 data of this project.
For this reason, changing the diagnostic criteria
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applied to serum B12 data from the RIA technique, may not 
be appropriate in the field situation, where sheep have a 
high roughage intake. Therefore, the results from this 
investigation can at present only be related to 
reproducing ewes on high concentrate diets.
More work is needed to clarify the position in 
different practical circumstances. For example, it is not 
clear how these arguments would apply to RIA determined 
serum B12 levels in gestational ewes at grass, when up to 
1 Kg/ewe of concentrates per day are fed in the latter 
stages of pregnancy. It may be that in such 
circumstances, significant concentrations of inactive 
analogues would be present in serum and differences 
between RIA and microbiologically analysed B12 data might 
exist.
It is also important to note that some workers have 
found no evidence of the presence of inactive analogues 
in sheep serum, or have detected them in only negligible 
amounts (Gawthorne, 1970, Marston, 1970 and Halpin et ab, 
1984). If this is the case, then the above arguments used 
to explain the differences in microbiological assay and 
RIA B12 data would not be valid.
In addition, it has been postulated that the RIA method 
may not measure only 'true' B12 in serum (Millar and 
Penrose, 1980 and Wright, Taylor and Greer, 1982). 
Residual binding of inactive analogues to the added 
binder may occur in this technique, even in the presence 
of inactive analogue blockers. This would result in the
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measurement of 'true' B12, plus any analogues that were 
residually bound.
It is clear from this discussion that the situation is 
confused and complex and that this investigation of two 
analytical techniques for serum B12, can not answer all 
the questions posed. Therefore, more work is necessary to 
establish whether or not inactive analogues are present 
in sheep serum and exactly what forms of the vitamin are 
measured by the RIA method,
Millar and Penrose (1980) reported that microbiological 
and RIA methods gave good agreement on serum B 12 
concentrations in sheep, except in situations where 
analogue production was significant. Thus, it seems that 
the differences in the two techniques used in this 
investigation were probably due to varying rates of rumen 
microbial B12 analogue production and absorption into 
serum. In which case, the correct diagnostic criteria 
must be imposed on corresponding serum B 12 data, if 
accurate and reliable prognosis and diagnosis is to be 
achieved. The 'correct' criteria will depend on the 
interaction between the physiological state of the sheep 
and the type of ration fed. These factors must be 
considered before diagnosis is attempted.
Having discussed the results from Experiments 1 and 2 
and compared them with evidence in the literature, there 
is a need to decide on the most effective strategy for 
diagnosing Co deficiency in pregnant ewes. However,
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before such statements can be positively made other 
factors, such as the effect of feeding on serum B12 and 
MMA concentatlons, require investigation. Such influences 
will be studied in Chapter 4.
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CHAPTER 4.
D E V E L O P M E N T  O F  S E R U M  V I T A M I N  B 1 2  A N D  M E T H Y L M A L O N I C  A C I D  
A S  D I A G N O S T I C  M A R K E R S  O F  C O B A L T  D E F I C I E N C Y  I N  S H E E P .
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4 . 1  I N T R O D U C T I O N .
The use of serum vitamin B12 and MMA concentrations 
in the diagnosis of Co deficiency in pregnant ewes, was 
described in Chapter 3. Three aspects require further 
investigation: a) The possible presence of diurnal
fluctuations in serum B12 and MMA levels, b) The effect 
of feeding and changing feeding times on the 
concentrations of B12 and MMA in serum, c) The effect of 
starvation on serum B12 and MMA levels.
4.1.1 Diurnal Flucuations and Feeding Pattern.
The possibility that concentrations of vitamin B12 in 
the blood of sheep might fluctate in a diurnal pattern 
was first proposed by Somers and Gawthorne (1969). In a 
trial with 10 individually housed Merino wethers fed 
controlled diets of graded Co content, these workers 
found marked fluctuations in plasma B12 levels during a 
day of intensive sampling, when blood was collected by 
jugular-puncture every 4 hours. Plasma B12 concentrations 
varied over a 24 hr. period by up to 130 per cent.
Such fluctuations could have been related to the 
exogenous stimulation of feeding frequency, or endogenous 
stimuli associated with the time of day. However, 
fluctuations in blood B12 levels only occurred in some 
sheep. In other wethers there seemed to be no 
relationship between time of feed intake, or time of day 
and the rise and fall in plasma B12 levels. Where 
variations did exist, they were more marked in animals
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with generally high plasma B12 concentrations and given a 
Co-sufficient intake, than in those showing low levels 
and receiving a Co-deficient diet.
Somers and Gawthorne (1969) concluded that plasma B12 
concentrations did not appear to be affected by animal 
handling, but were dependent upon feed and thus Co 
intake. After a period of feeding, microbial production 
of vitamin B12 would increase in the reticulorumen of Co­
sufficient sheep, followed by a rise in plasma 
concentrations. Liver stores would have been adequate and 
thus have had no buffering effect on large fluctuations 
in plasma B12 levels. On the contrary, in Co-deficient 
animals a rise in microbial production of B12 after a 
period of feeding on a diet deficient in the trace 
element, would not be as marked. In this case, liver 
stores would have been low and any vitamin transported in 
the blood would have been quickly used or stored in the 
liver and thus fluctuations in plasma B12 levels were 
buffered. Although this scenario explains the variations 
found by Somers and Gawthorne (1969) these investigators 
made no attempt to define any innate daily fluctations in 
plasma B12 concentrations, other than those associated 
with twice daily feeding.
The findings of these earlier workers are in sharp 
contrast to those of Millar et al (1984), who took six 
sheep at pasture, housed them for one day, fed cut grass 
ad libitum and bled at hourly intervals. Although serum
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B12 concentrations in individual sheep ranged from 400 to 
2500 ng/1, no diurnal fluctations were evident. Further, 
in six sheep fed at pasture and bled every three hours 
over a two day period, there were no diurnal fluctuations 
in serum B12 levels. From this later work, it would 
appear that the diurnal flucuations found by Somers and 
Gawthorne (1969), were solely related to a twice daily 
feeding pattern and not to time of day per se.
Investigations into the possibility that diurnal or 
other fluctuations in the concentration of MMA in blood 
might exist, have not been reported -in the literature. 
Such characterisation is necessary if this parameter is 
to be used in the diagnosis of Co deficiency. This 
requirement for further work was identified by Andrews 
and Hogan (1972) who observed that "...the amount of MMA 
found in a sample is likely to vary according to the 
amount of propionate (from rumen fermentation) presented 
for metabolism, since propionate is a precursor for 
methy Imalonyl CoA; that is , the amount of MMA found may 
depend upon the amount of feed consumed during the recent 
past and the time elapsing between ingestion and 
sampling. These points require investigation."
4.1.2 The Effect of Starvation.
The effect of starvation on blood levels of vitamin B12 
and MMA is not clear. Inappetence due to Co deficiency is 
a classic clinical symptom of the disease (Underwood, 
1977). Therefore, the effect of such an occurrence on the
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role of these two diagnostic markers needs verification. 
Although many investigations documenting clinical Co 
deficiency have been reported in the literature (Andrews 
and Anderson, 1955; Andrews Hart and Stephenson, 1958 and 
MacPherson et al, 1976), there is no clear evidence of 
what effect starvation might have on serum B12 
concentrations.
That grossly depressed feed intake might result in a 
large decrease in the circulating levels of MMA in Co­
deficient sheep was proposed by Andrews and Hogan (1972). 
This possibility was highlighted more recently by Rice et 
a 1 (1987) who proposed that Co-deficient induced
inappetence would depress propionate load on the liver. 
In consequence, the abnormal production and secretion of 
MMA might sharply decline, or cease. In such 
circumstances, the application of MMA analysis to the 
diagnosis of clinical deficiency would fail.
Williams, Spray, Newman and O'Brien (1969) found that 
16 hours starvation of B12-deficient rats resulted in a 
marked decrease in the amount of MMA excreted in urine. 
After 24 hours starvation, an intraperitoneal injection 
of sodium propionate lead to the resumption of MMA 
excretion.
The objectives of this investigation were to 
characterise the effects of diurnal fluctuations and 
feeding pattern on serum concentrations of B12 and MMA. 
The implications of the results for the use of B12 and
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MMA as diagnostic markers for Co deficiency were 
considered. The effects of starvation were also studied.
4.2 MATERIALS AND METHODS.
4.2.1 Experimental Animals and Diet.
Eight Co-sufficient mule type wethers of various ages, 
were housed in one pen and bedded on sawdust. They were 
fed twice daily between 08:45 and 09:00, and 16:30 and 
16:45. All animals were fed the same Co-deficient ration 
(Table 1). The hay fed was treated with urea to provide 
the sheep with the required daily RDP intake (ARC, 1980). 
To achieve this a 40 per cent urea solution was allowed 
to soak into baled hay and provided an intake of 17g 
urea/sheep/day.
Table 1. Basal Co-deficient diet.
FEED Co CONTENT 
(mg/Kg DM ± S.E.D)
AMOUNT FED 
(g FW/head/day)
Flaked Maize 0.026 ± 0.005 660
Timothy Hay 0.06 ± 0.01 650
Water ad libitum
4.2.2 Experimental Design.
The experiment ran for 101 days. The Co-deficient diet 
was introduced to all sheep on day zero. On day 53, the 
four wethers with the highest serum vitamin B12
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concentrations were dosed orally with 0.7 mg Co/head, as 
cobalt sulphate (CoSO^. 7 H 2 O). These animals were 
designated the numbers 1, 2, 3 and 4 and were given a
further dose of 0.7 mg Co/head on day 58, and a final 
drench containing 0.35 mg Co/head on day 88.
The remaining four sheep, 5, 6, 7, and 8, were not
dosed with Co at any stage during the experiment. Thus, 
half of the wethers (1 to 4) were maintained on a 'high' 
C0 /BI2 status (+Co), whilst the other four (5 to 8) were 
kept on a 'low' C0 /BI2 level (-Co). Treatment allocation 
was thus not random. This was expedient in terms of the 
time taken to achieve a high and low Co status in the two 
groups of wethers.
Blood was collected from the sheep weekly. Such 
bleeding always took place before the morning feed. On 
day 50 all the wethers were bled hourly, between 08:45 
and 18:15. This day of intensive sampling was used to 
check the ‘system of blood collection and analysis and to 
acclimatise the animals to frequent sampling and 
restraint.
On day 98, the sheep were bled hourly between 08:45 and 
22:30, with feed offered at 09:00 and 16:30. On day 99, 
the wethers were again sampled hourly between 08:45 and 
22:30, with feed offered two hours later than on day 98, 
at 11:00 and 18:30.
On days 100 and 101 the sheep received no feed at all, 
but had access to water ad libitum. All eight animals 
were bled at 09:45 and 17:15 on day 100 and at 11:00 and
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17:00 on day 101. These sampling times corresponded to 
approximately 14.75, 22.25, 40.00 and 46.00 hours
starvation (time since the end of the last feed).
4.2.3 Blood Analysis.
Concentrations of vitamin B12 in serum were determined 
by the microbiological assay (Chapter 2, section 2.4.1). 
Levels of serum MMA were determined by solvent extraction 
and capillary GC (Chapter 2, section 2.5).
4 . 2 . 4  S t a t i s t i c a l  A n a l y s i s .
The means for serum B12 and MMA in the +Co and -Co 
sheep, were tested for significant difference at each 
weekly sampling and at each time of sampling, during days 
of intensive blood collection. One way analysis of 
variance was used to test for significant differences.
When variation within a treatment on one particular day 
was great, the means for both treatment groups were 
analysed for significant differences, between sampling 
times, within treatments. One way analysis of variance 
was also used to test for significant difference on these 
occasions.
4.3 RESULTS AND DESCRIPTION OF TRENDS IN THE DATA.
The results are presented in Figures 1 to 12. The B12 
and MMA data from the weekly samplings will be related, 
followed by the results from the days of intensive
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sampling. A description of the data will also be 
included. This will be derived directly from, and will 
contain no interpretation of, the results.
4.3.1 Serum Vitamin B12.
The mean serum vitamin B12 results from weekly 
samplings are presented in Figure 1 and Appendix 6. The 
serum B12 concentrations in all sheep showed a tendency 
to decline throughout the experiment, with marked 
variations between samplings. Serum B12 levels in the -Co 
animals were significantly less than those in the +Co 
group on day 58 (P<0.001). This was 5 days after the +Co 
sheep received their first oral dose of Co. The -Co 
wethers did however show mean serum B12 concentrations 
significantly lower than the +Co group before this time, 
on days 10 (P< 0.025 ) and 44 (P<0.01). This was not
surprising as the basis of group selection was serum B12 
status. After day 58, serum B12 levels in the -Co sheep 
remained significantly below those of the +Co treatment 
for the remainder of the experiment (P<0.05 to P<0.001).
Mean serum B12 concentrations in the -Co wethers fell 
below the lower normal limit (LNL) of 400 ng/1, at
approximately day 7 0 and remained below this threshold 
for the rest of the experiment. This occurred 10 weeks 
after the introduction of the Co-deficient ration. Serum 
B12 levels in the +Co animals were above the LNL 
throughout the experiment.
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Figure 1. Mean serum vitamin B12 concentrations in C o ­
supplemented (+Co) and non-supplemented (-Co) wethers, 
t h r o u g h o u t  t h e  e x p e r i m e n t a l  p e r i o d .  ( 'Î' = +Co s h e e p
dosed with Co).
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4.3.2 Serum MMA.
The mean serum MMA results from weekly samplings are 
presented in Figure 2 and Appendix 7. Although large 
differences in serum MMA levels between treatments were 
evident, they were only statistically significant on day 
94 (P<0.05). The general lack of significant difference
in this data could have been due to the small numbers of 
animals used.
Mean serum MMA in the +Co group remained below the 
upper normal limit (UNL) of 5 umol/1 throughout the 
experiment. Concentrations of serum MMA in the -Go 
treatment rose above the UNL at approximately day 75. 
This was only some 5 days after serum B12 levels in the 
same animals had fallen below the LNL. After day 75, 
serum MMA levels in the -Co wethers remained above the 
UNL for the remainder of the experiment.
4.3.3 Day 50 - Serum Vitamin B12.
Treatment mean serum B12 data for day 50 are presented 
in Figure 3. The raw data are presented in Appendix 8. At 
all samplings on this day, each sheep had serum B12 
concentrations above the LNL, with no significant 
differences between treatments.
Serum B12 levels in both groups dropped slightly after 
the morning feed. However, there was a marked rise after 
the evening feed. In the +Co animals, this rise seemed to 
start before the evening feed was given, with B12 
concentrations gradually increasing in serum betwen 14:00
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F i g u r e  2. M e a n  s e r u m  M M A  c o n c e n t r a t i o n s  in C o ­
supplemented <+Co) and non-supplemented (-Co) wethers, 
t h r o u g h o u t  t h e  e x p e r i m e n t a l  p e r i o d .  ( 't' = +Co s h e e p
dosed with Co).
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Figure 3. Mean serum vitamin B12 concentrations in Co- 
supplemented (+Co) and non-supplemented (-Co) wethers,
• between 08:45 and 18:15 on day 50. ((— j = feeding).
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and feeding time at 16:30.
The dramatic rise in serum B12 levels after the evening 
feed was not a consistent occurrence. Figures 4 and 5 
represent plots for individual animals on day 50. The 
post-evening feed rise in serum B12 was most marked in 
sheep numbers 4 (+Co), 7 and 8 (-Co). The rise in these
three wethers denoted an increase in serum B12 
concentrations between the pre and post-feeding 
samplings, of some 91 (sheep 4) to 193 per cent (sheep 
8).
4.3.4 Day 50 - Serum MMA.
Mean treatment serum MMA data for day 50 are presented 
in Figure 6. The raw data are presented in Appendix 9. At 
all sampling times on this day, each sheep had serum MMA 
levels below the UNL, with no significant differences 
between treatments.
A marked increase in the concentration of MMA in serum 
occurred in both groups after the morning feed. Levels in 
all animals then declined gradually throughout the day, 
with a second rise in response to the evening feed. There 
was also a sharp fall in concentrations just before the 
evening feed.
4.3.5 Day 98 - Serum Vitamin B12.
Mean serum B12 data for day 98 are presented in Figure 
7 and Appendix 10. Serum B12 concentrations in the +Co 
wethers declined throughout the day and were
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Figure 4. Serum vitamin B12 concentrations in the four 
Co-’Supplemented (+Co) wethers, between 08:45 and 18:15 on 
day 50. (ty = feeding).
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Figure 5. Serum vitamin B12 concentrations in the four 
non-supplemented (-Co) wethers, between 08:45 and 18:15 
on day 50. (|— I = feeding).
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Figure 6. Mean serum MMA concentrations in Co­
supplemented (+Co) and non-supplemented (-Co) wethers, 
between 08:45 and 18:15 on day 50. (t— i = feeding).
166
Serum vitamin E12 (ng/1)
600
500
400
300
200
-  MEAN OF +Co SHEEP 
• MEAN OF -C o  SHEEP100
0
1 6 .0 012. 00 20. 008.00
Time ( h r . )
F i g u r e  7 .  M ean  s e ru m  v i t a m i n  B12 c o n c e n t r a t i o n s  i n  Co­
s u p p le m e n t e d  (+ C o )  a n d  n o n - s u p p le m e n t e d  ( - C o )  w e t h e r s ,  
b e t w e e n  0 8 : 5 0  a n d  2 2 : 1 5  on  d a y  9 8 .  (I— I = f e e d i n g ) .
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significantly higher than levels in the -Co sheep at all 
samplings (P<0.05 to P<0.01). Serum B12 concentrations in 
the -Co animals remained below the LNL on this day, and 
ranged between 203 and 328 ng/1.
There were no apparent responses in serum B12 levels in 
the -Co group to the two feeds. Further, there was only a 
small rise in serum B12 in the +Co animals after the 
morning feed, with no response to the evening feed. 
However, there was a general rise in B12 concentrations 
in both treatments between the 20:15 and 22:30 samplings.
4.3.6 Day 98 - Serum MMA.
Mean serum MMA data on day 98 are presented in Figure 8 
and Appendix 10. Levels in the -Co wethers were above the 
UNL throughout the day, while those in the +Co animals 
were below this threshold. There were no statistically 
significant differences between the two treatments, 
except at the 16:15 sampling.
As on day 98, concentrations of MMA in serum rose in 
response to the morning feed. This was most marked in the 
-Co group, where the increase denoted a rise of 91 per 
cent in mean serum MMA levels between 08:55 and 10:50 
(non-significant). After the 09:00 feed a plateau in MMA 
concentrations in the -Co sheep was reached and 
maintained until just before the evening feed, when serum 
MMA concentrations in both treatments showed a small 
fall. After the evening feed, MMA levels in both 
treatments demonstrated a responsive rise.
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Figure 8. Mean serum MMA concentrations in Co­
supplemented (+Co) and non-supplemented (-Co) wethers, 
between 08:50 and 22:15 on day 98. (H = feeding).
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Serum MMA in all animals tended to fall at the end of 
the sampling period (20:15 to 22:30), which corresponded 
to the rise in serum B12 levels at this time.
4*3.7 Day 99 - Serum Vitamin B12.
Mean serum B12 data for day 99 are presented in Figure 
9 and Appendix 11. The pattern of serum B 12 
concentrations in both treatments on this day was 
markedly different from that evident on day 98. On day 
99, the morning and evening feeds were given two hours 
later than on day 98.
Serum B12 levels in the -Co wethers were below the LNL 
throughout the day. Those in the +Co animals remained 
above the LNL, until the 19:05 sampling, when they fell 
below this threshold and remained below 400 ng/1 for the 
remaining two samplings. Serum B12 concentrations in the 
+Co sheep were significantly above those in the -Co 
animals at all samplings (P<0.05 to P<0.001).
In all sheep, serum B12 levels fell until after the 
morning feed. The increase in response to this feed 
intake was dramatic and denoted a rise in mean serum B12 
concentrations in the -Co wethers between 13:05 and 
15:05, of 207 per cent (P<0,01). For the +Co animals, the 
rise represented a mean increase in serum B12 levels 
between 14:05 and 16:05 of 172 per cent (P<0.01). This 
response to the morning feed occurred more rapidly in the 
-Co than in the +Co group. However, the response in all 
the sheep was not as quick as that shown to a previous
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Figure 9. Mean serum vitamin B12 concentrations in Co­
supplemented (+Co) and non-supplemented (-Co) wethers, 
between 08:50 and 22:15 on day 99. (|— i = feeding).
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feed, on the evening of day 50. A comparison between B12 
concentrations on days 98 and 99 is presented in Figure 
10.
4.3.8 Day 99 - Serum MMA.
The mean serum MMA results for day 99 are presented in 
Figure 11 and Appendix 11. Levels in the -Co wethers were 
above the UNL throughout the day, while those in the +Co 
group were below this threshold. Statistically 
significant differences between treatments were evident 
at all samplings (P<0.05), except those collected at. 
08:55, 11:00, 18:05, 20:10 and 22:30.
In contrast to day 98, there was no evidence of a 
response in the serum MMA concentrations of +Co animals 
to either the 11:00, or the 18:30 feeds. MMA levels in 
these sheep tended to rise throughout the day, with an 
intermediate fall at approximately 16:00.
Serum MMA concentrations in the -Co treatment showed a 
similar response to feeding, as on day 98. However, these 
changes were not as marked as those of the previous day. 
The response to the 11:00 feeding by the -Co animals, 
represented a rise of 37 per cent (non-significant), 
between 11:00 and 12:00,
Similar to day 98, serum MMA concentrations in all the 
sheep tended to fall at the end of the sampling period, 
between 20:10 and 22:30. A comparison between serum MMA 
concentrations on days 98 and 99 is presented in Figure 
12.
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Figure 10. Mean serum vitamin B12 concentrations in Co­
supplemented (+Co) and non-supplemented (-Co) wethers, 
on days 98 and 99. (H = feeding).
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Figure 11. Mean serum MMA concentrations in Co­
supplemented (+Co) and non-supplemented (-Co) wethers, 
between 08:50 and 22:15 on day 99. (m  = feeding).
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4.3.9 Days 100 and 101 Serum Vitamin B12
The data for mean serum B12 concentrations in both 
treatments on days 100 and 101 are presented in Table 2.
Table 2. The response of mean serum vitamin B12 
concentrations (ng/1 + SED) in +Co and -Co wethers to
starvation on days 100 and 101.
DAY SAMPLING
TIME
HOURS
STARVATION
SERUM B12 
+Co
SERUM B12 
-Co
Sig. 
Dif.
100 09:50 14.75 606 ± 219 238 + 64 *
100 17 :15 22.25 579 ± 225 229 ± 45 *
101 11:00 40 . 00 861 ± 302 330 ± 120 *
101 17:00 46.00 933 + 249 428 ± 165 *
Although differences within treatments, between 
samplings over these two days were not significant, 
there was a trend for serum B12 levels to increase with 
prolonged feed deprivation. This was evident in both 
treatments and was most marked on day 101.
4.3.10 Day 100 and 101 - Serum MMA.
Due to an accidental loss of sera, MMA concentrations 
in the blood of sheep on days 100 and 101 could not be 
determined.
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4.4 DISCUSSION.
4.4.1 Variabi1ity in Serum Vitamin B12 and MMA Levels.
The first notable aspect of the results was the 
variability of serum B12 data in comparison with serum 
MMA results. This was evident in the weekly samplings 
(Figures 1 and 2) and also in the intensive sampling 
periods on individual days. Although weekly samples were 
taken at the same time of day on each occasion, Figure 1 
demonstrated that great variability existed in serum B12 
concentrations between samplings in the same group of 
wethers.
Variation of this kind leads to difficulties in the use 
of serum B12 data in the diagnosis of Co deficiency. Mean 
serum B12 concentrations in the -Co sheep dropped below 
the LNL of 400 ng/1, on day 44 ( 343 ng/1. Figure 1). By 
day 50, the corresponding level in these animals was 550 
ng/1 and did not drop below the LNL again until day 7 3 
(373 ng/1). Findlay (1972) observed that it might be 
difficult to obtain an accurate and precise diagnosis 
from such variable data.
In contrast, the concentrations of MMA in serum were 
less variable (Figure 2). When levels in the -Co wethers 
rose above the UNL of 5.0 umol/1, this rise was marked 
and consistent with a sharp increase between day 73 (3.66 
umol/1) and day 79 (6.26 umol/1).
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4.4.2 Diurnal Fluctuations in Serum Vitamin B12 and MMA
Levels.
In response to feeding, serum vitamin B12 
concentrations in both +Co and -Co sheep increased.
However, this pattern was not consistent between days, or 
animals. For example, while the response to the evening 
feed on day 50 (Figure 3) and both feeds on day 99 
(Figure 9) were evident, there was no such change in 
serum B12 levels on day 98 (Figure 7). Further, only 
three animals showed a marked rise in serum B 12 
concentrations after the evening feed on day 50 (Figures 
4 and 5), although this had a discernable effect on the 
mean values. An opposite effect was also noted on day 50, 
when mean serum B12 levels in both treatments showed a 
slight drop immediately after the morning feed.
The results collected from this experiment did not 
reveal why serum B12 concentrations tended to rise after 
feeding. However, reasons can be speculated from evidence 
in the literature. That feeding can result in an increase 
of B12 levels in blood was reported by Somers and 
Gawthorne (1969). Similar to the results of this 
experiment, these workers found that this response varied 
between individual sheep. The rise in blood B12 levels 
after the evening feed on day 50, could be detected 
within an hour of the feed being offered. Somers and 
Gawthorne (1969) discovered a response only after 4 hours 
post-feeding, which was similar to the delay in response 
to the morning feed evident on day 99. However, the
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sampling regime employed by these workers did not allow 
for earlier detection of fluctuations in serum B12 
concentrations.
That an input of Co to the rumen, in this case from 
feeding, results in increased ruminai production of 
vitamin B12 and subsequent absorption across the mucosa 
of the small intestine into the circulation, was 
established by Hedrich et ^  (1973). Thus the response 
shown to feeding in this experiment, although 
inconsistent, was probably due to increased ruminai 
microbial production of B12 and absorption into 
circulation.
The results presented suggested that the response of 
serum MMA concentrations to twice daily feeding, was a 
fall just before, followed by a restoration of levels 
after feed intake. This effect was detected on days 50, 
98 and 99 (Figures 6, 8 and 11, respectively). On some
occasions (for example, in the -Co and +Co wethers after 
the evening feed on day 98) the post-feeding increase 
raised serum MMA concentrations above the level evident 
pre-feeding. As with serum B12, the response varied 
between animals and sampling days, but was far more 
consistent than the rise in serum Bl2 levels due to 
feeding.
The results of this experiment did not reveal why serum 
MMA concentrations responded to feed intake in such a 
manner. As with the serum B12 data, the responses may
179
have been linked with ruminai effects. The fall in serum 
MMA concentrations just before the evening feeds on days 
50 , 98 and 99 may have been associated with the
physiological effects of the 'anticipation' of feeding in 
the sheep.
It is interesting to note that the response of serum 
MMA post-feeding was actually a rise and not a fall in 
concentrations. As the response of serum B12 was to rise, 
it might have been expected that the response of serum 
MMA levels would have been to fall. The anticipated 
pattern would be that as serum B12 rose post-feeding, 
liver B12 concentrations might also have been augmented 
resulting in increased activity of the methylmalonyl CoA 
mutase enzyme. This would have enhanced the conversion of 
methylmalonyl CoA to succinyl CoA, with a subsequent drop 
in serum MMA levels. This did not happen.
The rise in serum MMA concentrations after feeding, may 
have been associated with an increased propionate load on 
the liver at such times. That feed intake leads to a 
surge in propionate production and absorption, is well 
documented (McDonald et aJL, 1981). In a Co-sufficient
situation, this input of propionate to the liver would 
result in an increase in methylmalonyl CoA production 
(Williams et 1969 ). Some of this might be degraded
and excreted, accounting for a short increase in serum 
MMA levels. As the propionate is catabolised liver 
concentrations of methylmalonyl CoA would fall, along 
with serum MMA. Such a case was demonstrated by all the
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wethers on day 50 (Figure 6) and by the +Co sheep on day 
98 (Figure 8). In these two instances, a short rise in 
serum MMA levels post-feeding was followed by a decline, 
before a second increase after the evening feed.
In a Co-deficient situation, the post-feeding rise in 
serum MMA due to increased propionate load on the liver, 
is again evident. However, there is insufficient vitamin 
B12 present to act as co-factor for the enzymic 
conversion of methylmalonyl CoA to succinyl CoA. Thus, 
methylmalonyl CoA levels in the liver rise post-feeding, 
but are not dissipated and this is reflected by serum MMA 
concentrations. Such a case was evident in the -Co 
animals on days 98 and 99 (Figures 8 and 10), where a 
plateau in serum MMA levels was established after the
post-morning feed rise, which was not dissipated before 
the post-evening feed response.
The increases in serum concentrations of B12 and MMA 
post-feeding, resulted in the presence of exogenously 
stimulated fluctuations in the circulating levels of
these diagnostic parameters. Such variations were found
by Somers and Gawthorne (1969) for B12 and were proposed 
for MMA by Andrews and Hogan (19 72).
The question arises as to whether there are other 
endogenously stimulated fluctuations in serum B12 or MMA 
concentrations, which are not associated with the
exogenous stimulation of feeding pattern? In a trial with 
grazing sheep, which were given no daily supplementary
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feed, Millar et al (1984) found no evidence of diurnal 
fluctuations in serum B12 levels. This could have been 
due to a more even pattern of feed intake during the day. 
In this situation, there would be periods of feeding and 
other periods of ruminating, resting and sleeping. 
However, surges in B12 and propionate production after 
isolated feedings would not occur.
While this reasoning might explain the absence of 
diurnal fluctations in the data of Millar et al (1984), 
these workers also found no evidence of other, 
endogenous, daily fluctuations in serum B12 
concentrations. The results from the smaller housed 
experiment undertaken here, would substantiate these 
findings. No variations in serum B12 or MMA levels, 
other than those due to feeding pattern, were apparent on 
any of the three intensive sampling days. Small rises in 
the serum B12 concentrations in sheep at the end of days 
98 and 99, associated with falls in serum MMA levels, 
were evident. These were most likely to be related to the 
absence of feed at these times, rather than to any other 
factor. However, sampling over a full 24 hr. period was 
not undertaken. Thus, endogenous fluctuations which may
have occurred during the night, could not be detected.
4.4.3 The Effect of Delayed Feeding.
Delaying both the morning and evening feeds by 2 hours 
on day 99 compared to day 98, had a profound effect on 
the response to feed intake of serum B12 concentrations,
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but not on serum MMA levels. This was best illustrated by 
the plots of serum B12/MMA against time for both days, 
presented in Figures 10 and 12.
Compared to the results from day 98, delaying feeding 
for 2 hours on day 99 had the effect of steadily reducing 
serum B12 concentrations in all sheep, until after the 
11:00 feed. This may have been a reflection of the 
absence of substrate and energy input for the production 
of B12 by rumen microorganisms. Thus, less vitamin was 
absorbed and detected in circulation. However, the rise 
in serum B12 levels following the 11:00 feed was dramatic 
and much more marked than it had been to the evening feed 
on day 50. This was even more surprising when there had 
only been a small response to the morning feed in the +Co 
wethers, in the whole analysis of day 98.
The explanation for such a dramatic rise in serum B12 
levels after witholding feed, was probably associated 
with the rumen microbes which produce the vitamin. The 
period of activity and growth by microbial populations in 
the rumen following feed intake (McDonald ^  ad, 1981),
may have been enhanced by simple extension of the period 
of relative quiescence, prior to feeding. Thus, the rise 
in microbial B12 production after the morning feed 
(11:00) on this occasion, may have occurred in a burst, 
with a resultant surge in serum B12 concentrations.
The evening (18:30) feed on day 99, although 2 hours 
later than the evening feed of day 98, was given after
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the usual time interval between feeds. In this way, the 
populations of rumen microorganisms may have returned to 
a customary state by the time the evening feed was given. 
Thus, no dramatic surge in serum B12 response to the 
evening feeding was apparent after 18:30 on day 99.
The effect of delaying feeding time on serum MMA 
concentrations was not marked (Figure 12). The rise in 
MMA levels in serum after feeding on day 99 was 
consistent with the responses evident on days 50 and 98. 
However, serum MMA concentrations did show an increase 
over the three samplings taken prior to the 11:00 feed on 
day 99 (Figure 11). These coincided with concurrent falls 
in serum B12 levels.
It may be postulated that in this extended fast, serum 
MMA concentrations showed small rises prior to delayed 
feeding, due to continuation of basal propionate 
catabolism in the liver, which would produce 
methylmalonyl CoA, while decreased concentrations of B12 
were available to act as a co-factor for the conversion 
and dissipation of methylmalonyl CoA to succinyl CoA. MMA 
levels in serum would thus rise during such time.
It must be stressed that these explanations for the 
effect of feeding on serum B12 and MMA concentrations are 
speculative. They can only be refuted or substantiated if 
a similar experiment is undertaken, in which rumen 
microbial Bl2 production and influx rates of B 12 and 
propionate to the liver were measured, with more frequent 
collection of blood samples. This could be achieved by
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using rumen fistulated sheep with duodenal and hepatic 
portal vein re-entrant canulae. This would enable the 
response of B12 and propionate production to measured Co 
and feed intakes, along with effects on serum levels of 
B12 and MMA, to be determined.
4.4.4 The Effect of Starvation.
The effect of starvation on days 100 and 101, was 
initially to depress and then to increase vitamin B12 
concentrations in serum. The fall in circulating Bl2 
between the 09:50 and 17:15 samplings on day 100, was 
perhaps due to declining levels of microbial vitamin 
production and thus animal absorption. With some of the 
vitamin in blood being used or stored in the liver, serum 
B12 concentrations fell. However, starvation would reduce 
the propionate load and therefore the necessity for B12, 
in the liver. A basal level of B12 input from the rumen 
to the host animal would continue in these 46 hours of 
absent feed intake. Thus, the balance between liver 
demand for B12 from serum and the input of vitamin to 
circulation from the rumen might change, resulting in the 
net increase in serum B12 levels as starvation continued.
Although the increases in serum vitamin B12 between 
14.75 and 46.00 hours of starvation were not statisically 
significant within treatments, they represented rises of 
54 and 79 per cent in serum B12 concentrations for the 
+Co and -Co treatments, respectively. This increased mean
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serum B12 levels in the - C o  g r o u p  f r o m  d i a g n o s t i c a l l y  
deficient to sufficient concentrations, without the 
addition of Co supplementation.
The effect of starvation on serum MMA levels could not 
be determined. However, with rising concentrations of 
serum B12 and a lack of propionate load on the liver, it 
may be postulated that the result would have been a 
marked depression in serum MMA status. This scenario 
would agree with that proposed by Rice et ad (1987).
4.4.5 Consequences for the Diaanos is of Cobalt
Deficiency.
The results of this experiment suggested that the -Co 
wethers were sub-clinically Co-deficient from day 70 
onward. That is, they showed mean serum vitamin Bl2 
levels consistently between 200 and 400 ng/1, with serum 
MMA concentrations between 5.0 and 15.0 umol/1.
The investigation produced strong evidence for the 
presence of diurnal fluctuations in serum B12 and MMA 
concentrations, due to the exogenous stimulation of 
feeding pattern. As such, the time of sampling in 
relation to feeding may have a profound" effect on the use 
of these two markers in the diagnosis of Co deficiency in 
sheep.
The feeding response was most prevalent in the serum 
B 12 data. Increases of over 100 per cent in B12 
concentrations due to a feed intake response may render 
the employment of such data, useless for diagnosis. This
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would be the case if sampling for diagnostic purposes was 
performed shortly after feeding.
However, Millar et al (1984) have shown that when sheep 
are at pasture and no supplementary feed is given, 
diurnal fluctuations in serum B12 concentrations do not 
exist. In this situation, the points stated here would 
have no relevance to the use of serum B12 levels in the 
diagnosis of Co deficiency.
The data presented suggested that serum B12 was a 
sensitive indicator of Co intake and ruminai vitamin 
production in the ovine. This was in agreement with 
MacPherson et ad (1976) and Sutherland (1980). However, 
there was considerable variation both within and between 
animals in serum B12 response to Co intake, over the long 
(weeks) and short (hours) term. Such variation was 
generally more marked in the Co-sufficient sheep, 
compared to deficient controls. These findings reiterated 
those of Somers and Gawthorne (1969), Findlay (1972), 
Millar and Albyt (1984) and Millar et ad, (1984)
Despite the evident variation, serum B 12 levels 
reflected declining Co intake in both groups of wethers 
(Figure 1). It should also be noted that no false 
diagnoses would have been made of the +Co sheep, using 
serum B12 concentrations and that the risks of a false 
diagnosis in the -Co group only existed for approximately 
three weeks.
Serum MMA concentrations tended to fall just before and 
rise after feed intake. Such effects might lead to
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confusion in the use of this marker for the diagnosis of 
Co deficiency. If blood samples are taken just before or 
after feeding, the data obtained may imply a false 
diagnosis of Co status. This would be particularly 
relevant in the detection of sub-clinical Co deficiency, 
where levels of MMA in serum might be slightly above or 
at the UNL of 5.0 umol/1.
The data collected during starvation of the sheep would 
suggest a need for caution, if serum B12 or MMA levels 
are to be used in the diagnosis of clinical and severe 
ovine Co deficiency. In such cases, the effects of Co 
deficiency induced inappetence on liver function, via 
rumen microbial influences, may result in apparent low 
serum MMA concentrations and vitamin B12 levels which 
would imply only marginal deficiency, or. even adequacy.
4.4.6 Recommendations for the Diagnosis of Cobalt
Deficiency in Pregnant Ewes.
The results of Chapters 3 and 4 can be drawn together 
to produce recommendations for the use of serum B12 and 
MMA concentrations, in the diagnosis of Co deficiency in 
pregnant ewes. The most accurate and reliable technique 
for the prognosis and diagnosis of Co deficiency, 
particularly in the sub-clinical form, is to use the 
criteria presented in Chapter 3, Table 2. Blood should be 
collected several hours before the provision of 
supplementary feed and several hours after the last 
supplementary feed intake. Extraordinarily high
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concentrations of serum MMA should be excluded from 
diagnostic analysis. When serum B12 concentrations are 
used, consideration must be given to the analytical 
technique employed and the criteria applied to the 
results. Where clinical Co deficiency is suspected, the 
determination of low serum MMA concentrations should be 
viewed with caution, as these may in some circumstances 
lead to a false negative diagnosis.
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CHAPTER 5.
THE EFFECT OF COBALT DEFICIENCY IN THE PREGNANT EWE ON 
REPRODUCTIVE PERFORMANCE AND LAMB VIABILITY.
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5.1 INTRODUCTION.
In a review of Co deficiency in ruminant animals, Mills 
(1981) suggested that there was a lack of research 
evidence on the effects of the disease on reproductive 
performance. Few reports can be cited which relate to 
this aspect of the syndrome. Thus, there is a need to 
study the influences of this deficiency disease on the 
reproducing ewe and subsequent lamb performance, 
particularly in the sub-clinical region.
Dunlop (1946b) reported that sub-clinical Co deficiency 
on farms in the south west of Scotland, had a detrimental 
effect on sheep production. More recently, Duncan et ad 
(1981) reported that clinically Co-deficient ewes 
produced fewer lambs with incidence of stillbirths and 
neonatal mortalities, compared to Co-sufficient animals. 
Carton et ad (1981) related these findings to vitamin B12 
and MMA status of the dams, and adverse neuropathology 
evident in both ewes and lambs . However their 
investigations employed very small numbers of animals and 
were therefore not conclusive.
The objectives of this work were to investigate the 
effects of Co deficiency in pregnant hill sheep, on 
reproductive performance and neonatal lamb viability. Two 
housed experiments with hill ewes were undertaken and 
tupping and lambing performances were recorded in sub- 
clinically Co-deficient dams and sufficient controls. The 
viability of lambs from ewes of sufficient and deficient 
Co status was measured up to four weeks of age.
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Observations were related to ewe and lamb Co/vitamin B12 
status, by measurement of serum B 12 and MMA 
concentrations.
5.2 MATERIALS AND METHODS.
5.2.1 Animals and Treatments.
The animals used in the two investigations were the 
same as those already detailed in Chapter 3, for the 
study of the diagnosis of Co deficiency in pregnant ewes. 
Thus, the Experiments 1 and 2 discussed in this chapter, 
refer to the same sheep and experiments as Chapter 3.
The treatments imposed on the ewes in both 
investigations, were described in Chapter 3. The NS (non­
supplemented) group in both experiments received a Co­
deficient intake for the whole of pregnancy. However, 
whereas in Experiment 1 the NS sheep were rendered sub- 
clinically Co-deficient only after tupping, in Experiment 
2 these animals experienced this degree of disease 
during mating.
The HS treatment in Experiment '1 were placed on a Co­
deficient intake for the second half of gestation only 
whilst in Experiment 2 this group were sub-clinically Co­
deficient for the first half of pregnancy and replenished 
from mid-term. In both experiments, the FS ewes received 
a Co-sufficient intake for the whole of pregnancy.
Thus, in Experiment 1 the emphasis of the investigation 
was on the effects of Co deficiency in the second half of
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gestation. • Experiment 2 concentrated more on the 
consequences of disease imposed at tupping and during the 
first half of pregnancy. These differences were reflected 
by the HS treatment, while the NS and FS groups of both 
experiments acted as negative and positive controls, 
respectively.
5.2.2 Experiment 1 (1985/86) .
5.2.2.1 Cobalt deficient ration.
All sheep were introduced to a Co-deficient diet on 
30/9/85. The Co contents of the feeds were detailed in 
Chapter 3, Table 1. Day zero of the experiment was at the 
first blood sampling on 10/10/85 and the ration fed 
thereafter is presented in Table 1.
This diet was designed to meet all the nutrient 
requirements, excluding Co, of pregnancy and lactation 
for ewes with multiple lambs. Small amounts of sodium 
chloride, dicalcium phosphate and magnesium were added to 
the ration, but these supplements contained insignificant 
levels of Co. All the sheep were on a rising plain of 
nutrition up to tupping, in an attempt to obtain a 
flushing effect.
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Table 1. Basal Co-deficient ration fed to all ewes in
Experiment 1.
DAYS
HAY
FEED 
MAIZE 1
(Kg/hd/d) 
MAIZE 2 MILK
Co INTAKE 
(mg/hd/d)
PREGNANCY
0 - 1 1 0.40 0.30 0.075 _ 0.034
12 - 76 0.66 0.25 0 . 050 _ 0.048
77 - 127 0.90* 0.40 0.100 0.067
128 - 140 0.90* 0.67 0 .150 0.076
LACTATION
141 - 1.00* 0.64 0.250 0.10 0 . 086
KEY:
HAY = Timothy hay 
MAIZE 1 = Micronised maize 
MAIZE 2 = 60 % Maize gluten 
MILK - Skimmed milk powder 
* = Fed ad libitum
5.2.2.2 Tupping, gestation and lambing management.
The 60 ewes in this experiment were cycle synchronised 
using 'Veramix' progesterone vaginal implant sponges 
(Upjohn Ltd,, Crawley, Sussex). For mating the sheep were 
split into four groups of 15, each separately penned. 
They were mated to four experienced, Co-sufficient 
Suffolk rams. These tups were rotated around the pens for 
a four day period, encompassing the peak of each tupping 
activity. The rams were thus moved from pen to pen, twice 
daily.
The sequence of management is presented in Table 2.
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Table 2. Tupping, gestation and lambing in the ewes of 
Experiment 1.
DATE DAY ACTION
30/09/85 -10 Introduction of Co-deficient ration.
01/10/85 - 9 Progesterone sponges into all ewes and 
dosed with albendazole general wormer.
14/10/85 4 Sponges taken out of half of the ewes.
15/10/85 5 Sponges taken out of remaining ewes.
16/10/85 6 Ewes put to tup. Peak of 1st tupping 
period.
30/10/85 20 1st of weekly oral Co supplements to HS 
and FS ewes.
01/11/85 22 Peak of 2nd tupping period.
20/12/85 71 Ultrasonic scanning of ewes for lambs.
30/12/85 81 Co supplement removed from HS ewes.
15/01/86 97 All ewes dosed with a flukacide.
10/02/86 123 All ewes vaccinated against clostridial 
diseases.
05/03/86-
15/03/86
- 146- 
156
1st lambing period.
24/03/86-
31/03/86
- 165- 
172
2nd lambing period.
The ewes were weighed and condition scored fortnightly. 
Condition scores were determined by the author on each 
occasion, to eliminate scorer bias and the procedure was 
carried out in accordance with the recommendations of 
ADAS Leaflet 787 (1984).
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5.2.2.3 Measurements of fertility and gestational
performance.
A. Conception rate.
When running the tups with the ewes, keel paint was 
employed to enable observation of mating progress. A 
conception rate for each treatment at each of the two 
tupping periods (TP) was calculated as follows:
TPl
No: marked in TPl -- No: returns in TP2
----------------------------------------  XlOO
No: marked in TPl
TP2
No: marked in TP2 -- No: of these scanned empty
------------------------------------------------ XlOO
No: marked in TP2
B. Reabsorption rate.
Implantation of the developing fertilised oocyte 
(blastocyst), occurs approximately one cycle's length 
after ovulation and fertilisation. In the ovine, the 
cycle is about 16.5 days long and is equivalent to the 
time between the peak activity of 'two tupping periods. If 
conception occurred, but implantation failed and the 
blastocyst was reabsorbed, this could be recorded for 
each treatment at the first tupping period as follows:
TPl
No: marked in TPl, not at TP2, and scanned empty
-------------------------------------------------XlOO
No: marked at TPl
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C. Lambing rate.
A prospective lambing rate for each treatment was 
calculated from the scanning data as follows:
Lambing rate at scan =
No: of lambs from the scan
--------------------------- XlOO
No: of ewes put to tup
Two actual lambing rates were obtained for each treatment
group, using the following equations:
Lambing rate at birth =
No: of lambs born
---------------------- XlOO
No: of ewes put to tup
Lambing rate at 4 weeks =
No: of lambs alive at 4 weeks of age
-------------------------------------  XlOO
No: of ewes put to tup
The length of gestation in each ewe was calculated as 
the period from the peak day of the tupping period in 
which conception occurred, to the day of parturition. A 
spread of gestation length and the mean for each 
treatment could thus be obtained,
5.2.2.4 Biochemical profile of the ewes.
The ewes were bled fortnightly throughout the 
experiment. Samples were analysed for whole blood 
haemoglobin (Hb) and glutathione peroxidase (GSH+Px) 
concentrations. Plasma copper (Cu), calcium (Ca) and
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magnesium (Mg) levels were also determined. Serum vitamin 
B12 and MMA concentrations were measured by 
microbiological assay and capillary GC, respectively. 
Plasma glucose was determined spectrophotometrically.
5.2.2.5 Lambing arrangements.
Before lambing, the main pens were mucked out, but not 
disinfected.
Wherever possible ewes were moved to small lambing pens 
before parturition. If the ewe and lamb(s) were healthy, 
they were removed from the lambing pen after 24 hours and 
placed in a mothering up pen. After a further 48 hours, 
half the ewes and lambs from each treatment were turned 
out to grass and taken off the experiment. The other half 
were returned to the main pens for further investigation.
The lambs were sexed, weighed and their umbilical cords 
dipped in an iodine solution, within 6 hours of birth. 
Prophylactic dosing of new born lambs with antibiotics 
was not undertaken, but where necessary such treatment 
was given for ill-health and the incident noted.
The numbers of stillbirths and neonatal mortalities 
occurring in each treatment group were recorded. For the 
purposes of these investigations, a neonatal mortality 
was defined as the death of a lamb whic'h was born alive, 
any time up to four weeks of age. Post mortem 
examinations were carried out on all dead lambs and the 
livers analysed for Co content.
The lambs kept indoors after parturition and mothering
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up were blood sampled at two and four weeks of age. Serum 
Bl2 and MMA concentrations were determined in these 
samples.
5.2.3 Experiment 2. ( 1986/87 \ .
5.2.3.1 Cobalt deficient ration.
All sheep were introduced to a Co-deficient diet on 
10/10/86. The feeds and general design of the diet were 
the same as those used in Experiment 1. Day zero of the 
experiment was at the first blood sampling on 10/9/86, 
and the ration fed is detailed in Table 3. Due to low 
blood GSH+Px concentrations, all ewes received an oral 
dose of 4 mg Se/head on day 63.
Table 3. Basal Co -deficient diet fed to 
Experiment 2.
all ewes in
DAYS
HAY
FEED 
MAIZE 1
(Kg/hd/d) 
MAIZE 2 MILK
Co INTAKE 
(mg/hd/d)
PREGNANCY
0 - 7 2 0.58 0.25 0.10 0.044
73 - 161 0.83* 0.30 0.10 0.061
162 - 208 0.70* 0.41 0.12 0.058
209 - 228 0.59* 0 . 64 0.15 0. 058
LACTATION
229 - 0.66* 0.65 0.25 -- 0.066
KEY;
HAY = Timothy hay
MAIZE 1 = Micronised maize
MILK - Skimmed milk powder
MAIZE 2 = 60 % Maize gluten 
* = Fed ad libitum
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The same mineral supplements added to the ration in 
Experiment 1, were also used for the diet in Experiment 
2. The ewes in Experiment 2 were 'flushed' in the same 
manner as those in Experiment 1.
5.2.3.2 Tupping, gestation and lambing management.
Cycle synchronisation and management of tupping was 
similar to that employed in Experiment 1. However, four 
Co-sufficient Blue-faced Leicester ram lambs were used 
for mating in this second experiment. After the first 
cycle, the number of ewes marked with keel paint was 
unexpectedly low. Therefore, these tups were supplemented 
with four more experienced Blue-faced Leicester rams, 
before the second tupping period began. A third tupping 
period was also employed, to compensate for the poor tup 
performance at the first cycle.
The sequence of management is presented in Table 4.
All ewes were weighed and condition scored as for 
Experiment 1.
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Table 4. Tupping, gestation and lambing in the ewes of
Experiment 2.
DATE DAY ACTION
24/09/86 15 All ewes dosed with albendazole, general 
wormer.
10/10/86 31 Introduction of Co-deficient ration.
22/10/86 43 1st of weekly oral Co supplements to FS 
ewes .
12/11/86 63 All ewes dosed with 4 mg selenium/hd.
21/11/86 73 Progesterone sponges into all ewes.
04/12/86 86 Sponges taken out of half of the ewes.
05/12/86 87 Sponges taken out of remaining ewes.
06/12/86 88 Ewes put to tup. Peak of 1st tupping 
period.
22/12/86 104 Peak of 2nd tupping period.
07/01/87 120 Peak of 3rd tupping period.
14/01/87 127 All ewes dosed with a flukacide.
13/02/87 157 Ultrasonic scanning of ewes for lambs.
17/02/87 161 1st of weekly oral Co repletion 
supplements to HS ewes.
10/04/87 212 All ewes vaccinated against clostridial 
diseases.
27/04/87-
02/05/87
229-
234
1st lambing period.
10/05/87-
20/05/87-
242-
252
2nd lambing period.
27/05/87-
04/06/87
259-
267
3rd lambing period.
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5.2.3.3 Measurements ô£ fertility and gestational
performance.
A. Conception rate.
Conception rates were calculated for each treatment at 
each tupping period, in the same manner as those 
determined in Experiment 1. The following equations were 
employed:
TPl
No: marked in TPl -- No: returning in TP2
------------------------------------------- XlOO
No: marked in TPl
TP2
No: marked in TP2 —  No: returning in TPS
•------------------------------------------- XlOO
No: marked in TP2
TP 3
No: marked in TP3 -- No: of these scanned empty
------------------------------------- ^----------- XlOO
No: marked in TP3
B. Reabsorption rates.
Reabsorption rates in each treatment at the first two 
tupping periods, were calculated as follows:
TPl
No; marked in TPl, not in TP2, but returning for TP3 or
scanned empty
No: marked in TPl XlOO
TP2
No: marked in TP2, not in TP3, but scanned empty
--------------------------------------------------- XlOO
No; marked in TP2
For each treatment, these reabsorption rates were
combined, to give an overall percentage value.
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c . Lambing rate.
Lambing rates were calculated for the ewes in each 
treatment at scanning, birth and four weeks of age, in 
exactly the same manner as for Experiment 1.
The mean and spread of gestation length for each 
treatment was determined by the method used in Experiment 
1.
5.2.3.4 Biochemical profile of the ewes in Experiment 2.
In Experiment 2, blood samples were collected and
analysed by the same procedures and techniques employed 
in Experiment 1,
5.2.3.5 Lambing arrangements.
Before lambing, the main pens were mucked out and 
thoroughly disinfected. This was in contrast to 
Experiment 1, where the pens were mucked out, but not 
disinfected before lambing.
Lambing arrangements, record taking and blood sampling 
in Experiment 2, were kept as close as possible to those 
employed in Experiment 1. However, in this second 
investigation it was considered desirable to monitor how 
vigorous the lambs appeared post partum, as a guide to 
any later effects on lamb viability. For this purpose, 
most births were observed first hand (Plate 3). In each 
case, the time taken for each lamb to perform three 
functions, namely standing, finding the udder and 
suckling, were recorded.
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The point of first 'standing' was taken when a lamb 
achieved balance with all four feet on the ground and the 
legs straight. When a lamb first touched the udder with 
any part of the head, was viewed as 'finding the udder.' 
When a lamb took a teat into the mouth and sucked, was 
recorded as the first 'suckle.'
Where lambings were attended and no assistance 
required, births were allowed to take place in the main 
pens. Ewes in labour were not placed in the small lambing 
pens so that handling did not interfere with parturition, 
or observation of the lambs' first movements. After 
observations were complete the ewe and lamb(s) were moved 
to a lambing pen for 24 hours and thence to a mothering 
up pen. In Experiment 2, all the ewes and lambs were 
eventually returned to the main pens for further 
investigation (Plate 4).
If a ewe required assistance, it was removed to a 
lambing pen immediately. When a dystocia was considered 
to have markedly weakened a ewe and its lamb(s), lamb 
vigour data from the birth were not included in 
statistical analysis. If a weak lamb did not suckle 
within 2 hours of parturition, it was encouraged and put 
on the teat. Where necessary in such situations 150 ml of 
colostrum from the ewe was given to the lamb at 4 hour 
intervals, by stomach tube. Prophylactic dosing of new 
born lambs with antibiotics was not undertaken, but where 
necessary such treatment was given for ill-health and the 
incident recorded. The lambs were bled at 2 and 4 weeks
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Plate 3. A HS treatment ewe lambing in one of the main
pens. Experiment 2.
Plate 4. Four week old lambs with their ewes. Experiment 2
of age and sera were analysed for B12 and MMA 
concentrations.
5.2.4 Statistical Analysis - Experiments 1, and 2.
Data for ewe liveweight^ condition score, whole blood 
Hb and GSH+Px, plasma Ca, Cu, Mg and glucose, were tested 
for significant difference among treatments at each 
sampling, using one way analysis of variance. The 
analysis of serum B12 and MMA results was detailed in 
Chapter 3.
Treatment differences in the numbers of barren ewes,
conception, reabsorption and lambing rates, number of 
lambs born, stillbirths, neonatal mortalities and 
incidence of lamb ill-health, were tested using Chi- 
squared analysis.
Differences in lamb mean serum B12 and MMA 
concentrations and lamb vigour data among treatments, 
were tested using one way analysis of variance. Where a 
significant difference existed between treatments, the
degree of significance was ascertained using the least
significant difference analysis.
Lamb birthweight data were tested by two way analysis 
of variance, using singles and twins as blocks. 
Variation due to differences in the numbers of singles 
and twins born in each treatment, could then be
eliminated from the test. Mean lamb birthweight in each 
treatment was also adjusted to account for the different 
numbers of singles and twins in each group.
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5.3 RESULTS.
5.3.1 Experiment: 1.
5.3.1.1 Ewe liveweight and condition score.
The ewe liveweight and condition score data from 
Experiment 1 are presented in Figures 1 and 2, 
respectively and Appendix 12. There were no significant 
differences among treatments for either mean liveweight 
or condition score values, at any sampling date. However, 
a trend was evident in which the NS ewes lost and the FS 
sheep gained ground in terms of liveweight, relative to 
all the animals as a whole. This was evident in the data 
obtained during the weight loss incurred by lambing. For 
example, the respective mean liveweights of the NS and FS 
treatments just before lambing on day 133, were 62.9 and 
62.8 Kg. After lambing on day 189, the corresponding
weights were 52.9 and 56.4 Kg. This trend was not
reflected in the condition score data.
5.3.1.2 Biochemical profile of the ewes.
Whole blood Hb and GSH + Px data for the ewes in
Experiment 1 are presented in Figures 3 and 4, 
respectively. There were no significant differences among 
treatments for mean whole blood Hb or GSH+Px 
concentrations, at any sampling date. Levels of these two 
parameters in all treatment groups were within normal 
ranges throughout the experiment, implying that the sheep 
were selenium sufficient with no signs of anaemia.
There were no significant differences in mean
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Figure 1. Mean liveweight of the ewes in Experiment 1. (|-----1 =
Tupping period; |----- 1 = Lambing period; ^  = Point at which the
weekly oral Co supplement was removed from the HS sheep),
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Figure 2. Mean condition score of the ewes in Experiment 1.
(I 1 = Tupping period; |----1= Lambing period; ^  = Point at which
the weekly oral Co supplement was removed from the HS sheep).
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Figure 3. Mean whole blood haemoglobin concentrations in the ewes
of Experiment 1.
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Figure 4. Mean whole blood glutathione peroxidase concentrations
in the ewes of Experiment 1.
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concentrations of plasma Ca, Cu or Mg among groups, at 
any sampling date. Treatment mean values for plasma Cu 
and Mg were within the normal ranges of 9.4 to 19.0 
umol/1 and 0.7 to 1.2 mmol/I, respectively, throughout 
the experiment. Low plasma Ca levels (less than 2.0 
mmol/ 1 ) were recorded in all groups as lambing 
approached. These were immediately corrected in the short 
term by injections of calcium borogluconate (Crown 
Chemicals Co, Ltd., Kent) and in the long term by extra 
additions of dicalcium phosphate to the diet.
Levels of plasma glucose within treatments at different 
sampling dates, were very varied. However, there were no 
significant differences in mean plasma glucose levels 
among groups at any sampling date. Further, 
concentrations were always within the normal range 
between 60 and 75 mg/100 ml (MacPherson et ad, 1976).
This implied adequate energy supply to all the ewes and 
normal energy metabolism throughout gestation.
5.3.1.3 Ewe serum vitamin B12 and MMA concentrations.
Mean serum B12 and MMA concentrations in the treatments 
of Experiment 1 were presented in Chapter 3. The data 
from these two diagnostic markers suggested that the FS 
ewes were Co-sufficient throughout Experiment 1. The HS 
sheep were sub-clinically Co-deficient at lambing and 
remained so until the end of the experiment. The NS ewes 
became sub-clinically Co-deficient before lambing and 
suffered from this degree of the disease until the end of
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the experimenti
5.3.1.4 Ewe fertility and gestational performance.
The fertility and gestational performance of the ewes 
in Experiment 1 are presented in Table 5. There were no 
significant differences among treatments for the 
parameters presented in Table 5, except for lambing rate 
to 4 weeks (see Appendix 13). The lambing rate to 4 weeks 
of age in the NS group (40 per cent), was significantly 
lower than those shown by the HS (80 per cent) and FS (95 
per cent) ewes (P<0.05).
Table 5. Ewe fertility and gestational performance in
Experiment 1.
PARAMETER
NS
TREATMENT
HS FS
No: of ewes to the tup 2 0 2 0 2 0
Conception rate, TPl (%) 71 78 74
Conception rate, TP2 (%) 80 80 80
Reabsorption rate (%) 6 6 1 1
No: ewes barren at scan 4 2 4
Lambing rate at scanning (%) 125 1 0 0 90
Lambing rate at birth (%) 95 85 105
Lambing rate at 4 weeks (%) 40 80 95
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The mean (+ SED) length of gestation in the NS, HS and 
FS groups, were 147.4 + 1.1, 147.9 ± 0.8 and 148.3 ± 0.7 
days, respectively, with no significant differences among 
treatments.
The frequency distribution of lambings in each 
treatment is presented in Figure 5. The percentage of 
lambing ewes in each group that gave birth in the two 
lambing periods, is presented in Figure 6 . There were no 
significant differences among treatments for any of these 
measurements.
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Figure 5. Histogram showing lambing frequency relative to
gestation length in the ewes of Experiment 1.
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Figure 6 . Histogram showing the percentage of ewes in each 
treatment, which gave birth in the two lambing periods of 
Experiment 1.
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5.3.1.5 Lambing records and post mortem results.
The lambing data for each treatment group in Experiment 
1 are presented in Table 6 . There were more neonatal 
mortalities in the NS lambs, compared to the HS and FS 
neonates (P<0.001, see Appendix 14). Significantly more 
lambs from the HS ewes were given antibiotic treatment 
for ill-health, than those from the NS and FS sheep 
(P<0.05). An example of the statistical analysis of lamb 
birthweights is presented in Appendix 15.
The liver Co contents of stillborn lambs, or those 
dying in the first four weeks post partum, are presented 
in Table 7 ;
Details of the post mortem examinations of dead lambs 
from this experiment, are presented in Table 8 .
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Table 6. Lambing record from Experiment 1.
PARAMETER TREATMENT 
NS HS FS
Lambs born 1 9 a 1 7 a 2 1 ®
Mean birthweight (Kg) 
Av. SED = 0.2 6
5.1^ 4.6® 5.1®
Stillbirths 2 ^ 0 ® 1 ®
Neonatal mortalities 9 a 1 ^ lb
Treated for ill-health la 4 b 0 ®
Values in rows with different 
least at P<0.05.
superscripts, differed at
Table 7. Liver Co contents of dead
Experiment 1.
lambs from
NS
TREATMENT
HS FS
No: of samples 6 1 1
Mean Co content 
(mg/Kg fresh wght)
0 .017 0 . 04 0 . 16
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Table 8. Details of post mortem examinations of dead
lambs from Experiment 1.
Tag AGE (Days) CAUSE OF DEATH
TREATMENT - NS
— Stillbirth Dystocia. Haemorrhage of liver during 
birth.
— Stillbirth Dystocia.
51 9 Slight infectious prenatal brain 
lesion, cause unknown. Significant 
coli infection of kidney, luna and 
intestinal lesions.
52 1 0 No significant findings.
53 27 Bacterial bronchopneumonia and 
nephritis with tubular degeneration. 
Degenerative changes in liver.
75 1 0 No significant findings.
TWINS
1
2
No significant findings.
Gastritis and enteritis. E. coli and 
Clostridium perfrinaens isolated from 
small intestine.
94 6 No significant findings.
99 2 2 Lesions suggested crushing.
1 0 0 2 Diffuse myositis in skeletal muscle. 
Tubular nephritis in kidney.
TREATMENT HS
— 2 Small, premature lamb (2.7 Kg).
TREATMENT FS
Stillbirth Dystocia.
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5.3.1.6 Lamb serum vitamin B12 and MMA concentrations.
Treatment mean serum B12 concentrations at 2 and 4 
Weeks post partum in the lambs from Experiment 1 , are 
presented in Table 9. Mean serum MMA levels in all lambs 
at 2 and 4 weeks post partum were 3.40 + 0.24 and 3.73 + 
0.26 umol/1 , respectively, with no trends or significant 
differences amongst treatments being evident.
Table 9. Lamb serum vitamin B12 concentrations from
Experiment 1.
MEAN VIT. B12 
(ng/1) AT; NS
TREATMENT
HS FS
SIG.
DIF. SED
2 weeks pp 147® 153® 27lb * * * 25
4 weeks pp 150® 164® 2 5 9 b ■ft 42
Means in rows with sifferent superscripts were 
significantly different.
5.3.2 Experiment 2.
5.3.2.1 Ewe liveweight and condition score.
The ewe liveweight and condition score data from 
Experiment 2 are presented in Figures 7 and 8, 
respectively and Appendix 16. There were no significant 
differences among treatments for either mean liveweight 
or condition score values, at any sampling date. However, 
a general trend of the FS group gaining and the NS sheep 
losing ground for both parameters, relative to all the 
animals as a whole, continued through gestation and 
lambing. This was evident in the liveweight data, where
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Figure 7. Mean liveweight of the ewes in Experiment 2 • ( |-
Tupping period; |----1 = Lambing period; ^  = Start of weekly oral
Co supplementation of the HS sheep). *
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Figure 8 . Mean condition score of the ewes in Experiment 2.
(I 1 = Tupping period; |---- 1 = Lambing period; /|\ = Start of
weekly oral Co supplementation of the HS sheep).
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the mean values for the NS and FS ewes at the start of 
tupping (day 87) were 60.3 and 55.8 Kg, respectively. At 
the last weighing after lambing (day 260), this 4.5 Kg 
advantage of the NS group had been lost and the 
equivalent values were 56.5 and 59.0 Kg. A similar trend 
between the NS and FS treatments was revealed by the 
condition score results, where mean values were 2.99 and 
2.85 (day 87) and 2.48 and 2.55 (day 260), respectively.
5.3.2.2 Biochemical profile of the ewes.
Whole blood Hb and GSH + Px data for the ewes of 
Experiment 2 are presented in Figures 9 and 10, 
respectively. There were no significant differences among 
treatments for mean whole blood Hb or GSH+Px 
concentrations, at any sampling date. Levels of Hb in all 
treatment groups were within the normal range (above 9.0 
g/ 1 0 0  ml whole blood) throughout the experiment, implying 
that the sheep at no time suffered from anaemia.
Mean GSH+Px concentrations were in the deficient range 
(less than 27 units/ml), implying selenium deficiency, on 
day 26. All ewes were given an oral dose of 4 mg Se/hd as 
sodium selenate (Na2 SeO^. 78^0) before tupping, on day 
63. Mean GSH+Px levels in all groups then increased to 
normal values and remained so for the whole of pregnancy 
and lactation.
No confidence could be placed in the plasma glucose 
concentrations determined in ewes from Experiment 2. This 
was due to continual problems with the analytical
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Figure 9. Mean whole blood haemoglobin concentrations in the ewes
of Experiment 2.
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Figure 10. Mean whole blood haemoglobin concentrations in the 
ewes of Experiment 2. ( = Timing of single oral dose of 4
mg/hd selenium, to all sheep).
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technique of large variations in the results. These 
variations appeared to be due to the method, rather than 
any effect of treatment on the sheep. However, energy 
status in a sample of twelve ewes (four from each 
treatment) was tested on day 218 by measurement of serum 
beta-hydroxybutyrate levels. These were all normal (less 
than 0.80 mmol/1) and ranged from 0.10 to 0.42 mmol/1. 
These indicated normal energy metabolism in the sheep 
just before lambing.
There were no significant differences in the mean 
concentrations of plasma Ca, Cu or Mg amongst treatments, 
at any sampling date. Levels of these three minerals in 
all groups were within the normal ranges throughout the 
investigation.
5.3.2.3 Ewe serum vitamin B12 and MMA concentrations.
Mean serum B12 and MMA concentrations in the ewes from
Experiment 2 were presented in Chapter 3. The FS ewes 
were Co-sufficient throughout Experiment 2. The HS sheep 
were sub-clinically Co-deficient for the first half of 
pregnancy^ but were sufficient for the second half and 
the remainder of the experiment. The NS ewes were 
rendered sub-clinically Co-deficient at tupping and the 
disease progressed to the clinical form at lambing.
5.3.2.4 Ewe fertility and gestational performance.
The fertility and gestational performance of the ewes 
in Experiment 2 are presented in Table 10. There were no
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significant differences among treatments for any of the 
parameters shown. However, there was a tendency for the 
NS and HS groups to have lower lambing rates at birth and 
4 weeks, compared to the FS sheep.
Table 10. Ewe fertility and gestational performance in
Experiment 2.
PARAMETER
NS
TREATMENT
HS FS
No: of ewes to the tup 2 0 2 0 2 0
Conception rate, TPl (%) 4 6 25 33
Conception rate, TP2 (%) 67 67 57
Conception rate, TP3 (%) 1 0 0 1 0 0 1 0 0
Reabsorption rate (%) 16 25 2 0
No: of ewes barren at scan 1 3 1
Lambing rate at scan (%) 130 1 2 0 1 2 0
Lambing rate at birth (%) 105 105 115
Lambing rate at 4 weeks (%) 85 ' 1 0 0 115
The frequency of lambings in each treatment are 
presented in Figure 11. The percentage of lambing ewes in 
each treatment that gave birth in each of the three 
lambing periods, are presented in Figure 12. The mean 
length of gestation in the NS, HS and FS sheep, was 146.1 
+ 1.0, 145.7 + 0.6 and 146.8 + 0.7, respectively. There
were no significant differences among treatments, for any 
of these measurements.
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Figure 1 1 , Histogram showing lambing frequency relative to
gestation length in the ewes of Experiment 2.
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Figure 12. Histogram showing the percentage of ewes in each 
treatment, which gave birth in the three lambing periods of 
Experiment 2.
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5.3.2.5 Lambing records, post mortem results and lamb
vigour.
The lambing data for each treatment in Experiment 2 are 
presented in Table 11.
Table 11. Lambing record from Experiment 2.
PARAMETER
NS
TREATMENT
HS FS
No : of lambs born 2 1 2 1 23
Mean birthweight (Kg) 
SED = 0.27
4.3 4.8 4.7
Stillbirths 4 1 0
Neonatal mortalities 0 0 0
Treated for ill-health 1 2 1
There were no significant differences among treatments 
for any of the parameters in the lambing record, except 
the number of stillbirths. The NS group had a 
significantly higher incidence of stillbirths, compared 
to the HS and FS sheep (P<0.05). Two ewes in the NS group 
were scanned as carrying twins, but were found to be 
empty at lambing time. One other sheep in this treatment 
aborted twin lambs.
The post mortem results for the lamb deaths in 
Experiment 2 are presented in Table 12. Liver samples 
taken from three of the stillborn lambs in the NS 
treatment and samples from the twins aborted by a NS ewe.
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showed a deficient mean Co content of 0.014 + 0.002 mg/Kg 
fresh weight. A similar sample from the stillborn lamb in 
the HS group revealed an adequate Co level of 0.11 mg/Kg 
fresh weight.
Lamb vigour data are presented in Table 13.
Table 12. Results of post mortem examinations of dead
lambs from Experiment 2.
TAG AGE (Days) CAUSE OF DEATH
TREATMENT NS
Stillbirth No significant findings.
Stillbirth Mummified lamb (2.2 Kg).
Stillbirth Dystocia.
Stillbirth Dorsal and lateral curvature of the 
thoracic spine, of unknown aetiology. 
Some colonies of Pasteurella 
haemolvtica (type 15  ^ isolated from 
lungs.
TREATMENT HS
Stillbirth Staphylococcus aureus isolated 
from liver tissue. Neuropathology 
revealed lesions suggestive of
toxoplasmosis.
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Table 13. Measurements of lamb vigour.
TIME FROM 
BIRTH TO:- 
(Min.) NS
TREATMENT
HS FS
SIG.
DIF. SED
Standing 22,4&b 2 8 , 7 3 1 5 ,3 b * 4,9
Finding udder 4 0 . 7 3 4 3 . 5 3 2 3 .7 b ** 5.8
Suckling 76.23 6 0 .5 b 30.7 C * * * 6.9
Means in rows with different superscripts differed 
significantly.
5.3.2.6 Lamb serum vitamin B12 and MMA concentrations.
Treatment mean serum B12 and MMA concentrations in the 
lambs of Experiment, 2 at 2 and 4 weeks post partum, are 
presented in Table 14.
Table 14. Lamb serum vitamin B12 and MMA concentrations
in Experiment 2.
WEEKS post TREATMENT SIG.
partum
NS HS FS
DIF.
SED
Vit. B12 2 533 153b 300^ *** 40
(ng/1)
4 943 248b 330b ** * 64
MMA 2 15.03 l.ob 1 . lb ** * 3.1
(uraol/1)
4 20.33 2.4b 2.3b * * * 4.4
Means in rows with different superscripts, differed at 
P<0.001.
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5.4 DISCUSSION.
The effects of Co deficiency in pregnant ewes on 
reproduction evident in Experiments 1 and 2, will be 
discussed in terms of the fertility and gestational 
performance of the sheep and lamb viability. These 
results will be related to the degree of Co deficiency 
disease experienced by the ewes in the two experiments 
and the serum vitamin B12 and MMA status of the neonatal 
lambs.
5.4.1 General Effects on the Ewes.
The extent of the deficiencies imposed on the ewes in 
both Experiments 1 and 2 were reflected by the liveweight 
and condition score data (Figures 1, 2, 6 and 7). While 
there was a tendency for the NS sheep to lose ground 
relative to the other animals in terms of these two 
parameters, no significant differences among treatments 
were evident. This indicated that the degree of Co 
deficiency imposed on the NS and HS groups in both 
experiments was sub-clinical, although the NS sheep were 
experiencing the clinical disease at lambing in 
Experiment 2, due to the extended period on a low Co diet 
in this second experiment.
The analysis of plasma glucose levels in Experiment 1 
and beta-hydroxybutyrate concentrations in Experiment 2 
supported these conclusions. The data from these 
determinations implied that all the animals in Experiment 
1 had a normal energy metabolism. The energy status of
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the sheep in Experiment 2 could also be presumed to be 
normal, up to the start of lambing, when the beta- 
hydroxybutyrate determinations were made.
The sub-clinical Co deficiencies imposed on the ewes in 
Experiments 1 and 2 did not affect whole blood Hb 
concentrations (Figures 3 and 7). Thus, the animals were 
at no time suffering from anaemia, which can be 
associated with severe clinical Co deficiency (MacPherson 
et al, 1976).
In both experiments the whole blood GSH+Px (Figures 4 
and 8 ) and plasma Ca, Cu and Mg concentrations in the 
sheep were usually in the normal range. Where levels of 
GSH+Px and Ca were low, relevant supplementation was 
provided immediately. For this reason, selenium or other 
mineral deficiencies did not complicate the investigation 
of the effect of Co deficiency in these experiments.
5.4.2 Fertility and Gestational Performance.
In both experiments a Co-deficient intake did not 
affect the tupping performance of the ewes in terras of 
conception rates, reabsorption rates, or the number of 
ewes barren at scanning (Tables 5 and 9). This was even 
the case in Experiment 2, where the NS and HS sheep were 
rendered sub-clinically Co-deficient during the mating 
period. In this second experiment, 10 per cent (4 out of 
40) of the animals on a Co-deficient intake (NS and HS 
treatments) were barren at scanning compared to only 5
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per cent (1 out of 20) of those given a sufficient Co 
supply (FS group). However, this difference was not 
statistically significant.
The poor conception rates evident in all treatments at 
tupping periods 1 and 2 in Experiment 2, were due to the 
use of inexperienced ram lambs for mating. The high 
reabsorption rates recorded for all groups in this 
experiment were also caused by these tups, who appeared 
to mark ewes without actually joining. Thus, a large 
number of sheep were apparently returning to service, 
when in fact many of these had not been tupped in a 
previous cycle.
These results were in contrast with those of Dunlop 
(1946b), who reported greater infertility in "sub- 
minimally" Co-deficient ewes, compared to Co-dosed 
controls. However, if the animals in these two 
experiments had been rendered sub-clinically Co-deficient 
earlier before mating and tupped by deficient rams, then 
the data might have been more in agreement with that of 
Dunlop (1946b).
Despite these negative results, the imposed 
deficiencies did adversely affect the gestation and 
lambing performance of the sheep in both experiments. 
These effects could be summarised by the observation that 
lambs from sub-clinially Co-deficient ewes had a 
decreased pre- and post-natal viability, compared to 
those from sufficient controls.
This adverse effect was evident in the lambing rate
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data from both experiments, The prospective lambing rates 
calculated at scanning were not actually achieved by the 
NS and HS ewes, but were accomplished by the FS animals. 
This drop in lambing rate between scanning and birth in 
the NS and HS treatments was due to an increased number 
of abortions and probable reabsorptions in the deficient 
sheep, compared to FS controls. For example, in 
Experiment 2, two NS ewes were scanned as carrying twins, 
but were found to be empty at lambing. These animals 
either aborted or reabsorbed their lambs in the second 
half of gestation.
The depression in lambing rate between scanning and 
birth in both experiments, was more marked in the NS than 
in the HS treatment. However, it was still a problem in 
the HS ewes. This fact implied that Co supplementation of 
sub-clinically Co-deficient sheep in either the first 
(Experiment 1) or second (Experiment 2) half of 
pregnancy, was not adequate to protect these ewes fully 
from pre-natal lamb losses due to the deficiency.
A further decrease in lambing rate between birth and 4 
weeks of age was evident in both investigations. In 
Experiment 1 this was most marked in the NS group, where 
lambing rate between these two times dropped from 95 to 
40 per cent. This was due to the increased number of 
neonatal mortalities occurring in this treatment, 
compared to the FS controls, (Table 6 ). In Experiment 2, 
this depression in lambing rate was again evident in the
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HS and NS treatments, but this time was caused by- 
increased numbers of stillbirths, rather than neonatal 
mortalities, relative to the FS group.
These results are in agreement with those of Quirk and 
Norton (1987) who reported increased numbers of 
reabsorptions, abortions and stillbirths in Co-deficient 
ewes compared to sufficient controls. These workers 
tried to characterise the effects of clinical Co 
deficiency on reproductive performance and subsequent 
lamb growth. They established four treatments: 'C' - 8
non-supplemented controls; " LC " - 6 given 0.03 mg
Co/head/day in a weekly oral dose; 'HC' - 6 given 0.06 mg 
Co/head/day in a weekly oral dose; and "CB" - 6 given a 
Co bullet and grinder. All treatments were administered 
from before tupping. The effects of these treatments on 
ewe reproductive performance are shown in Table 15.
Table 15. The reproductive performance of ewes recieving
various levels of Co supplementation.
PARAMETER
CB
TREATMENT
HC
GROUP
LC C
Ewes cycling/ewes joined (%) 1 0 0 1 0 0 1 0 0 8 8
Returns to service/ewes 
cycling (%) 0 0 0 29
Ewes lambing/ewes joined (%) 83 83 83 50
Lambs born/ ewes joined {%) 116 83 83 50
(After Quirk and Norton, 1987).
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Further to these results, Co-supplemented sheep were 
heavier than non-supplemented controls throughout 
pregnancy and lactation (P<0.05). Lambs from the HC and 
LC treatments had greater birthweights than those from C 
dams (P<0.05), and CB, HC and LC lambs grew faster in the 
14 weeks of lactation before weaning, than the C lambs 
(P<0.05).
The detailed study of Quirk and Norton (1987) also 
attempted to relate serum B12 and urinary MMA and FIGLU 
concentrations to these findings, Serum B12 levels in C 
group ewes were in the clinical range and less than a 
mean of 160 ng/ 1  throughout the trial, while those in the 
other treatments indicated Co sufficiency.
Urinary MMA and FIGLU were not detected in the CB, HC 
and LC ewes during pregnancy and lactation, but 
consistently high levels (up to means of 4847 umol MMA/1 
and 232 umol FIGLU/1 urine) were evident in the C group 
sheep throughout the experiment. These concentrations 
were indicative of clinical Co deficiency in the non­
supplemented animals.
It is important to note that the results of Quirk and 
Norton (1987) were obtained from clinically Co-deficient 
and sufficient ewes. The investigations discussed here 
implied that such effects can occur in sub-clinically 
deficient animals.
In Experiments 1 and 2. trends were also discernable in 
the data relating to differences in gestation length 
among treatments. In both experiments there was a
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tendency for the NS ewes to lamb over a longer period 
than either the HS or FS groups. This was evident from 
Figures 5 and 11, which showed that the NS animals 
started lambing three days before the FS treatment, in 
both experiments. The NS and HS groups of both 
experiments also had slightly shorter mean gestation 
lengths than the FS sheep.
These observations of greater inconsistency in 
gestation length in sub-clinically Co-deficient sheep, 
compared to sufficient controls, may be linked to the 
cyclical hormonal changes which Mgongo et. aT (1985) 
reported in clinically deficient goats. These workers 
found evidence of inconsistent oestrus cycle length in 
Co-deficient animals, compared to sufficient 
counterparts. However, the trend reported here for Co­
deficient sheep to have shorter gestation lengths, can 
not be supported by any direct evidence in the 
literature.
5.4.3 Lambing Records, post mortem Examinations and Lamb
Vigour.
Sub-clinical Co deficiency in the NS and HS ewes of 
Experiments 1 and 2 did not have any marked effect on the 
numbers of lambs born, or the mean lamb birthweights 
among treatments. However, a profound adverse affect on 
post-natal lamb viability was evident. These results were 
indicated by the lambing records, presented in Tables 6 
and 10.
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Although there was a tendency in both experiments for 
the NS and HS treatments to yield fewer lambs than the FS 
group; these differences were not statistically 
significant. In addition, there was a trend for the HS 
ewes in Experiment 1 and the NS sheep in Experiment 2 to 
produce lighter lambs than the FS animals, but again 
these differences were not statistically significant.
Decreased . post-natal viability of lambs from Co­
deficient ewes, compared to those from sufficient dams, 
was evident in both experiments. In Experiment 1, this 
was manifest by a significantly higher number of neonatal 
mortalities in the NS, compared to the HS and FS 
treatments (9 vs. 1 vs. 1, respectively, P<0.05). In 
Experiment 2, the effect was found in a significantly 
higher number of stillbirths in the NS relative to the HS 
and FS groups (4 vs. 1 vs. 0, respectively, P<0.05). 
These effects led to the depression of lambing rate in 
the NS ewes, discussed in the previous section. These 
observations are supported by the work of Duncan et 
(1981), who reported an increased incidence of 
stillbirths and perinatal mortalities in lambs from a 
small group of clinically Co-deficient sheep, compared to 
sufficient controls.
This impairment of post-natal viablility in lambs 
requires explanation. In the two experiments described 
the effect seemed to be related in part to the ability of 
the sheep to resist infection before lambing, and the
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ability of the lambs to resist infection post partum.
This conclusion can be drawn from the results of the 
post mortem examinations of dead lambs in both 
experiments, presented in Tables 7 and 11. In two of the 
stillbirths from Experiment 2 (one in each of the NS and 
HS treatments), bacterial infections were implicated in 
the cause of death. Further, in 4 of the 9 neonatal 
mortalities in the NS group of Experiment 1, bacterial 
infections were again implicated in the cause of death.
However, there may be a flaw in this argument as 
neonatal mortalities were recorded in Experiment 1, but 
not in Experiment 2, This discrepancy must be explained 
if the theory is to be substantiated. In the first 
experiment, the pens were mucked out and re-bedded before 
lambing, but not disinfected. In the second 
investigation, the pens were again mucked out, but were 
also thoroughly washed and disinfected. The level of 
pathogenic challenge to new born lambs in Experiment 1, 
was therefore probably greater than that experienced in 
Experiment 2. This could account for the discrepancy in 
the incidence of neonatal mortalities between 
experiments.
A major cause of the decreased ability of lambs from 
Co-deficient ewes to resist infection, compared to 
sufficient controls, was revealed by the lamb vigour data 
of Experiment 2 (Table 13). These results showed that 
lambs from both the NS and HS treatments took, on 
average, at least twice as long to start suckling,
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relative to lambs from the FS group. Such an effect was 
also noted subjectively in Experiment 1. In general, 
lambs from Co-deficient ewes did not appear to be weaker 
or 'less willing' to stand and suckle than sufficient 
controls. Rather, lambs from deficient sheep simply took 
longer to perform these tasks.
It may therefore be postulated that lambs with 
depressed vigour from Co-deficient ewes would suckle less 
frequently in the first hours and days of life. Suckling 
frequency was not measured in these experiments, but it 
may be that a lamb from a NS or HS dam which took more 
than 60 minutes to start suckling, fed from the teat less 
frequently than a lamb from a FS sheep, which started to 
suckle after only 30 minutes.
If this were the case, then the levels of energy and 
passive immunity acquired by NS and HS lambs from their 
mothers' colostrum and milk would be reduced, relative 
to that achieved by the FS lambs. Thus, lambs from Co­
deficient ewes would have a decreased energy supply and 
ability to resist infection compared to those from 
sufficient controls. Such an effect would account for the 
increased incidence of neonatal mortalities in the NS 
group and numbers requiring anti-biotic treatment for 
ill-health in lambs from HS group in Experiment 1, and 
the overall depression in post-natal lamb viability 
evident in both experiments.
Interestingly, Garton et ad (1981) reported cases of
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neuropathological abnormalities in lambs born to 
clinically Co-deficient ewes. These workers related their 
findings to an observed depression in viability in lambs 
from these deficient dams, compared to sufficient 
controls. However, in the post mortem examinations 
carried out in both of the present experiments no 
significant neuropathological effects could be found in 
any of the treatment groups,
There are no similar experiments reported in the 
literature which would support or refute the evidence 
from Experiments 1 and 2, concerning lamb vigour. 
However, it is likely that depressed lamb vigour due to 
sub-clinical Co deficiency in dams would result in the 
offspring of such sheep having a decreased post-natal 
viability. This may be related to a reduced energy intake 
in early life and to an impaired mothering ability in 
deficient ewes. These parameters were not measured in the 
experiments reported here. To assess their influence on 
lamb vigour and subsequent viability, determinations of 
lamb energy status would need to be made. This could be 
achieved by continued weighing of the new born lambs at 
regular intervals and by analysis of lamb plasma samples 
for glucose concentrations. Behavioural studies of dams 
post partum, would enable an assessment of mothering 
ability to be made.
The effect of sub-clinical Co-deficiency in the ewe on 
the transfer of passive immunity from dam to lamb and 
consequent lamb viability, will be discussed fully in
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Chapter 6 . It should be noted here however, that Co 
repletion of the HS sheep in the second half of pregnancy 
in Experiment 2, did not significantly improve the vigour 
of the lambs from this treatment above that evident in 
the NS group. Further, Co supplementation of the HS ewes 
in the first half of gestation in Experiment 1 did not 
ensure post-natal viability in these lambs equivalent to 
that found in the FS group.
5.4.4 Lamb Serum Vitamin B12 and MMA Status■
The effects of sub-clinical Co deficiency in pregnant 
ewes on lamb viability, could be related in some degree 
to the serum vitamin B12 and MMA concentrations of the 
lambs. The exact relationship was not clear, but this 
section will attempt to discuss the relevance of the data 
obtained.
In Experiment 1, lambs from Co-deficient ewes had
significantly lower serum B12 levels at 2 and 4 weeks
post partum than those from the sufficient sheep (Table 
9). In Experiment 2, lambs from the NS and HS ewes at 2 
weeks, and those from the NS dams at 4 weeks post partum, 
had significantly lower concentrations of B12 in serum 
compared to lambs from the FS treatment (Table 14).
Vitamin B12 in all of the lambs would be derived from
pre-natal placental transfer and post-natal absorption 
from colostrum and milk (Quirk and Norton, 1987). That Co 
supplementation of deficient ewes raises the B12 content
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of their milk, above non-supplemented controls, was 
established by Hart and Andrews (1959) and O'Halloran and 
Skerman (19 61).
These latter workers also reported that lambs from 
deficient sheep have lower liver B12 concentrations than 
those born to sufficient animals. These results were 
confirmed by the analysis of liver Co content in dead 
lambs from Experiment 1 (Table 7). These showed that 
lambs from the NS and HS ewes, which were sub-clinically 
Co-deficient at lambing, had lower levels of Co in liver 
than those from the sufficient FS treatment.
In Experiment 2 there was a significant graded 
treatment effect in lamb serum B12 concentrations in the 
first month post partum (Table 14). FS group lambs had 
the highest levels and the NS lambs the lowest, with 
those in the HS lambs intermediate (P<0.001). These 
results implied that even though the HS ewes received Co 
supplementation from mid-pregnancy, stores had not built 
up to the extent that B12 status of the HS group lambs 
was equivalent to that of the FS controls. Whether this 
was caused by less placental transfer of the vitamin, or 
decreased levels of B12 in the colostrum and milk of the 
HS group compared to the FS treatment, could not be 
ascertained from the data collected.
The lamb mean serum vitamin B12 concentrations in all 
treatments of both Experiments 1 and 2, at 2 and 4 weeks 
post partum, were below the lower normal limit of 400 
ng/1 for sheep. Levels in lambs from the NS group at both
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samplings in both experiments, and those from the HS 
treatment at 2 and 4 weeks of age in Experiment 1 and at 
2 weeks post partum in Experiment 2, were below 200 ng/1. 
These concentrations would suggest clinical Co deficiency 
in mature sheep.
Quirk and Norton (1987) also reported low serum B12 
levels in lambs from clinically Co-deficient and 
sufficient ewes. These workers found that serum B12 
concentrations in pre-weaned lambs were variable, but 
were generally below 160 ng/1, regardless of the Co 
status of the dams.
The significance of these 'low' concentrations of serum 
B12 in neonatal lambs is not clear. This is basically 
because the B12 requirements of such 'pre-ruminant' 
lambs, are not known. It may be that the B12 status 
evident in the FS lambs was adequate at 2 and 4 weeks 
after lambing. At this time the vitamin is not needed as 
an enzyme co-factor in the catabolism of propionate, as 
this metabolic pathway will not be fully developed until 
the lamb converts from a milk to a roughage/concentrate 
ration. During and after the development of a 
reticulorumen at around weaning time and subsequent 
establishment of a rumen microflora and production of 
propionate, the requirement for B12 would increase and 
become high. However, these lambs had not reached this 
stage and the serum B12 concentration evident in lambs 
from FS ewes, although apparently low, may have been
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adequate for optimal viability and growth at this stage.
In comparison, the neonatal lamb requirement for B12 as 
à co-factor to the methyltetrahydrofolate 
methyltransferase enzyme (Chapter 1, Figure 3.), in the 
metabolism of homocysteine and folate, may be 
significant. For this reason, the possibility that the 
evident differences in lamb serum B 1 2  levels between 
treatments had an effect on lamb viability, can not be 
ignored.
Some discrepancy was evident between Experiments 1 and 
2 in the lamb serum MMA data at 2 and 4 weeks post 
partum. In Experiment 1 there were no significant 
differences in mean serum MMA levels among treatments, 
while in Experiment 2 lambs from NS ewes had higher 
concentrations of this metabolite in serum, compared to 
the HS and FS groups (P<0.001). Further, the mean levels 
of serum MMA found in these NS treatment lambs at 2 and 4 
weeks of age, were 15.0 and 20.3 umol/1, respectively. 
Such values would be indicative of clinical Co deficiency 
in mature sheep.
These discrepancies require explanation. It may be 
postulated that serum MMA in lambs arose solely from 
absorption of the metabolite from ewe colostrum and milk. 
It would not be caused by abnormal propionate metabolism 
(as it is in mature sheep) as this volatile fatty acid 
would not be produced in the immature rumens of these 
lambs. In Experiment 1 none of the ewes were showing very 
high levels of MMA in serum at lambing time.
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Consequently, little was present in colostrum and milk 
and available for absorption by the lambs. However, in 
Experiment 2 the NS dams had very high concentrations of 
serum MMA at lambing (up to a mean of 145 umol/1 on day 
260). Thus, enough was probably present in the colostrum 
and milk of these ewes to be absorbed by their offspring 
and appear in lamb serum in significant amounts. In 
Experiment 2 the NS ewes were the only sheep to show low 
serum B12 and high MMA concentrations at lambing time. 
Consequently, the NS lambs were the only ones in this 
experiment to have significant levels of the metabolite 
in serum at 2 and 4 weeks post partum.
There is no known role for MMA in such young lambs and 
the possible consequences of the differences shown in 
Experiment 2 are therefore not clear. Garton et al (1981) 
stated that high serum MMA concentrations may be related 
to failure of Co-deficient ewes to produce viable lambs. 
However, a greater number of lambs survived to 4 weeks of 
age in the NS treatment of Experiment 2 (17), than
survived in the NS group of Experiment 1 (8 ). This was 
despite the NS ewes and lambs of Experiment 2 having much 
higher serum MMA concentrations than' the NS dams and 
lambs of Experiment 1. These results are not consistent 
with the statement of Garton et al (1981).
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5.4.5 Consequences for Farming Practice.
The results of these two experiments indicated that the 
reproductive performance of Co-deficient ewes was 
impaired, relative to Co-sufficient controls. This was 
evident in reduced gestational and lambing performance in 
the sheep and depressed post-natal vigour and viability 
in their lambs. These findings were in agreement with 
those already reported by Dunlop (1946b), Duncan et al 
(1981), Garton aj. (1981) and Quirk and Norton ( 1987 ).
These workers however, with the possible exception of 
Dunlop (1946b), gained such evidence from ewes of 
sufficient and clinically Co-deficient status. In 
contrast, the two experiments described here suggested 
that similar detrimental effects can occur where only 
sub-clinical Co deficiency exists. Further, this work 
also suggested that some depression in reproductive 
performance would be evident if ewes were sub-clinically 
deficient for only the first or second half of pregnancy. 
Thus, in terms of prevention, full protection from these 
adverse effects would only be afforded by Co 
supplementation of deficient ewes before tupping and 
maintenance of an adequate Co intake throughout pregnancy 
and lactation.
The increased mortality and morbidity of the lambs from 
Co-deficient ewes demonstrated in these two experiments, 
may have been associated with the housing of these 
animals. The pathogenic challenge which the sheep of both 
investigations experienced, would not have been the same
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as those present in the field situation. Therefore, it 
may be difficult to relate the findings of these 
investigations and those of Duncan et al (1981) and 
Garton et a% (1981), directly to practical farming 
circumstances. However, that Co-deficient ewes have 
reduced fertility and gestational performance, with 
depressed lamb viability, compared to sufficient 
controls, has been established in the field situation by 
Quirk and Norton (1987).
On this basis, the findings reported here have 
implications for lamb viability on the farm. If the 
lambing of sub-clinically Co-deficient ewes takes place 
on the open hill or upland pastures, it may be expected 
that lambs which took much longer to suckle and thus gain 
energy, have less chance of survival than those from 
sufficient dams which get to the teat more quickly. This 
would be particularly relevant during inclement weather 
conditions where lambs from deficient ewes which are slow 
to rise and suckle, would be more susceptible to loss by 
hypothermia. This is especially relevant in countries 
such as Scotland, where lambing conditions can be harsh 
and Co deficiency is a particular problem of upland and 
hill type farms.
How apparent the effects of sub-clinical Co deficiency 
might be in the field situation, would depend on the 
lambing regime of individual farms. If lambing takes 
place on the open hill or upland, or is difficult to
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monitor closely, the effect may be recorded as large 
numbers of stillbirths and low lambing rates, with a 
number of barren ewes. The data from these experiments 
suggests that in reality some of these lambs would have 
been born alive, but were not sufficiently vigorous to 
survive. If this is normal for a farm, suspicions that 
improvememts could be made would not be aroused. Where 
lambing takes place on more closely supervised in-by 
pastures, the effect would be manifest by a number of 
barren ewes and stillbirths with a great need for 
assisting lambs to the teat.
5.4.6 Future Work.
The detrimental effects of sub-clinical Co deficiency 
in pregnant ewes on reproductive performance are evident 
from the results presented. However, many of the exact 
causes are still not known. For example, further work is 
required to ascertain why Co-deficient ewes fail to carry 
lambs to full-term and produce non-viable offspring. 
Increased rates of reabsorption, abortion and stillbirths 
may be due to abnormal hormonal balance during gestation 
and parturition (Mgongo et, 1985 ). The observed
depression in lamb vigour may be a consequence of subtle 
neurological and hormonal changes, poor mothering 
ability, or low serum B12 concentrations. These aspects 
require further investigation.
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CHAPTER 6.
THE EFFECT OF COBALT DEFICIENCY IN THE PREGNANT EWE ON 
NEUTROPHIL FUNCTION AND THE TRANSFER OF PASSIVE IMMUNITY.
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6.1 INTRODUCTION.
Evidence of the detrimental effects of Se and Cu trace 
element deficiencies on immunocompetent cell function in 
steers, was reported by Boyne and Arthur (1979 and 1981). 
MacPherson et a 1 ( 1987 ) have also shown that Co
deficiency in steers results in a reduction in the 
ability of isolated neutrophils to kill the yeast 
organism Candida albicans in vitro. Kaplan and Basford 
(1976) established that hexose monophosphate shunt 
(HMPS) pathway activity was depressed in leucocytes 
isolated from vitamin B12 deficient patients. However, 
there is no evidence in the literature to suggest that 
C0 /BI2 deficiency in sheep might have similar effects.
The transfer of passive immunity from ewe to lamb in 
the first 12 to 24 hours after parturition is a complex 
process, which is influenced by many factors (Halliday, 
1965). It involves the absorption of immunoglobulin (Ig) 
by the neonate lamb, from ingested c o lostrum. The 
neonatal lamb is incapable of synthesising Ig's ^  novo 
and the acquisition of maternal Ig's in this passive 
manner is essential to the ability to resist infection 
and survive in early life (Campbell, 1974). However, 
there is no evidence in the literature to suggest that Co 
deficiency in pregnant ewes might have any adverse effect 
on the transfer of passive immunity from dam to lamb.
The ability of the pregnant ewe to resist pathogenic 
infection and effectively to transfer passive immunity in 
the first hours post partum, are essential to the
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viability of pre- and post-natal lambs. The results 
presented in Chapter 5 suggested that lambs from sub- 
clinically Co-deficient ewes had depressed viability 
before and after lambing. In some cases this was shown at 
post mortem to be associated with pathogenic bacterial 
infections. .
The objectives of this study were to investigate the 
effects of Co deficiency in pregnant ewes, on cellular 
immune function and the transfer of passive immunity to 
newborn lambs. One aspect of immune function in pregnant 
sheep was determined, by measurement of the ability of 
isolated neutrophils to phagocytose and kill C_^  albicans 
cells in vitro. The transfer of passive immunity was 
monitored by the estimation of IgG concentrations in ewe 
colostrum and lamb serum samples and by the zinc sulphate 
turbidity test.
6.2 MATERIALS AND METHODS,
6.2.1 Animals and Treatments.
The ewes and lambs employed in the two investigations 
to be described, were the same as those already detailed 
in Chapter 3 and Chapter 5. Thus, Experiments 1 and 2 
discussed in this chapter, refer to the same sheep and 
experiments of these previous chapters. Observations on 
immune competence could be directly related to Co/Bl2 
status in the animals and other effects of the deficiency 
disease.
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The treatments and diets imposed on the animals in both 
investigations were described in Chapter 3 and Chapter 5. 
The blood sampling regimes for the ewes and lambs and 
lambing routines of both Experiments 1 and 2, were also 
detailed in these chapters.
6.2.2 Neutrophil Function.
In both experiments, 24 ewes comprising 8 from each 
treatment were monitored for neutrophil function by the 
neutrophil function test (NFT, Chapter 2, section 2.9). 
These 8 sheep from each group were randomly selected and 
split into two groups of 4. Thus, at each fortnightly 
sampling blood from 12 ewes (4 from each treatment) was 
employed for the NFT. The two groups of 12 were tested 
alternately at samplings throughout the experiments.
6.2.3 The Transfer of Passive Immunity.
The lambs of both experiments were bled at 2 and 4 
weeks of age. In the first experiment, only those lambs 
whose mothers were kept inside after parturition were 
used in this investigation, In the second experiment, all 
ewes and lambs were kept on trial post partum and thus 
all available lambs were employed in this study.
To determine the level of passively acquired immunity 
obtained by the lambs, serum samples were analysed for 
IgG concentration (Chapter 2, section 2.10) and by the 
zinc sulphate turbidity test test (ZST, Chapter 2, 
section 2 .1 1 ).
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Where lambings were attended in both experiments, 
samples of colostrum were taken from the ewes before 
suckling commenced. Approximately 10 ml of colostrum from 
each teat were taken and mixed together, to form the 
sample from a particular ewe. Whey was extracted from 
these pre-suckling colostrum samples and analysed for IgG 
content.
In both experiments, prophylactic dosing of new born 
lambs with anti-biotics was not undertaken. However, 
where ill-health was apparent the lamb(s) was treated 
with intramuscular injections of terramycin (Pfizer, 
Pfizer Central Research, Kent) and the incident recorded. 
The occurrence of ill-health and neonatal mortalities in 
the lambs of Experiments 1 and 2, could be compared and 
related to IgG and ZST values measured in these animals.
6.2.4 Statistical Analysis.
In both experiments, one way analysis of variance was 
used to test for significant differences in mean per cent 
(%) kill of C_j_ albicans among treatments at each 
fortnightly sampling. This statistical test was also 
employed to analyse differences among treatments for mean 
colostrum IgG content, and lamb serum ZST values and IgG 
concentrations at 2 and 4 weeks post partum.
A regression analysis of treatment mean lamb serum ZST 
values on IgG levels was also performed.
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6.3 RESULTS AND DESCRIPTION OF TRENDS IN THE DATA.
The results will be presented along with a description 
of the data. This will be derived directly from, and will 
contain no interpretation of, the results.
6.3.1 Neutrophil Function.
The mean % kill of C_i. albicans by isolated neutrophils 
from the ewes of each treatment, for Experiments 1 and 2, 
are presented in Figures 1 and 2 and Appendices 17 and 
18, respectively.
6.3.1.1 Experiment 1.
The mean candidacidal activity of neutrophils in all 
three treatments was within the range 35 to 54 % kill, 
with no significant differences among groups, until day 
70 (Figure 1). At this point, activity in the NS ewes 
(28.75 % kill) was significantly below that of the two Co 
supplemented treatments (FS ~ 36.75 %, HS = 36.25 %, 
P<0.01).
This first significant difference in the NFT occurred 
43 days after mean serum vitamin B12 concentrations in 
the NS sheep (Chapter 3, Figure 1) had fallen to the 
region of the lower normal limit (LNL). On day 70, serum 
B12 levels in the NS treatment were lower than those in 
the HS and FS groups (P<0.001). At this stage, the mean 
serum MMA level in the NS animals was still below the 
upper normal limit (UNL) and not significantly different 
from those in the HS and FS ewes (Chapter 3, Figure 2).
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Figure 1. Candidacidal activity of neutrophils isolated from the
ewes of Experiment 1, measured by the NFT. (j 1 = Tupping
period, |---- 1 = Lambing period, J/ " Removal of the weekly oral Co
supplement from the HS sheep).
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Figure 2. Candidacidal activity of neutrophils from the ewes of
Experiment 2, measured by the NFT. ( 1----1= Tupping period,f- h =
Lambing period, ^ = Start of weekly oral Co supplementation of
the HS sheep).
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The HS ewes were placed on a Co-deficient intake from 
day 82 onward. The % kill of C_^  albicans by neutrophils 
from these animals fell to be significantly lower than 
the Co-sufficient FS sheep on day 133 (P<0.001), but were 
still above the NS group (P<0.001). On day 146, 
candidacidal activity in the HS treatment had fallen to 
be equivalent to and not significanlty different from 
that shown by the NS sheep (27 vs 24 % kill,
respectively).
This drop in candiacidal activity in the HS ewes to the 
level shown by the NS sheep, occurred. 42 days after the 
mean serum vitamin B12 concentrations in the HS group had 
fallen to the region of the LNL (Chapter 3, Figure 1). On 
day 146, serum B12 levels in the HS treatment were lower 
than those in the FS group (P<0.001), but were not
significantly different from the NS sheep. At this stage, 
the mean serum MMA concentration in the HS animals was 
below the UNL of 5.0 umol/1 and not significantly
different from the FS sheep (Chapter 3, Figure 2).
Once candidacidal activity of neutrophils from either 
the NS or HS treatments had fallen significantly below 
that shown by the Co-sufficient animals, the % kills 
remained low and showed a tendency to fall even further. 
By the end of the experiment on day 189, the values for
these two treatments were 21.75 and 20.5 % kill,
respectively. This was less than half that of the FS ewes 
(46.5 %). Mean % kill by neutrophils from the FS
animals remained high throughout the experiment, within
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the range 36.75 to 51,25 %.
6 . 3 . 1 . 2  E x p e r i m e n t  2.
From the start of this experiment, the NS and HS
treatments were both on a Co-deficient intake. Neutrophil 
dysfunction was initially evident in these two groups on 
day 70, with candidacidal activity falling below that of 
the Co-sufficient FS ewes (Figure 2). These differences 
first became significant at day 98 (P<0.01), when the
mean % kill shown by neutrophils in the NS, HS and FS
treatments was 29.25, 34.25 and 51.75 %, respectively.
This first significant difference in neutrophil activity, 
occurred 28 days after the mean serum vitamin B12 
concentrations in the two deficient groups had fallen to 
the region of the LNL (Chapter 3, Figure 3). At day 98, 
serum B12 levels in the NS and HS ewes were significantly 
lower than those of the FS animals (P<0.001). At this 
stage, mean serum MMA concentrations in the NS and HS
treatments were below the UNL, but were significantly 
higher than those in FS group (P<0.01).
Candidacidal activity in neutrophils from the NS ewes 
continued to fall to a basal level, within the range 21 
to 31 % kill. As in Experiment 1, this was half that 
shown by the FS ewes (P<0.001), whose mean % kill 
remained high and between 46.5 and 58.25 % throughout
Experiment 2.
The % kill of C_^  albicans by neutrophils from the HS
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treatment fell to a low of 24.25 % at day 146. These ewes 
were repleted with Co from day 161. In consequence, 
candidacidal activity in this group rose significantly 
above the NS ewes (P<0.05), but still below the FS 
animals (P<0.01) on day 175. When sampled on day 189, %
kill by HS sheep neutrophils had risen further to the 
'normal' range of the FS ewes and still significantly 
above that of the NS treatment (P<0.001).
This return to normal neutrophil function in the HS 
treatment occurred 28 days after the start of repletion. 
However, the mean serum vitamin B12 concentrations in 
these ewes did not rise above the LNL until day 204; 43
days after the start of repletion.
6 . 3 . 2  T h e  T r a n s f e r  o f  P a s s i v e  I m m u n i t v .
6 . 3 . 2 . 1  C o l o s t r u m  I g G  c o n c e n t r a t i o n s .
In Experiments 1 and 2, the mean concentrations of IgG 
in pre-suckled colostrum samples from all the ewes were 
12,310 ±  562 (n = 21) and 11,381 + 489 (n = 32),
respectively. There were no significant differences among 
treatments in either experiment.
6 . 3 . 2 . 2  L a m b  s e r u m  I g G  a n d  Z S T  d a t a .
The results for mean lamb serum IgG and ZST values at 2 
and 4 weeks post partum in Experiments 1 and 2, are 
presented in Tables 1 and 2, respectively.
In Experiment 1, lambs from HS ewes had significantly 
less IgG in serum at 2 and 4 weeks post partum, compared
261
to those from the NS and FS groups (P<0.05).
Table 1. Lamb mean serum IgG and ZST levels
Experiment 1.
IgG
(mg/lOOml) NS
TREATMENT
HS FS
SIG.
DIF. SED
2 wks pp 1220^ 7 5 7 b 14845 * 162
4 wks pp 925& 6 5 7 b 9385 * 68
ZST (Arbitrary units)
2 wks pp 11.85 9.15 12 . 7 5 NS 2.5
4 wks pp 8 . 7 5 9.q5 12.l5 NS 2.2
Table 2. Lamb mean serum IgG and ZST 
Experiment 2.
levels -
IgG 
(rag/lOOml) NS
TREATMENT
HS FS
SIG.
DIF. SED
2 wks pp 247Q5 2 2 0 4 5 360lb ■k 543
4 wks pp 1 7 9 9 5 1 5 2 3 5 2908b k - k 401
ZST (Arbitrary units)
2 wks pp 15.25 1 4 . 9 5 2 0 .4 b k 3.1
4 wks pp 1 3 .7 5 b 1 1 .4 b 17 . l5 k 2.8
pp = post partum
For data in both Tables 1 and 2, means in rows with 
different superscripts differed significantly.
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No significant differences among treatments for lamb 
ZST test values were evident in this experiment. However, 
at 2 weeks after lambing the HS group showed mean ZST 
levels 3.6 units below the FS animals and at 4 weeks, 
both the NS and HS group lambs had values over 3 units 
less than the FS treatment.
In Experiment 2, mean lamb serum IgG concentrations and 
ZST test values for all treatments were generally higher 
than those found in Experiment 1. Lambs from the NS and 
HS groups had significantly less IgG in serum, compared 
to the FS controls, at 2 (P<0.05) and 4 (P<0.01) weeks
post partum.
Mean ZST values in NS and HS lambs were significantly 
below the FS treatment 2 weeks after lambing (P<0.05). 
At 4 weeks post partum, the mean ZST values of the HS 
lambs were again significantly less than those of the FS 
group (P<0.05). However, levels in the NS animals at this 
time, while not significantly above those in the HS 
lambs, were not significantly different from the FS 
treatment.
A statistically significant regression was found 
between ZST values and IgG concentrations in lamb serum 
at 2 and 4 weeks post partum (Figure 3). The data for 
this regression were drawn from the treatment group means 
of both experiments (Tables 1 and 2). The regression 
equation is presented below:
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Figure 3. Scatter diagram showing the relationship between values 
of ZST and concentrations of IgG in lamb serum at 2 and 4 weeks 
post partum. in Experiments 1 and 2.
y = 0.0037X + 6.66 (r = 0.94, RSD = 0.89, n = 12, P<0.001).
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y = 0.0037X + 6 . 6 6  
RSD for variation about y = 0.89 
r = 0.94 n = 12 (P<0.001)
Where, y = serum ZST value (arbitrary units) and x = 
serum IgG concentration (mg/100 ml).
6 . 3 . 2 . 3  Z S T  v a l u e s  a n d  i n c i d e n c e  o f  l a m b  m o r t a l i t y  a n d
m o r b i d i t y .
6 . 3 . 2 . 3 . 1  E x p e r i m e n t  1.
In this experiment, there were 9 neonatal mortalities 
in the NS treatment and one each in the HS and FS 
groups. The details of these were presented in Chapter 5, 
Table 8 , Five of the 9 lambs from NS ewes which died 
within 4 weeks of birth, had post mortem ZST values below 
the normal threshold of 14 units. One other had an 
adequate ZST value (>14) and the test could not be 
performed on the other 3 lambs, due to haemolytic 
changes.
The ZST values of lambs requiring treatment for ill- 
health in Experiment 1, are presented in Table 3.
6 . 3 . 2 . 3 . 2  E x p e r i m e n t  2.
In this experiment, there were no neonatal mortalities 
in any treatment. One lamb in each group required 
treatment for ill-health and the ZST values in these 
animals are presented in Table 4.
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Table 3. Incidence of ill-health in lambs from
Experiment 1.
AGE 
TAG (Days)
REASON FOR TREATMENT 
AND ZST VALUES
NS GROUP
89 12 + 16 Scouring. Inadequate ZST (9 and 13).
HS GROUP
93 8 Scouring. Inadequate ZST (5 and 5).
86 5, 6 + 7 Joint ill,. Inadequate ZST (8 and 8).
88 5 Scouring. Inadequate ZST (8 and 11).
90 4 Scouring. Inadequate ZST (11 and 14).
Table 4. Incidence of ill-health in lambs from
Experiment 2.
AGE 
TAG (Days)
REASON FOR TREATMENT 
AND ZST VALUES
NS GROUP
44 40 + 41 Scouring. Inadequate ZST (8 and 11).
HS GROUP
76 5 Joint ill. Inadequate ZST (13 and 13).
FS GROUP
70 5 Joint ill. Adequate ZST (15 and 15).
In
ZST
Tables
value
3 and 4, the numbers in brackets 
for that lamb at 2 and 4 weeks
refer to the 
post partum.
respectively.
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6.4 DISCUSSION.
The results of this investigation will be discussed in 
two sections. The first will deal with the depression of 
neutrophil function in Co-deficient ewes, compared to 
sufficient controls, which was evident in Experiments 1 
and 2. The second will relate the general decrease in 
passive immunity acquired by lambs from Co-deficient 
ewes, relative to those from sufficient dams, to post 
partum lamb viability in both experiments.
6.4.1 Neutrophil Function in Pregnant Ewes.
Before the data on neutrophil candidacidal activity can 
be related to the ability of pregnant ewes to resist 
pathogenic infection, the limitations of this
determination must be considered. The NFT is a relatively 
subjective test. Results are dependent on operator 
observation of isolated neutrophils containing either 
dead or viable Candida cells. Although in both
experiments all tests were performed by the same
operator, the author has observed that exact percentage 
results can be operator dependent.
It was also clear from the data presented in Figures 1 
and 2 that the candidacidal activity of a particular 
treatment, receiving a constant Co intake, varies between 
samplings. For example, the FS group of both
investigations showed various levels of % kill over the 
experimental periods. This was presumably due to subtle 
changes in test conditions between sampling dates. These
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may have involved slight variations in the numbers of 
neutrophils and yeast cells used and in the methylene 
blue stain employed. However, where differences in 
neutrophil function between Co-sufficient and deficient 
treatments existed, the statistical significance obtained 
was large (up to P<0.001).
Additional limitations of the NFT were described by 
Stinnett (1983), who stated that the technique is a gross 
determination. PMN's possess a normal 'overkill' of 
pathogens. Therefore, this worker suggested that 
differences in microbicidal killing between 'treated' and 
'control' groups of less than one half a log, are 
probably not relevant in terms of host immune resistance. 
However, the method was stated to be a useful primary 
screen of cellular immune function.
With these points noted, the results of Experiments 1 
and 2 suggested that Co deficiency in pregnant e w e s  had a 
depressive effect on the candidacidal activity of 
circulating neutrophils. However, this could not be 
related to incidence of disease. The differences obtained 
between Co treated and untreated groups in these two 
experiments, did not reach the large proportions 
discussed by Stinnett (1983). Further, there were no 
treatment trends in the amount or degree of recorded 
incidences of pathogenic disease in the ewes during 
pregnancy. However, MacPherson et ^  (1976) reported that 
Co deficiency in sheep can lead to increased
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susceptibility to infective disease. In addition, it is 
likely that a 50 per cent reduction in microbicidal 
activity due to sub-clinical Co deficiency, which was 
observed in both Experiments 1 and 2, would have some 
detrimental effect on the ability of the deficient 
animals to resist infection.
It is important to note that neutrophils are an 
essential and integral part of a hosts immune system and 
ability to resist pathogens. As circulating PMN's they 
are employed as a major part of the general phagocytic 
and killing function of the system, along with 
macrophages and leucocytes, both non-specifically and in 
conjunction with antigen specific humoral immune factors. 
Therefore, a reduction in neutrophil microbicidal 
activity of 50 per cent, would presumably have an adverse 
affect on host animal immune resistance.
The results presented do not provide evidence of where 
dysfunction(s ) in the neutrophil cell occurs in a 
Co/vitamin B12 deficient situation. Gershwin, et, a_l 
(1985) described the NFT as being relatively non­
specific, in that a measured abnormality in killing does 
not indicate where the defect may actually arise. 
However, Kaplan and Basford (1976) reported a depressive 
effect of vitamin B12 deficiency on HMPS pathway activity 
in human leucocytes and this may be a universal effect on 
higher animal PMN's. The HMPS pathway produces NADPH in 
the cell, which is oxidised by a flavoprotein oxidase to 
yield the killing agents superoxide (0 %") and hydogen
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peroxide (H2 O2 ). Thus a reduction in HMPS activity would 
account for a depression in the ability of PMN cells to 
kill engulphed microbes. Such a mechanism would also 
explain the reduction in candidacidal activity of 
neutrophils from sub-clinically Co-deficient sheep, 
demonstrated in this study.
In the two experiments described here and in the 
investigation of Paterson and MacPherson (1987) with 
calves, the level of Co deficiency necessary to 
precipitate a detrimental effect on neutrophil function 
was sub-clinical. Indeed, in both experiments neutrophil 
function in a treatment group was significantly affected 
when mean serum B12 concentrations in the animals were in 
the range 200 to 400 ng/1, and before serum MMA levels 
had risen above the UNL of 5.0 umol/1. It was argued in 
Chapter 3 that 'sub-clinical' Co deficiency in pregnant 
ewes was indicated only when concurrent concentrations of 
B12 and MMA in serum, were in the ranges 200 to 400 ng/1 
and 5.0 to 15.0 umol/1, respectively. Therefore, the 
evidence suggested that neutrophil dysfunction due to Co 
deficiency could occur early in the development of the 
condition, even before sub-clinical disease was 
detectable.
The adverse effect of Co deficiency on neutrophil 
function was probably mediated directly by low Co/Bl2 
levels. Animals in all treatments were feeding normally 
with equal energy intakes and normal energy metabolism
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when depression in neutrophil candidacidal activity first 
became evident. As the deficiency was sub-clinical and no 
differences in liveweight among treatments were found, it 
can be contended that the effect was direct through a 
deficit in Co/vitamin B12 supply to the neutrophils, 
rather than due to depression of energy input or balance 
which may result from the effect of Co deficiency on 
propionate metabolism and clinical inappetence.
The effect of Co repletion of the HS ewes in Experiment 
2 on neutrophil function, supported this theory. Co 
supplementation of these sheep resulted in a rapid return 
to normal■candidacidal activity in neutrophils isolated 
from this group. This evidence was consistent with 
similar repletion studies in cattle by Paterson and 
MacPherson (1987) and also with vitamin B12 therapy of 
pernicious anaemic patients in the work of Kaplan and 
Basford ( 1976). Mean % kill by HS sheep neutrophils was 
equivalent to that in the FS group, only 28 days after 
the start of Co supplementation. This was the same time 
period that mean serum MMA concentrations took to return 
below the UNL in this treatment. Restoration of 
neutrophil function also occurred before serum B12 levels 
rose above the LNL in response to repletion. These 
observations are in accord with the theory that the 
effect of C0 /BI2 deficiency on neutrophil function, was 
direct on the PMN cells. If the effect had been mediated 
via a lack of energy, caused by vitamin B12 deficiency, 
then neutrophil function would have been restored only
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a f t e r  s e r u m  B 1 2  c o n c e n t r a t i o n s  h a d  r e t u r n e d  t o  s u f f i c i e n t  
levels and after normal energy balance had been attained.
6 . 4 . 2  F u t u r e  R e s e a r c h .
It is evident from this discussion that more work is 
needed on the intracellular effects of Co/vitamin B12 
deficiency on neutrophils and other PMN's. This is 
necessary if exact mechanisms for the detrimental effects 
of deficiency are to be obtained. It would be pertinent 
to concentrate on the HMPS pathway, as this seems a 
likely site of action for B12. Close investigation of 
reduced neutrophil function as a result of Co deficiency 
and its effects on the ability to resist specific 
pathogenic infections, is also necessary to determine the 
practical relevance of the data presented.
6.4.3 The Transfer of Passive Immunity.
6.4.3.1 Colostrum IgG concentrations.
In comparison with the literature, the levels of IgG in
colostrum in these two experiments appeared to be 
adequate for the normal transfer of passive immunity from 
ewe to lamb. The concentrations of IgG in pre-suckled 
colostrum were higher than those quoted as normal for 
Scottish Blackface ewes by Halliday (1978a). This worker 
reported a range of 9000 to 9600 mg/100 ml for this 
breed. However, the levels found in Experiments 1 and 2 
did approximate to the mean of 11,500 mg/100 ml, reported
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by Hunter et al, (1977) for the Columbia breed of sheep.
Many factors influence the level of Xg's present in ewe 
colostrum (Halliday, 1978a). In Experiment 1, the ewes 
were of crossbred origin from Swaledale rams and in 
Experiment 2, half of the sheep were of similar breeding. 
These differences may partly account for the range of 
concentrations in Halliday's (1978a) animals, not 
coinciding with those evident in these two experiments. 
Differences in nutrition between investigations also have 
a profound effect on the Ig levels of pre-suckled ovine 
colostrum (Halliday, 1978b). Shubber et aj, (1979b) stated 
that errors could be made in the interpretation of 
colostral Ig estimations, if the proportion of whey in 
the samples was not taken into account. These workers 
therefore recommended that the results be expressed on a 
whey content basis. Like the majority of investigations 
pertaining to the transfer of passive immunity, the 
proportion of whey in samples of colostrum in Experiments 
1 and 2 was not determined.
6 .4.3.2 Lamb serum IgG and ZST levels.
To determine the biological and practical significance 
of the IgG and ZST results in terms of the ability of 
lambs to resist infection and survive, it is important to 
compare them with normal values for serum concentrations 
reported in the literature. Unfortunately, there is no 
published evidence to suggest what normal levels in 2 and 
4 week old lambs might be. However, Halliday (1971a and
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1978a) stated that normal concentrations of IgG in 
Scottish Blackface lambs at 24 hr. post partum were in 
the range 1560 to 2500 mg/100ml, depending on litter 
size. The results from these two experiments did not 
distinguish between single and twin lambs, as there was 
no apparent effect of litter size on serum IgG levels at 
the sampling times employed; This was also reported to be 
the case by Hunter et ^  (1977) and Halliday (1971b).
For these reasons it is difficult to make direct 
comparisons between the study detailed here and 'normal' 
values quoted by previous workers. It is perhaps logical 
that differences in passive immune status due to litter 
size, whilst evident at 24 or 48 hr, after parturition, 
become non-existent at 2 and 4 weeks of age. Several 
weeks after birth the absorbed Ig's are well distributed 
within the body interstitium (Mayhofer, 1984). The 
situation is further complicated when consideration is 
given to the fact that the lambs ' own active immune 
system can begin to acquire functional competence at 
approximately 4 weeks of age.
With these points noted, the levels of serum IgG 
evident in Experiments 1 and 2 were high compared to 
those quoted in the literature. Normally, Ig 
concentrations in lamb serum reach a peak between 1 2 and 
24 hr. post partum when absorption begins to close down, 
and fall consistently thereafter (Shubber ^  al., 1979a). 
The apparent high levels in these investigations at 2 and
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4 weeks after parturition could have been due to 
differences in the analytical techniques employed between 
these experiments and those of other workers. Differences 
in experimental diets may also have caused this 
discrepancy. The fact that the animals were housed in 
Experiments 1 and 2, and therefore not at pasture, may 
also have had an influence. More contact between ewe and 
lamb may occur in the indoor situation with more frequent 
suckling activity and greater acquisition of Ig's, 
compared to outdoor field experiments such as that 
conducted by Halliday (1978a).
The onset of competence in the lambs' own immune system 
did not appear to influence the 'high' serum ZST and IgG 
levels evident in the lambs of Experiments 1 and 2. 
Serum IgG concentrations and ZST levels in these neonates 
fell between 2 and 4 weeks of age. This was presumably 
due to interstitium distribution and utilisation of the 
passively acquired IgG. If the lambs' own immune function 
had been significant at 4 weeks post partum, then an 
increase rather than a decrease in concentrations between 
2 and 4 weeks might have been expected.
The normal range for lamb serum ZST test levels from 2 
days of age, is generally accepted to be any value above 
14 units. By this criterion, all mean levels for serum 
ZST in all treatments were low in Experiment 1. The 
reasons for this are not clear, especially as the 
concentrations of IgG in pre-suckled colostrum samples in 
this experiment were adequate. In Experiment 2, the mean
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serum ZST levels for all treatments at 2 weeks after 
lambing and for lambs from FS ewes at 4 weeks post 
partum, were above 14 units. Mean values for the NS and 
HS group lambs 4 weeks after parturition, were less than 
14 units. These increased values in the second 
investigation coincided with higher IgG concentrations in 
Experiment 2, compared with Experiment 1.
. In order to try and ascertain a normal concentration 
for lamb serum IgG, a regression analysis of mean lamb 
serum ZST levels on mean IgG values was calculated for 
all treatment groups in both experiments (Figure 3). If 
the ' threshold ' ZST value of 14 is imposed on the 
regression equation, the corresponding IgG concentration 
was 1973 mg/100ml serum. Mean serum IgG concentrations in 
all the groups of Experiment 1 were below this level. In 
Experiment 2, all treatment mean IgG values were above 
1973 mg/100 ml serum at two weeks post partum. Those in 
the NS and HS groups were below this value, 4 weeks after 
lambing.
The question arises as to whether these two values can 
be used as indicators of the adequate transfer of 
passive immunity, under the experimental conditions 
employed? If this were the case, then lambs with serum 
levels below 14 units for the ZST test and 1973 mg/100 ml 
serum for IgG concentration, would be more susceptible to 
infection than those with levels greater than these.
The answer to this question lies in comparing evidence
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in the literature with the lambing records and post 
mortem findings from these two experiments. Campbell 
(1974) reported that lambs receiving little or no 
colostrum and thus presumably with low levels of 
passively acquired Ig's in serum, were more likely to die 
after a measured E . co 1 i infection than neonates 
receiving a normal colostrum intake. In a field 
investigation, Marker (1974) reported that neonatal 
mortalities occurred in lambs with a mean ZST value of 
5.7. Survivors had mean ZST levels far above 14 units. A 
cause and effect relationship between low neonatal lamb 
serum Ig concentrations and ZST values and increased 
susceptibility to infection and death, is therefore 
established in the literature.
There were significantly more neonatal mortalities in 
lambs from the Co-deficient NS ewes in Experiment 1 
(P<0.05), compared to those from either the HS or FS 
sheep (9 vs 1 vs 1, respectively). In 4 of these 9 cases, 
there were no significant findings at post mortem. One 
lamb which possibly died by accidental crushing had an 
inadequate ZST value. In the 4 other cases, isolated
pathogens were implicated in the cause of death and in
all 3 serum ZST levels were inadequate (<14 units). The
one neonatal mortality in the HS group in Experiment 1,
was of a small premature lamb. The death in the FS 
treatment was due to infection as a result of inadequate 
iodine dipping of the umbilical cord. This latter lamb 
was thus weak and died accidentally with a serum ZST
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value of just 1 unit.
In the 5 lambs requiring treatment for ill-health in 
Experiment 1 (1 from the NS and 4 from the HS groups),’
all appeared to be due to pathogenic attack. All these 
lambs had inadequate ZST levels at 2 and 4 weeks post 
partum. None of the lambs from FS ewes were observed in 
ill-health.
There were no neonatal mortalities in Experiment 2. 
This was possibly due to changes in management practice 
in the preparation of pens for lambing, which were 
discussed in Chapter 5. Of the 3 lambs needing treatment 
for ill-health (one in each group), all were for 
pathogenic infection. Two of these neonates (from NS and 
HS ewes) had inadequate ZST values. The lamb from the FS 
group had adequate ZST levels.
The results from both experiments thus indicated a 
detrimental effect of sub-clinical Co deficiency in 
pregnant sheep, on the transfer of passive immunity from 
ewes to lambs. The resultant depression in serum Ig 
concentrations and ZST levels in lambs from deficient 
dams, compared to sufficient controls, was evident in 
both experiments. That these differences resulted in 
lambs from Co-deficient ewes being more susceptible to 
pathogenic infection was demonstrated by the increased 
numbers of neonatal mortalities and incidences of ill- 
health in these lambs, compared to sufficient controls.
A scenario can thus be composed from the results, which
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would explain the influence of Co deficiency on the 
transfer of passive immunity. In these housed 
investigations, the lambs from deficient ewes obtained 
colostral Ig's immediately after parturition, as all 
lambs were seen to suckle within the first hours of life. 
However, the levels acquired were not generally 
sufficient to provide effective and sustained resistance 
to infection, until such time as the lambs' own immune 
system gained competence and produced an endogenous Ig 
supply. The peak in lamb serum Ig concentrations occurs 
between 12 and 24 hr. post partum. The acquisition of 
colostral Ig's to this peak must be adequate to sustain 
resistance over this period, considering that the 
passively absorbed Ig's will be continually used and 
degraded. Lambs from Co-sufficient ewes managed to obtain 
adequate levels of passive resistance to survive until 
they could produce their own Ig's. Some of those from Co­
deficient sheep did not obtain such levels and the 
pathogenic infections which resulted could have caused 
the observed increases in morbidity and mortality, 
possibly complicated by other effects of Co deficiency.
The reasons for a depression in the levels of passively 
acquired immunity in lambs from Co-deficient ewes, 
compared to sufficient controls, may be complex. It did 
not appear to involve treatment differences in the 
concentration of Ig's in pre-suckled colostrum, as these 
were not evident. The main cause seemed to result from 
depressed vigour in lambs from deficient ewes, compared
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to sufficient animals (Chapter 5, Table 13). This was the 
case whether the dams were sub-clinically Co-deficient 
for just the first half (HS group), or for the whole (NS 
group) of gestation. This was demonstrated by the 
observation in Experiment 2 that lambs from NS and HS 
ewes took significantly longer to stand, find the udder 
and start suckling^ than those from the FS group.
The direct cause of these differences in lamb vigour 
were not clear. The effect in terms of the acquisition of 
passive immunity, was probably a general decreased 
frequency in suckling in lambs from the NS and HS 
treatments, relative to FS counterparts. Although 
suckling frequency was not measured, it was clear that 
lambs from deficient ewes (which took on average twice as 
long to commence suckling) showed markedly reduced 
activity in the crucial first hours of life, including 
suckling behaviour, relative to controls from sufficient 
dams* Thus, in the vital first 12 to 24 hr* after 
parturition, lambs from Co-deficient groups probably did 
not suckle enough to obtain sufficient levels of 
colostral Ig's, for effective resistance to infection. 
Consequently, these lambs showed depressed post-natal 
viability, relative to the FS treatment controls.
6.4.3.3 Future research.
There may be other factors affecting this scenario,
such as a possible depression of mothering activity and
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maternal encouragement of the lamb to suckle in sub- 
clinically Co-deficient ewes. These further influences 
need investigation, along with study of the specific 
effects of Co/vitamin B12 deficiency on neonatal lambs, 
if the detailed causes of the depressed lamb viability 
and acquisition of passive immunity, which were observed 
in both experiments, are to be understood.
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CHAPTER 7.
A SURVEY OF COBALT STATUS IN PREGNANT EWES ON FARMS IN
SCOTLAND IN 1988.
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7.1 INTRODUCTION.
The results and discussions of the work already 
reported in this project suggested that Co deficiency 
could have a profound detrimental effect on the pregnant 
ewe. The evidence established that sub-clinical Co 
deficiency could lead to depressed pre- and post-natal 
lamb viability, relative to sheep that were sufficient in 
the trace element. These effects were recorded in ewes 
which were deficient for either the first or the second 
half of gestation, but were most marked when a Co­
deficient status was maintained for the whole of 
pregnancy.
The problems associated with the prognosis and 
diagnosis of Co deficiency in pregnant sheep were 
discussed in Chapter 3 and Chapter 4. The data presented 
suggested that the most accurate and precise means of 
diagnosing the syndrome, particularly the sub-clinical 
form of the disease, was by the determination of serum 
MMA and B12 concentrations. However, it was found that 
close consideration should be given to the analytical 
techniques and diagnostic criteria employed, and to the 
time of sampling in relation to supplementary feeding.
Although this diagnostic approach may provide the most 
accurate and earliest indication of Co deficiency in 
pregnant ewes, the main method of diagnosis used in 
practice is still the analysis of serum for vitamin B12 
levels only (Millar and Penrose, 1980, MacPherson, 1982 
and Taylor and Greer, 1982).
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The adverse effects of Co deficiency on sheep farming 
have long been recognised in Scotland (Hogg, 1831). 
Previous surveys and reports of Co deficiency, 
particularly on hill and upland farms, have shown that 
the disease can occur throughout Scotland (Corner, 1939, 
Stewart et a2r 1941 and 1942, Dunlop, 1946a and Boddie, 
1947). The occurrence and severity of the syndrome have 
been observed to vary from season to season, according to 
climatic conditions and grass growth (Stewart et ad, 1946 
and Andrews, Stephenson, Anderson and Faithful, 1958, 
MacPherson, Voss and Dixon, 1978, MacPherson, 1982 and 
McDonald and Suttle, 1983).
Co deficiency in pregnant ewes can be alleviated by the 
administration of intraruminal slow release Co bullets 
(Hart and Andrews, 1959 and O'Halloran and Skerman, 
1961). This form of treatment has also proved successful 
for other classes of sheep (Connolly and Poole, 1967, 
Poole and Connolly, 1967 and Whitelaw and Russel, 1979),
In view of the harmful effects of sub-clinical Co 
deficiency, the problems with diagnosis and the history 
of the disease in Scotland, the objectives of this survey 
were to assess the distribution and severity of the 
syndrome on a sample of farms throughout Scotland. The 
results were compared and discussed in terms of the 
conclusions already made from the data of this project. 
The use of an isolated sampling and analysis of one 
parameter, namely s e r u m  v i t a m i n  B12, t o  d i a g n o s e  Co
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deficiency in field situations, was also assessed.
On one farm, a study was made of the effect of 
supplementation by Co bullets, given to ewes before 
tupping and at mid-pregnancy, on the serum B12 
concentrations of ewes and lambs.
7.2 MATERIALS AND METHODS.
7.2.1 General Survey.
Fifteen farms throughout Scotland (designated the 
letters A to O) were chosen for the survey. Each had a 
proportion of hill and/or upland pastures within their 
land. All the farms were in areas notorious for the 
syndrome, or had a previous history of Co deficiency, or 
low serum B12 concentrations had been evident in sheep 
from the farm in the past.
All the farms were visited between 25/01/88 and 
17/02/88. This time period corresponded approximately to 
mid-pregnancy in the ewes, as tupping had begun on most 
of the farms on the traditional date of 12th November in 
the previous year. Between 10 and 20 randomly picked 
pregnant sheep were sampled on each farm. The recent 
grazing and supplementary feeding history of the sheep 
was obtained from the farmers. SerUm vitamin B 12 
concentrations were determined in all samples by the 
microbiological assay, using Lactobacillus leichmannii as 
the test organism.
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7.2.2 Experiment at Farm O.
One farm (Calla, Carnwarth, Lanarkshire - Farm'O') was 
visited on various occasions during the 1987/88 breeding 
season. On 17/10/87 (day zero) 60 ewes were randomly 
selected from the breeding flock on the hill. On this 
date, before the start of tupping, 20 of the sheep ('CB') 
were tagged and administered with an intraruminal cobalt 
oxide bullet ('S Permaco', Tasman Vaccine Laboratories 
[UK] Ltd., Bury St, Edmonds, Suffolk, England - active 
ingredient 30 per cent). 20 others ('MPCB') were tagged, 
but did not receive a Co bullet until mid-pregnancy. A 
further 20 ('NCB') were also tagged, but did not receive 
Co supplementation at any time during gestation or 
lactation. Blood samples were taken from all 60 ewes on 
this date and on 17/12/87 (day 41).
At approximately mid-pregnancy (13/02/88 - day 109) all 
60 sheep were again brought down off the hill and blood 
sampled. The MPCB ewes each received a Co bullet on this 
occasion.
Approximately 8 weeks before lambing, the ewes were 
taken off the hill and confined on in-bye pastures. All 
were fed daily on a supplementary commercial concentrate 
mix. On 15/06/88 (day 230) a random selection of the ewes 
and 1 2  lambs from each treatment were blood sampled and 
the farmer was asked for his opinion of the lambing 
performance in each group. At this final sampling date, 
the lambs were approximately 6 weeks old.
At each sampling, blood was analysed for serum vitamin
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B12 concentration, by the microbiological assay.
7.3 RESULTS.
7.3.1 General Survey.
The results of the survey are presented in Table 1. On 
farms A, D, E, H, J, K, N and 0 ( * in Table 1) no
supplementary feed had been given to the ewes at grass 
before they were sampled. On farms L and M (# in Table 1) 
t h e  history of s u p p l e m e n t a r y  feeding was u n k n o w n .  On f a r m  
B the ewes had grazed arable stubble for three weeks 
before the sampling. On farm C the ewes were fed molasses 
for two days prior to the sampling. On farm F the ewes 
had been fed molasses and supplementary hay. On farm G 
the ewes were housed and fed silage for 1 0  days prior to 
the sampling. On farm I the ewes were given an oral dose 
of cobalt sulphate two weeks before and had free access 
to silage in the field at the time of sampling. The farms 
where some form of supplementary feed was provided to the 
ewes before sampling, are marked in Table 1 by
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Table 1. Serum vitamin B12 concentrations in pregnant
ewes on 15 farms in Scotland in 1988.
FARM !
NUMBER 
OF EWES
MEAN SERUM VIT.
BREED B12 (ng/1) RANGE
*A Grainston,
Stirlingshire
16 Mules >1250 >1250
&B Souchin,
Stirlingshire
14 Mules >1250 >1250
&C Auchinlay,
Stirlingshire
15 Scottish
Blackface
1185 750 - >1250
*D Langbank,
Stirlingshire
15 Scottish
Blackface
1203 960 - >1250
*E U.Auchinlay, 
Stirlingshire
15 Scottish
Blackface
795 370 - >1250
&F Braco Castle, 
Perthshire
15 Mules 1179 770 - >1250
SeG Drum,
Dumfries and 
Galloway
15 Mules 1 2 2 0 800 - >1250
Clerkhill, 
Dumfries arid 
Galloway
15 South
Cheviots
1 1 0 1 500 - >1250
Douganhill,
Kirkcudbright
15 Scottish
Blackface
1237 1050 - >1250
Drumbuie,
kirkudbright
15 Scottish
Blackface
1168 690 - >1250
*K Houdston,
Ayrshired
1 2 Scottish
Blackface
>1250 >1250
#L Rougag, 1 0 Unknown 916 520 - >1250
#M Achnahanaid,
Skye
1 2 Scottish
Blackface
>1250 >1250
*N Scorrybreck,
Skye
7 Scottish
Blackface
>1250 >1250
* 0 Calla,
Lanarkshire
2 0 Scottish >1250 >1250
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7.3.2 Experiment at Farm O.
The results of the additional analysis and treatments 
at Farm O, are presented in Table 2 and Figure 1.
Table 2. Mean serum vitamin B12 
the ewes
concentrations 
of Farm 0.
(ng/1 ) in
DAY OF 
EXP. NCB
TREATMENT
MPCB CB
SIG.
DIF. SED
0 845& 786® 837® NS 76
41 1026& 1389^ 1767C * * * 170
109 2190^ 2332^ 2117^ NS 135
230 480® 696® 2150^ * * * 322
In Table 2, means in rows with different superscripts 
differed significantly.
On day 230 the range of serum B12 concentrations in the 
NCB, MPCB and CB group ewes were 260 to 820, 150 to 2500
and 380 to 1840 ng/1, respectively. Mean serum B12 
concentrations in lambs from NCB, MPCB, and CB ewes on 
day 230 were 123, 200 and 392 ng/1, respectively, with no 
significant differences among treatments.
According to the farmer, there were no differences 
among treatments in gestational or lambing performance.
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7.4 DISCUSSION.
The results will be discussed in two sections. Firstly, 
the data and implications of the survey will be 
considered. Secondly, the results from the experiment at 
Farm O will be discussed.
7.4.1 General Survey.
The results of the Co survey were generally negative in 
terms of the detection of Co deficiency. On all 15 farms 
the mean serum vitamin B12 concentrations in the ewes 
sampled, were above the lower normal limit (LNL) of 400 
ng/1. A serum B12 level below this threshold was only 
evident on one farm (Farm E) and this was found in only 
one sheep (370 ng/1). Thus, the data indicated that the 
mid-pregnant ewes on these farms were Co-sufficient at 
the time of sampling.
The negative results of the survey may have been 
associated with seasonal variations in Co status. All the 
farms sampled were either in known Co-deficient areas, 
or had a history of low serum B12 concentrations in 
sheep. On this occasion the ewes were sampled at the 
beginning of the year, between grass growing seasons. At 
this time sward length is low and Co status may rise in 
sheep due to increased soil ingestion (Andrews et 
1958 and MacPherson, 1982). During the grass growing 
season when sward length is higher, soil ingestion tends 
to diminish and Co status declines in deficient areas. 
The effect of soil intake on increasing Co status may be
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more marked if the autumn and winter are particularly 
wet. In this situation the increased rainfall leads to 
soil contamination of the existing herbage and thus a 
greater intake of soil by grazing sheep. That soil 
ingestion can boost the Co status of sheep was reported 
by MacPherson ^  a_l, ( 1978 ) and McDonald and Suttle, 
(1983) .
Particularly high rainfalls were experienced in 
Scotland in the Autumn of 1987, just before this survey 
was undertaken. Many of the farmers in the survey 
complained of the extraordinarily wet conditions at this 
time. Thus, the high Co status of ewes in mid-pregnancy 
in this survey of farms with histories of Co deficiency, 
was probably due to seasonal variations and climatic 
conditions.
An additional reason for the high Co status of ewes on 
these farms was the provision of supplementary feeding, 
and on Farm I the sheep were orally dosed with Co shortly 
before the sampling. It was evident from Table 1 that the 
ewes on farms where supplementary feed was offered before 
the sampling, had generally higher serum B12 
concentrations than those on farms where such additional 
feeding had not been provided. Farmers may give hill and 
upland breeding ewes supplementary feed from 
approximately mid-pregnancy onward. In areas where Co 
deficiency can be a problem in some seasons, a dose of Co 
may also be administered at this time and supplementary
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feed introduced earlier to alleviate any effects which 
might occur.
The results of the survey only indicated the Co status 
of the ewes at mid-pregnancy and it has been argued here 
that the occurrence of Co deficiency can vary according 
to season and climatic conditions. Further, the data 
reported in Chapter 3 and Chapter 4 suggested that Co 
status as reflected by serum B12 and MMA concentrations 
can change within a matter of hours to weeks under the 
influence of Co intake. The results of Chapter 3 also 
provided evidence that post-natal viability of lambs was 
depressed when ewes had been sub-clinically Co-deficient 
in either the first or second half of gestation. For 
these reasons, the data in Table 1 only relate to the 
ewes at the time of sampling and provide no indication of 
Co status at other times during pregnancy and lactation. 
Some ewes may have been Co-deficient earlier in gestation 
(although this is unlikely) and Co status may have fallen 
to deficient levels by the end of lambing and/or 
lactation.
A single sampling of pregnant ewes using only the 
determination of serum vitamin B12 as a diagnostic 
marker, does not therefore provide sufficient evidence on 
which to base advice to farmers, A farmer will wish to 
know the Co status of a flock and whether or not there 
is a need for Co supplementation. Where Co status is 
adequate, the sole analysis of serum for vitamin B12 
suffices in indicating the situation. However, where Co
293
deficiency is evident, then the data of Chapter* 3 
suggested that the estimation of serum for MMA levels was 
also necessary to provide confirmatory evidence of the 
diagnosis. Further, the presence or absence of the 
syndrome during pregnancy can only be ascertained if Co
status is monitorad regularly. This may be achieved by
sampling a proportion of ewes at tupping, mid-pregnancy, 
lambing and possibly also during lactation. However, such 
a sampling regime would be costly and impractical.
A decision must be made on how best to diagnose Co 
deficiency in pregnant ewes on the farm. The ewes on the 
farms in this survey could have been Co-deficient prior 
to tupping and/or in the first half of pregnancy. Such an 
occurrence would have had detrimental effects on 
gestational performance and lamb viability, despite Co 
status being adequate in mid-pregnancy. Such a possiblity 
could not be determined by a single sampling in mid­
pregnancy. However, because of the impracticalities of 
frequent sampling, diagnoses will continue to be made on 
the results of blood analysis' from single sampling 
occasions. For these reasons, it may be pertinent for 
farmers in Co-deficient areas to dose breeding ewes 
prophylactically with Co bullets before tupping and 
dispense with a diagnostic sampling during pregnancy. 
Where sampling before dosing is preferred however, this 
is best performed before tupping.
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7.4.2 Experiment at Farm O.
The Co status of all 60 experimental ewes on Farm O, 
indicated by serum B12 concentrations, was adequate on 
day zero when Co bullets were administered to the CB 
sheep (Table 2). This treatment raised the serum B12 
levels of the CB ewes significantly above those in the 
NCB and MPCB sheep on day 41 (P<0.001).
The serum B12 concentrations in all three groups were 
raised at mid-pregnancy on day 109 (Table 2 and Figure 
1), when the MPCB ewes received Co bullets. During 
lactation on day 230, the mean serum B12 level of the CB 
sheep was not different from that shown on day 109. 
However, mean serum B12 concentrations in the NCB and 
MPCB ewes had fallen markedly between days 109 and 230 
and were not significantly different, although both were 
significantly lower than the mean level in the CB animals 
(P<0.001). This fall in serum B12 concentrations in the 
MPCB ewes occurred despite the administration of a Co 
bullet to each sheep in the group on day 109. Further, 
serum B12 levels as low as 260 and 150 ng/1 were recorded 
on day 230 in the NCB and MPCB groups, respectively. 
These were well below the lower normal limit of 400 ng/1, 
although mean concentrations for both groups were above 
this threshold.
Serum vitamin B12 concentrations in all the ewes rose 
between day zero and day 109 (Figure 1). This result was 
consistent with the discussion of seasonal and climatic 
influences on Co status. During this time (mid-October to
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mid-Febuary) sward length would have been low and 
diminishing, with increasing soil ingestion by the sheep. 
Consequently, the Co status of the ewes improved.
The fall in serum B12 levels in the MPCB group between 
days 109 and 230 was unexpected. The Co bullet treatment 
of these sheep on day 109 should have provided adequate 
Co to give a high serum B12 status over this time period. 
Indeed, the Co bullets administered to the CB ewes on day 
zero provided an adequate Co supply thoughout the 
experiment and this was reflected by the high serum B12 
concentrations in these animals through to day 230.
That Co bullet treatment is effective in raising the Co 
status of pregnant ewes was reported by Hart and Andrews 
(1959), O'Halloran and Skerman (1961) and Quirk and 
Norton (1987).
The unsuccessful use of Co bullets in the MPCB ewes on 
this occasion, could have been caused by two reasons. 
Firstly, the treatment may have been successful but was 
administered too late in pregnancy to provide adequate Co 
and B 12 stores for the increased requirements of 
gestation and lactation. That pregnancy and lactation 
markedly increase the requirement of ewes for B12 and 
thus Co, was reported by Quirk and Norton (1987). 
However, this reason is unlikely as the Co bullets 
administered to the CB ewes 109 days before those given 
to the MPCB sheep, provided enough Co for pregnancy and 
lactation, as mean serum B12 concentration in the CB
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group remained high through to day 230.
The second explanation may have involved regurgitation 
of the bullets by the MPCB ewes, or the coating of the 
bullet surface with calcium phosphate. The bullets given 
to the MPCB sheep were the same as those provided to the 
CB group and they were administered by the same operator 
and balling-gun. As treatment of the CB ewes was 
successful, it is unlikely that regurgitation by the MPCB 
sheep was the cause of low serum B12 concentrations on 
day 230.
Dewey, Lee and Marston (1969) reported that Co bullets 
in the rumen could be rendered useless, due to surface 
coating with calcium phosphate. This effect reduces the 
release of Co from the bullet. This was more likely to 
occur when sheep were fed concentrates in the diet, but 
the effect was variable between animals. The MPCB ewes 
were given Co bullets just before the start of 
supplementary concentrate feeding of all the sheep on 
Farm O. Further, there was a wide range of serum B12 
levels in this group on day 230 (150 to 2500 ng/1). Thus, 
it is likely that the overall failure of the Co bullet 
treatment of the MPCB ewes was due to inconsistent but 
significant coating of the bullet surface in the rumen.
The fall in serum B12 concentrations in the NCB and 
MPCB ewes between days 109 and 230 , indicated the 
increased Co requirement and B12 utilisation of these 
animals during late pregnancy and lactation. Seasonal 
variations probably also influenced this fall in Co
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status. As the spring grass growing season had commenced 
by day 230, the increased sward height and decreased soil 
contamination of the herbage would have contributed to 
the fall in Co intake and serum B12 levels in these 
groups.
The mean serum B12 concentration in the NCB ewes on day 
230 (480 ng/1) was not below the LNL. However, a number
of sheep in this group had serum B12 levels below this 
threshold. Whether or not these individual ewes were Co­
deficient could not be determined, as serum MMA 
concentrations were not measured. Despite this 
observation, these low values and the fluctuations in 
serum B12 levels overall during the experiment (Figure 
1), demonstrated the need for monitoring Co status 
throughout pregnancy and lactation, rather than drawing 
conclusions from a single sampling. This was also 
concluded from the results of the general survey.
The effect of these low serum B12 concentrations in the 
NCB group on lamb growth could not be ascertained, as 
lamb growth rates were not measured. However, it was 
evident that the serum B12 levels before tupping and at 
mid-pregnancy gave no indication of the fall to low 
concentrations which were observed during lactation. 
Thus, constructive and accurate advice could only be 
given to the farmer if Co status was monitored throughout 
the breeding season.
The serum B12 levels in the lambs from all three groups
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were analogous to those found in the housed experiments 
described in Chapter 5, and those reported by Quirk and 
Norton (1987). These investigations reported 
concentrations of between 50 to 400 ng/1 in lambs from 
Co-sufficient and deficient ewes. On Farm O, serum B12 
concentrations in lambs from Co treated (CB) ewes were 
higher than those in lambs from non-supplemented (NCB) 
dams and the MPCB group. However, all mean values were 
below the LNL of 400 ng/1.
It is important to note the 'low' lamb serum B12 
concentrations recorded in this field situation. Most of 
the ewes in all three treatments were Co-sufficient 
throughout pregnancy and up to the point of sampling of 
the lambs at approximately 6 weeks of age. In Experiments 
1 and 2 of Chapter 5, similar serum B12 levels were found 
in 2 and 4 week old lambs from Co-deficient and 
sufficient ewes. It thus seems that the occurrence of 
serum B12 concentrations below 400 ng/1 is normal in pre­
weaned lambs from Co-sufficient mothers.
From the results of this field experiment and the 
experiments described in Chapter 5, the normal range of 
serum B12 concentrations in neonate lambs would appear to 
be in the region of 200 to 400 ng/1. However, as evident 
in the investigations of Chapter 5 and the work of Quirk 
and Norton (1987), the direct effects of serum B12 levels 
below 200 ng/1 in pre-weaned lambs from Co-deficient ewes 
are unclear and this aspect requires further study.
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CHAPTER 8
CONCLUSIONS
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8.1 THE DIAGNOSIS OF COBALT DEFICIENCY IN THE PREGNANT
EWE.
The results detailed in Chapters 3 and 4 suggested that 
serum MMA is a more accurate and precise diagnostic 
marker of Co deficiency, in the pregnant ewe, than serum 
B12. This is particularly the case for the sub-clinical 
form of the disease.
Serum MMA concentrations are less variable and relate 
more directly to Co/vitamin B12 deficiency in the liver 
than serum B12 levels. Analysis of serum for B12 may 
yield false positive diagnoses. In contrast, there is no 
problem from diagnosing false negatives by the analysis 
of serum for MMA. However, because of the possibility of 
very high serum MMA concentrations due to liver damage, 
this marker can not be recommended for use in the 
diagnosis of Co deficiency in a flock, on the basis of a 
small number of samples. For diagnosis in this situation, 
10 per cent or at least 30 sheep in a flock should be 
sampled.
Although serum MMA concentrations provide the most 
accurate marker of Co deficiency,’ serum B12 levels are a 
sensitive indicator of Co intake. The analysis of serum 
B12 is also cheaper than the determination of serum MMA. 
Thus, if Co deficiency is to be indicated prognostically 
as well as diagnostically, then the dual analysis of sera 
for B12 and MMA content is necessary.
If serum B12 concentrations are used as a diagnostic 
marker, determination by either the microbiological assay
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using Lj^  leichmannii as the test organism, or the RIA 
(Becton and Dickinson) is adequate. However, care must be 
taken in the choice of diagnostic criteria which may be 
applied to data obtained from these techniques. The 
criteria must be relevant to the method employed, the 
diet fed and the physiological state of the sheep. For 
pregnant ewes fed a ration high in concentrates, the 
range 160 ng B12/1 serum to 340 ng/1 should be used for 
the diagnosis of sub-clinical Co deficiency with the RIA. 
For the same sheep fed a roughouge type diet, the range 
200 to 400 ng/1 can be employed to indicate sub-clinical 
disease, regardless of the analytical technique used.
The results of Chapter 4 suggested that the analysis of 
serum B 12 or MMA concentrations in blood samples 
collected around the time of supplementary feeding, could 
yield false diagnoses of Co deficiency. Although the 
small housed experiment with wethers did not indicate the 
presence of endogenously stimulated diurnal fluctations 
in serum B 12 or MMA levels, marked changes in the 
concentrations of these two markers were caused by the 
exogenous stimulation of twice daily feed intake. Thus, 
where supplementary feed is offered to pregnant ewes, 
sampling for diagnostic purposes should only be 
undertaken outwith the time period of one hour before and 
two hours after the provision of such feeds.
The results of Chapter 7 suggest that the use of serum 
B12 concentrations alone, determined in blood samples 
taken at one point during gestation, is inadequate for
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diagnosing the Co status of a flock of ewes over the 
whole of tupping, pregnancy and lactation. For the 
provision of accurate advice to farmers, the Co status of 
a flock should be monitored throughout the breeding 
season, by analysis of serum B12 and MMA levels. However, 
such an approach is impractical and will not prove cost 
effective. Thus, diagnostic sampling should be undertaken 
during the grass growing season previous to tupping. 
This will ascertain the Co status of a flock when soil 
contamination of the herbage is low, and when Co status 
is likely to be at its lowest. Sampling at such a time 
will determine the likelihood of Co deficiency occurring 
in the flock during the year and will enable the most 
accurate and cost effective advice to be given to the 
farmer.
8.2 THE EFFECTS OF COBALT DEFICIENCY IN THE PREGNANT EWE.
The results of Chapter 5 suggested that sub-clinical Co 
deficiency in pregnant ewes can lead to a depression in 
pre- and post-natal lamb viability. Co-deficient ewes 
have a higher incidence of reabsorptions, abortions and 
stillbirths, compared to sufficient controls. Lambs from 
Co-deficient ewes are less vigorous and have a higher 
incidence of morbidity and mortality, than those from 
sufficient dams.
The results of Chapter 6 suggested that Sub-clinical Co 
deficiency also has a detrimental effect on the immune
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status of ewes and neonate lambs. Deficient ewes show a 
50 per cent reduction in neutrophil microbicidal 
activity, compared to sufficient controls. Less vigorous 
lambs from sub-c1inically Co-deficient ewes obtain a 
lower level of passively acquired immunity and vitamin 
B12, than those from sufficient dams. The effects of low 
serum B12 concentrations in neonate lambs are not clear. 
However, the increased morbidity and mortality in lambs 
from Co-deficient ewes, is associated with increased 
susceptibility to infection as a result of the depression 
in the level of passively acquired immunity.
These detrimental effects were evident irrespective of 
whether the ewes had been sub-clinically Co-deficient for 
either the first or second halves of pregnancy only. 
However, they were most marked if the sheep had been 
deficient for the whole of gestation. Thus, full 
protection from the adverse effects of Co deficiency 
would only be afforded if ewes in Co-deficient areas were 
supplemented during the whole of tupping, pregnancy and 
lactation.
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In the tables of this thesis, denotes a significant
difference at P<0.05, at P<0.01 and '***' at
P<0.001.
APPENDIX 1.
Mean Serum Vitamin B12 Concentrations (ng/1) in the Ewes 
of Experiment 1, Analysed by the Microbiological Assay.
DAY OF 
EXP. NS
TREATMENT
HS FS
SIG.
DIF. SED
0 613® 797® 1 0 0 1 ® NS 146
14 457® 609® 589® NS 116
27 369® 594® 681® NS 1 0 2
41 442® 1158^ 1208b * * * 115
55 375® 1358^ 1 3 9 9 b * * * 176
70 354® 843^ 8 6 7 b * * * 93
90 396® 765^ IIO9 C * * * 113
104 227® 4 1 4 b 9 4 3 C * * * 87
119 275® 4 1 9 b 5 5 4 C * * * 47
133 145® 197® 5 3 2 b * * * 35
146 258® 237® 79lb * * * 67
161 348® 251® 7 7 2 b * * 184
175 2 1 2 ® 239® 5 5 3 b * * 124
189 149® 199® 65lb * * * 149
Means in rows with different superscripts differed 
significantly.
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APPENDIX 2.
Mean Serum MMA Concentrations (umol/1) 
Experiment 1.
in the Ewes of
DAY OF 
EXP. NS
TREATMENT
HS FS
SIG.
DIF. SED
0 2.45® 2.38® 2.40® NS 0.13
14 2.50® 2.48® 2.45® NS 0 . 1 0
27 2.59® 2 .61® 2 .6 6 ® NS 0.05
41 2.79® 2.90® 2 . 80® NS 0.19
55 3.07® 2.92® 3.14® NS 0 . 18
70 3.15® 3.11® 3.04® NS 0.09
90 3.22® 3.19® 3.16® NS 0.03
104 3.57® 3.3lb 3 .2 0 C ■k 0 . 0 1
119 4.77® 3 .7 9 b 3 .O3 C * * * 0 . 05
133 5.14® 3 .8 9 b 3.40b * * * 0.39
146 6 .0 2 ® 4.4lb 3 .4 9 b ** 0.59
161 6.24® 7.60® 3 .5 4 b * * 0.99
175 7.44® 9 . 85® 3 . 6 2 b * 2 . 1 0
189 8.78® 4.83® 3 .4 3 b ■k k 1.71
Means in rows with different superscripts differed 
significantly.
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APPENDIX 3.
Mean Serum Vitamin B12 Concentrations (ng/1) in the Ewes
of Experiment 2, Analysed by the Microbiological Assay.
DAY OF 
EXP. NS
TREATMENT
HS FS
SIG.
DIF. SED
0 2152® 2383® 2329® NS 181
14 1545® 1559® 1955® NS 2 2 0
26 1398® 1449® 1671® NS 208
42 406® 444® 517® NS 77
56 509® 436® 7 lib * * * 71
70 425® 401® 700b * * * 64
84 235® 228® 348b ■k k  -k 2 2
98 231® 234® 56?b * * * 50
119 199® 2 1 0 ® 3 9 5 b k  k  k 27
133 152® 2 2 0 ® 6 8 lb k k k 63
147 187® 206® 5 1 3 b k  k  k 59
161 161® 165® 6 2 5 b k k k 36
175 108® 308^ 496^ k k k 73
189 98® 3 2 9 b 598^ k k k 92
204 91® 498b 560b k k k 1 0 2
218 171® 48lb 7 4 3 C k k k 1 2 2
232 173® 5 1 2 b 610b k k k 1 0 0
246 162® 718b 816b k k k 147
260 184® 730b 9 7 5 b k k k 215
M e a n s  in rows w i t h  d i f f e r e n t  s u p e r s c r i p t s  d i f f e r e d
significantly.
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APPENDIX 4.
Mean Serum Vitamin B12 Concentrations (ng/1) in the Ewes
of Experiment 2, Analysed by the RIA.
DAY OF 
EXP. NS
TREATMENT
HS FS
SIG.
DIF. SED
0 1550® 1773® 1860® NS 205
14 1241® 1303® 1433® NS 145
26 887® 710® 884® NS 109
42 392® 344® 397® NS 59
56 389® 363® 466® NS 48
70 340® 344® 536b * * 57
84 235® 178^ 3 0 5 C ■ k k k 26
98 176® 192® 428b k k k 35
119 159® 193® 41lb k k k 29
133 158® 186® 495® * * * 41
147 198® 172® 600b k k k 51
161 158® 169® 558b k k k 34
175 109® 26lb 40 3 C k k k 55
189 1 0 1 ® 2 9 4 b 470^ k k k 65
204 53® 4 3 7 b 5 2 5 C k k k 76
218 193® 40sb 613® k k k 89
232 163® 4 6 5 b 57lb k k k 104
246 137® 6 7 5 b 7 9 4 b k k k 150
260 143® 60ob 782b k k k 161
M e a n s  in rows w i t h  d i f f e r e n t  s u p e r s c r i p t s  d i f f e r e d
significantly.
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APPENDIX 5.
Mean Serum MMA Concentrations (umol/1) in the Ewes of
Experiment 2.
DAY OF 
EXP. NS
TREATMENT
HS FS
SIG.
DIF. SED
0 1.28® 1.28® 1.14® NS 0.28
14 1.80® 1.49® 1.76® NS 0.33
26 1.83® 1.43® 2 .1 1 ® NS 0.38
42 1.29® 1.49® 1.54® NS 0.33
55 1.93® 1.41® 1.70® NS 0.32
70 2.44® 1,85® 1 .2 2 ® NS 0.43
84 3.31® 3.43® 1. 85® NS 0 . 69
98 4.19® 3.94® i.ieb * * * 0 . 85
119 6.28® 4 . 80® 1 .2 4 b ■ k k k 1.25
133 5.41® 5.08® 1 .2 2 b k k k 1.33
146 8.04® 6.40® 1.50b k  k 2 . 0 0
161 6.56® 6.15® 1 .5 4 b k k k 1.16
175 16.59® 5.76^ 2 .7 7 b k k k 2.85
189 13 .17® 2 .0 2 b 1.36b k k k 3.34
204 18.68® 1 .9 9 b 2 .3 4 b k  k 6.35
218 11.17® 2 .0 7 b 1 .5 5 b k k k 2 . 1 0
232 33.99® 2 .4 3 b 1 .6 8 b k k k 8 . 0 0
246 46.06® 2 .6 3 b 1 .8 3 b k k k 9.34
260 145.24® 3 .0 5 b 2 .8 9 b k k k 38.26
Means in rows with different superscripts differed
significantly.
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APPENDIX 6^
Mean Serum Vitamin B12 Concentrations (ng/1) in the 
Wethers Throughout the Experimental Period, Sampled
Before the Morning Feed.
DAY OF 
EXP. +Co
TREATMENT
-Co
SIG.
DIF. SED
0 >1250 >1250 NS
1 0 1136 713 * 117
16 >1250 1193 NS 57
23 955 595 NS 199
29 >1250 1190 NS 37
37 1213 1028 NS 142
44 663 343 ■k * 8 6
50 793 550 NS 138
58 >1250 538 ■ k k k 1 0 0
73 1025 373 k  k 150
79 530 240 k  k 63
85 601 320 k  k 75
94 683 229 k 156
98 495 259 k  k 69
99 633 304 k 123
1 0 0 606 238 k 114
1 0 1 861 330 k 163
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APPENDIX 7.
Mean Serm MMA Concentrations (nmol/I) in the Wethers 
Throughout the Experimental Period, Sampled before the
Morning Feed.
DAY OF 
EXP. +Co
TREATMENT
-Co
SIG.
DIF. SED
0 1.78 2.26 NS 1.50
10 1. 03 1.46 NS 0.64
16 2.46 2 . 82 NS 0.61
23 2.46 2.25 NS 0.67
29 2.61 3.21 NS 0.60
44 2.33 3 . 65 NS 1.05
50 2.93 2 . 88 NS 0.71
58 2.14 3.56 NS 0 . 62
73 1.66 3.66 NS 0.74
79 2.76 6.26 NS 1.93
85 3.18 7.29 NS 2 .45
94 2.78 8.70 * 2.24
98 3.47 5.62 NS 1.49
99 3.20 7.84 NS 2.37
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APPENDIX 8.
Serum Vitamin B12 Concentrations (ng/1) in the 8 Wethers
at each Sampling Time on Day 50.
SAMPLING
TIME 1 2 3 
+Co
ANIMAL NUMBER 
4 5 6 7
Co
8
08:43 770 1050 490 860 400 740 480 580
Feeding between 08:52 and 09:30
09:15 780 1050 490 860 440 820 440 600
10:08 670 950 480 830 400 740 400 510
10:56 730 990 530 900 410 750 440 590
12:15 760 1090 530 780 420 750 235 600
13:13 800 940 400 650 480 670 330 430
14:06 620 910 440 690 320 560 360 420
15:06 740 960 500 660 300 610 400 400
16:06 840 1020 560 660 310 620 400 400
16:37 840 1140 600 780 300 610 450 430
Feeding between 16:50 and 17:20
17:13 840 1080 600 2000 320 650 1320 430
18:08 760 1070 640 600 430 660 430 380
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APPENDIX 9.
Serum MMA Concentrations (umol/1) in the 8 Wethers at
each Sampling Time on Day 50.
SAMPLING ANIMAL NUMBER
TIME 1 2 3 4 5 6 7 8
+Co -Co
08:43 4.02 2 .10 3.98 1. 62 3.77 2.45 2.29 3.01
Feeding between 08: 52 and 09 : 30
09:15 4.08 2.36 3.63 1.84 3.33 2.65 2.82 3.54
10:08 4.45 2.40 4.22 2.92 3.63 3.08 3.09 5.55
10:56 4.49 1.76 4 . 64 2.34 3.72 3.21 3.54 4.57
12:15 4.46 2.72 3.99 2.28 3.86 2.92 2 .86 4.35
13:13 1.74 2.78 4.10 2.47 3.80 3.60 2.91 3.78
14:06 3.52 3.63 3.93 2.29 3.48 3 .13 2.81 3 . 85
15:06 1.90 2.69 4.24 2.40 3.99 3.53 3.31 2.42
16:06 3.59 2.44 4.25 2.52 2.33 3.32 3.22 4.12
16:37 1.52 1.63 1.51 1.02 3.25 2.97 1. 39 2.02
Feeding between 16: 50 and 17:20
17:13 3.84 1.09 1.86 3.08 1. 72 1.44 3.10 4.63
18:08 1.47 1.17 4.52 1.08 3.82 1.79 1. 32 4.41
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APPENDIX 10.
Mean Serum Vitamin B12 (ng/1) and MMA (umol/1)
concentrations in the Wethers at each Sampling Time on
Day 9 8.
SAMPLING
TIME
VITAMIN B12 
+Co -Co SIG. SED +Co
MMA
-Co SIG. SED
08:54 495 250 * 69 3.47 5 . 62 NS 1.49
Feeding between 09:00 and 09 : 30
09:45 533 213 * 107 3 .88 7.57 NS 3.11
10:50 510 218 * * 69 4. 14 10.73 NS 2 . 84
11:50 475 235 * 83 4.01 10.27 NS 2 . 75
12:50 483 225 * 78 4.00 10.15 NS 3.45
13:50 465 210 ** 66 4.05 10.28 NS 2.91
14:50 486 229 * 82 4.30 10.31 NS 2.81
16:15 453 203 * * 42 3.56 9.75 k 2.02
Feeding between 16:30 and 16:55
17:16 418 208 * * 52 4.42 11.36 NS 3.00
18:10 415 218 * 62 4.48 11.64 NS 3.61
20:14 400 198 * 69 3.88 10.23 NS 3.14
22:17 463 220 * * 63 3.83 9.81 NS 2.85
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APPENDIX 11.
Mean Serum Vitamin B12 (ng/1) and MMA (umol/1)
Concentrations in the Wethers at each Sampling Time on
Day 9 9.
SAMPLING
TIME
VITAMIN 
+Co -Co
B12
SIG. SED +Co
MMA
-Co SIG. SED
08:56 633 304 * 123 3.20 7.84 NS 1.94
09:56 649 249 * * 83 3.55 8.47 k 1.99
10:59 574 191 * * 89 3.76 8 . 80 NS 2.08
Feeding between 11 : 03 and 11:40
12:02 488 156 * 127 4.00 12.02 k 2.44
13:04 445 111 * * 55 4.17 10.54 k 2.27
14:05 418 206 NS 87 4 .40 10.44 k 2.37
15:07 970 341 * 177 4.42 10.46 k 2.28
16:03 1138 340 kk 124 3.82 10 .23 k 2.23
17:04 738 355 NS 213 3.82 10 .23 k 2.50
18:05 433 166 * 64 3.95 9 . 60 NS 2.41
Feeding between 18 : 30 and 18:35
19:06 289 116 k 58 4.03 10 . 15 k 2.37
20:11 325 143 k 70 4.12 9.86 NS 2.49
22:16 374 129 k k 51 3.91 9.06 NS 2.39
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APPENDIX 12.
Mean Liveweight (Kg) and Condition Score of the Ewes
in Experiment 1.
DAY OF LIVEWEIGHT
EXP. NS HS FS
CONDITION SCORE 
NS HS FS
0 52 .1 51.5 50.2 2.63 2.79 2.69
14 50.7 51. 6 50.5 2 . 64 2 . 88 2 .78
26 52.5 52.5 51.4 2 . 80 2.97 2.81
41 51.9 52.2 51.6 2 . 72 2.92 2.84
55 51.3 50.4 50.2 2 .76 2.86 2.78
70 51.8 52.1 51.8 2.83 2.87 2.84
90 52.9 51.3 51.8 2.82 2.88 2.98
104 54.5 53.9 55.3 2.98 2 . 88 3 . 08
119 59.8 57.1 59.2 2.88 2.76 3.03
133 62.9 60. 6 62.8 2.95 2.89 2.89
161 52.3 52.9 54.3 2.38 2.50 2.34
175 54.3 54. 3 55.5 2 . 45 2 .58 2 .48
189 52.9 55.8 56.4 2 .50 2.72 2.72
316
APPENDIX 13.
The Use of Chi-Squared in the Statistical Analysis of Ewe
Fertility and Gestational Performance Data.
E x a m p l e  f r o m  E x p e r i m e n t  1 - L a m b i n g  p e r  c e n t  t o  4 W e e k s .
Contingency Table.
1 NS
TREATMENT
HS FS
1. No : of ewes with 0 lambs at 4 weeks PP 14 5 5
2. No : of ewes with 1 lamb at 4 weeks PP 5 13 11
3. No : of ewes with 2 lambs at 4 weeks PP 1 2 4
PP = post partum
NS HS FS ROW TOTAL
1. 14
(8.0)
5
(8.0)
5
(8 .0)
24
2. 5
(9.7)
13
(9.7)
11
(9 •7)
29
3. 1
(2.3)
2
(2.3)
4
(2 .3)
7
COLUMN TOTAL 20 20 20 60
'Expected' values (in brackets) =
Row Total X Column Total 
Overall Total
Chi-squared =
(Observed - Expected)^ 
Expected
(The sum of)
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Total Chi-squared = 4.50 + 1.12 + 1.12 +
2.25 + 1.15 + 0.18 +
0.76 + 0.05 + 1.19 +
= 12.34 (P<0.05)
Degrees of freedom = (3-1) X (3-1) = 4
Critical values of Chi-squared with 4 degrees of freedom
at P<0.05, P<0.01 and P<0.001 are 9.49, 13.28 and 18.46,
respectively.
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APPENDIX 14.
The Use of Chi-Squared in the Statistical Analysis of the
Lambing Records,
Example from Experiment 1 - Neonatal Mortalities.
Contingency Table,
TREATMENT 
NS HS FS
1. No: of lambs living at 4 weeks pp 10 16 20
2. No : of lambs dying before 4 weeks pp 9 1 1
pp = post partum
NS HS FS ROW TOTAL
1. 10 16 20 46
(15.3) (13.7) (16.9)
2. 9 1 1  11
(3.7) (3.3) (4.1)
COLUMN TOTAL 19 17 21 57
Total Chi-squared = 1.86 + 0.38 + 0.55 +
7.76 + 1.59 + 2.30
= 14.43 (P<0.001)
Degrees of freedom - (2-1) X (3-1) = 2
Critical values of Chi-squared with 2 degrees of
freedom at P<0.05, P<0.01 and P<0.001 are
13.82, respectively.
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APPENDIX 15.
The Statistical Analysis of Lamb Birthweight Data, 
Accounting for different Numbers of Single and Twin
Births in each Treatment,
Example from Experiment 1.
Raw birthweight (Ka) data.
NS
TREATMENT
HS FS
3.6,3.8 4.1,4.2 3.3,3.0
4.1,4.7 3.8,3.4 5 . 6, 4 . 6
4.8,3.5 5.5 3.0,5.2
5.5,4.0 5.5 4.4,3.9
5.4 5.4 4.5,5.5
5.8 5.4 5.4
6.2 5.7 5.6
5.5 5.3 5.6
5.3 6.3 5.2
5.3 6 . 0 5.4
3 . 8 6 . 0 5.4
6 . 8 5.0 5 . 2
6.1 2.7 7.0
5.1 3.8 5.7
5.9 3.6 5.5
5.8
No: of recordings 19 17 21
Crude means 5.0 4.8 5.0
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Birthweights shown together relate to twins. Those 
shown alone relate to single births. The data were 
analysed using the EDEX statistical computing package, 
devised for animal experimentation by the Animal Research 
Council, Edinburgh. Birthweights were analysed by a two 
way analysis of variance, with the number of singles and 
twins separated as blocks. Variation due to single and 
twin births could thus be eliminated from analysis of 
variance due to differences in birthweight. The means 
were adjusted by the computing package, according to the 
number of single and twin births occurring in each 
treatment.
Analysis of variance.
VARIABLE DF S3 MS F PROBABILITY
Blocks 1 21.9882 21.9882 36.038 ***
Treatments 2 3.1118 1.5559 2.550 NS
Blocks/
Treatments
2 0.2219 0.1110 0.182 NS
Error 51 31.1171 0.6101
Total 56 56.4389
Coefficient of Variation - 15.81 per cent
Adjusted means
NS = 5.1 HS1 = '4.6 FS = 5. 1 Average SED = 0.26
There was a significant 
between singles and twins.
difference in birthweights
There were no 
for birthweight
significant differences among treatments
There were 
twin births
no
and
significant 
treatments.
interactions between single/
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APPENDIX 16.
Mean Liveweight (kg) 
in
and Condition 
Experiment 2.
Score of the Ewes
DAY
EXP
OF
NS
LIVEWEIGHT
HS FS
CONDITION SCORE 
NS HS FS
0 56.2 56.5 56.6 2.48 2 . 50 2 . 60
14 57.6 55.7 54.4 2.66 2.79 2.58
26 57.3 56.4 53.3 2.76 2.75 2.54
42 57.1 57.7 54.5 2 . 80 2 .80 2 . 68
55 58.0 57.4 55.4 2.74 2.79 2.66
70 59.5 58.7 55.7 2 .81 2.85 2.74
84 60.3 58.2 55.8 2.99 2 . 90 2 . 85
98 58.3 57 . 0 54.9 2.90 2.81 2.75
119 57.0 55.7 54.9 2.96 2.90 2.86
133 58.7 55.7 56.0 2 .86 2.94 2 .90
146 59 .0 57 . 6 55.7 2 . 89 2.91 2.85
161 59.7 58.1 57.5 2.90 2.94 2.94
175 61.1 60.0 58.7 2.89 3.10 2.89
189 60.7 60.2 59.4 2.82 3.03 2.89
204 62.2 62.5 61.2 2 . 74 2 . 90 2 . 84
218 60.4 62 . 8 60 . 6 2 .73 3 . 06 2 . 92
232 65 . 3 67.9 65.2 3.05 2.75 2 . 87
246 68.1 69.1 70.7 2.82 3 .15 3.21
260 56.5 59 .2 59.0 2.48 2.82 2.55
322
APPENDIX 17
from the Ewes of Experiment 1 at each Sampling Date.
DAY OF 
EXP. NS
TREATMENT
HS FS
SIG.
DIF. SED
0 34.75® 45.00® 40.25® NS 4.91
14 48.50® 53.25® 50.50® NS 4.06
27 51.00® 50.00® 46.00® NS 3.86
41 38.25® 41.50® 38 .50® NS 2 .14
55 45.50® 47.00® 43.25® NS 2 . 63
70 28.75® 36.2 5 b 3 6 .7 5 b * * 3.08
90 25.50® 37 .50b 39.50b * * * 5.00
104 32.75® 44.50b 4 5 .2 5 b * * 4.91
119 30.75® 34.50® 43.75® NS 6.38
133 31.00® 4 4 .2 5 b 5 I.2 5 C * * * 6.29
146 24.00® 27.00® 4 4 .7 5 b * * * 7 .12
161 28.00® 3 1 .2 5 b 4 9 .2 5 C * * * 7 . 03
175 24.25® 31.00b 49.00^ * * * 7 .85
189 21.75® 20.50® 46 ,50b * * * 9.53
Means in rows with different superscripts differed 
significantly.
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APPENDIX 18.
Mean Per Cent Kill of C_^  albicans by Neutrophils Isolated 
from the Ewes of Experiment 2.
DAY OF 
EXP. NS
TREATMENT
HS FS
SIG.
DIF. SED
26 54.50® 52.75® 55.75® NS 1.83
42 52.25® 49.50® 47.25® NS 3.37
55 50.75® 49.25® 53.25® NS 3.87
70 44.25® 44.25® 50.00® NS 2.39
84 38.00® 41.50® 46.50® NS 4.17
98 29.25® 34.25® 5 1 .7 5 b ** 4.22
119 23.50® 28.00® 5 0 .7 5 b * * * 2 . 67
133 31.50® 2 5 .2 5 b 58.25C * * * 2.59
146 2 1 .0 0 ® 24.25® 52.50b * * * 3.57
161 28.50® 26.75® 56.00® * * * 4.08
175 25.00® 3 5 .2 5 b 56.00^ * * * 3.91
189 27.75® 50.00b 48.25b * * * 3.66
204 23.25® 4 7 .0 0 b 58.00® * * * 4.36
218 27.50® 49.50b 52.00b * * * 4.41
246 27.50® 49.50b 52 .7 5 b * * * 2 .93
260 31.00® 50.50b 5 0 .2 5 b * * * 2.38
Means in rows with different superscripts differed 
significantly.
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